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Abstract 
The renin angiotensin system plays a pivotal role in maintaining 
mean arterial blood pressure, and body fluid homeostasis. Renm catalyses 
the initial reaction in the renin-angiotensin cascade, producing the 
vasoactive peptide Ang II, from angiotensinogen. The release of active 
renin, from the juxtaglomerular cells (JG cells) of the kidney, is strictly 
regulated by a plethora of external stimuli, working in concert to maintain 
blood pressure. 
Cell culture experiments, to elucidate regulatory mechanisms 
involved in renin release, are hindered due to the lack of suitable renin 
expressing cell lines. The As4.1 cell line expresses its endogenous renin 
gene Ren1C,  constitutively secretes prorenin into the supernatant, but can 
no longer be stimulated to release active renin. Primary JG cell cultures 
lose their renin activity within 3 weeks of culture, and since they are only 
an 80% pure JG cell population, these cultures have limitations. Therefore 
there is a requirement for a cell line which can be stimulated to secrete 
renin, but which is as close to a pure primary JG cell culture as possible. 
This thesis describes the generation of modified genomic clones and 
their use to generate transgenic animals, which express the 13-Geo reporter 
gene in Ren-1" expressing cells. The bacterial artificial chromosome (BAC) 
clone, N10, spans both Ren-1 and Ren-2, and may contain sufficient 
flanking sequences to confer site independent expression of both renin 
genes. The reporter construct was inserted between exons 3 and 4 of Ren-1 
by intermolecular recombination in bacteria. An initial linear 
recombination approach produced many false positive clones, indicating a 
requirement for negative selection. However the BAC targeting strategy, 
utilising a temperature sensitive suicide vector successfully introduced the 
reporter construct within Ren-1 without introducing any additional 
modifications. Intermolecular recombination was also utilised to 
introduce site specific mutations into Ren-1, but despite the isolation of 
numerous co-integrations, resolved clones did not contain the mutated 
sequences, suggesting a different screening strategy is necessary. 
The transgenic mouse, TGM(N1ORn1/3Geo), is the first transgenic 
animal to express a reporter gene in renin expressing tissues, which is 
expressed throughout development and putatively in the adult. This 
transgenic line should facilitate the isolation of pure primary JG cells, by 
FACs sorting and selection with G418, in addition to generating 
conditionally immortal renin expressing cell lines, by crossing these 
animals with the immorto mouse. The expression of 13-Ceo in the 
developing kidney provides the means to study the role of the RAS in 
vascular and kidney development. Furthermore N1ORn113-Geo could be 
used to identify those elements involved in site independent expression of 




1.1 The renin angiotensin system 
The renin angiotensin system (RAS) is intrinsically involved in 
arterial blood pressure regulation and electrolyte composition of body 
fluid (1-4); (Figure 1.1), and a disruption in this system, either 
physiological or genetic, has been implicated in the pathogenesis of 
hypertension, cardiac hypertrophy, diabetes and renal disease (5-9). 
There are several lines of evidence which suggest that the RAS is an 
important regulator of blood pressure: 1) the injection of renm causes a 
direct increase in blood pressure in rabbits (10) and rats (11); 2) the 
observation that transgenic rats harbouring the mouse Ren-2 gene 
develop fulminant hypertension (12), which can be alleviated by the 
administration of angiotensin converting enzyme inhibitors, bringing 
blood pressures back within the normal range (12); 3) the use of specific 
antibodies to renin and angiotensinogen reduces blood pressure (13, 14). 
1.1.1 The systemic RAS 
The classical endocrine RAS is concerned with regulating mean 
arterial pressure. Renin is released into the circulation from 
juxtaglomerular cells located in the afferent arterioles of the kidney. Once 
present in the circulation it converts its only known substrate, the liver 
derived a2-globulin, angiotensinogen, to the decapeptide, angiotensin I 
(AngI).. AngI is subsequently cleaved to the active octapeptide angiotensin 
II (Angli), by angiotensin converting enzyme (ACE), present on the 
endothelial cells of the lungs and vasculature (15, 16). AnglI has 
widespread vasoconstrictor activity, increasing total peripheral resistance 
and also stimulates the adrenal cortex to release aldosterone. Angli causes 
an increase in blood pressure by increasing sodium reabsorption from the 
distal tubule, which in conjunction with the consequential increase in 
water reabsorption, increases blood volume (2-4). 
2 
Figure 1.1 The reniri-angiotensin system 
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1.1.2 AngIl receptors 
Angil has a plethora of activities which include controlling vascular 
tone, hormone secretion, tissue growth and direct stimulation of the 
autonomic nervous system (2, 17). Such diversity is mediated through the 
two different subgroups of Angli receptors AT 1 and AT2 (18, 19). AT 1 
receptors (AT1 R) are coupled to phosphatidylinositide hydrolysis via a G 
protein mediated stimulation of phospholipase C (9, 20), inducing rapid 
phosphorylation of tyrosine kinases (9, 20-22). There are two subtypes of 
AT 1 R, AT1AR and AT1BR, which are involved in vasoconstriction, 
aldosterone secretion, pressor and tachycardiac responses and are 
specifically blocked by losartan, an Angli antagonist (DuP753) (19). Both 
genes have been cloned (23-25), and are 95% homologous at the amino 
acid level. AT 1A R is mainly located in the vascular smooth muscle cells 
(VSMC), lung, liver and heart, with AT 1B R prevalent in the adrenal, 
pituitary and uterus (25, 26). 
The signalling and function of the AT2 receptor is largely unknown, 
though it can be blocked by the synthetic peptide PD123177. The AT 2R has 
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been cloned (27, 28) and has 34% sequence homology with AT 1 . AT2 R is 
predominantly expressed in foetal tissues, immature brin, skin wounds 
and atretic ovarian follicles, suggesting a role in growth and 
development. 
1.1.3 The juxtaglomerular apparatus 
The juxtaglomerular apparatus (JGA) (Figure 1.2) is located at the 
vascular pole of the renal corpuscle. It is comprised of the afferent and 
efferent glomerular arterioles, the renin expressing granular cells (29), the 
macula densa (MD) cells of the distal tubule (30) and the Goormaghtigh's 
cell field, or extraglomerular mesangial cells (31), which are contiguous 
with the glomerular mesangium (32-34). The JGA is involved in blood 
pressure regulation, and it was Golgi, in 1898, who first proposed the 
theory that the JGA could participate in autoregulation, after observing 
that the distal tubule returns to its glomerulus of origin. 
The JGA maintains blood pressure through the release of renin from 
the granulated, renin expressing, modified smooth muscle cells. These 
cells represent the principal source of plasma active renin (2), and are 
known as juxtaglomerular cells (JG  cells). Two types of granular cells are 
observed by microscopy epitheloid and intermediate cells. Epitheloid cells 
are fully transformed smooth muscle cells (SMC), located at the distal 
portion of the afferent arteriole. They are identified by the cytoplasmic 
dense secretory granules, which contain active renin (35, 36), a well 
developed Golgi apparatus and rough endoplasmic reticulum, with barely 
any myosin or thick myofilaments (37, 38). Intermediate cells are, as the 
name suggests, an intermediate cell type between VSMC and epitheloid 
cells. They possess myofilaments and attachment sites, along with renin 
containing secretory granules (37, 38), and represent the majority of renin 
expressing cells. The efferent arteriole and individual cells of the 
Goormaghtigh's cell field have been identified to express renin. 
Additionally renin staining can be identified throughout the afferent 
arteriole in hypotensive conditions, and so the term granulated 
(granular), or renin expressing cells of the kidney is generally used (33, 
39). However in the context of this thesis they shall be referred to as JG 
cells. 
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Figure 1.2 The juxtaglomerular apparatus. 
The JGA consists of the afferent (AA), and efferent (EA) arterioles, the macula densa cells 
(MD) of the distal tubule, in contact with the granular renin expressing cells (JGC), and 
the Goormaghtigh cell field. Nerve axons (N) innervate both the afferent and efferent 
arteriole. 
This figure is a modification of the picture from Gorgas (40). 
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The number of renin expressing cells along the afferent arteriole, 
increases in physiological conditions which stimulate the RAS and by the 
use of RAS inhibitors (33, 41). This process is termed metaplastic 
differentiation which involves the recruitment of smooth muscle cells 
into renin expressing phenotype, as demonstrated by Cantin et al (42). In 
addition to an increased number of renin expressing cells there is an 
increase in renin content (43-46), which is thought to suggest a 
quantitative correlation between renin release and content. 
1.1.4 The regulation of renin release 
The release of renin from the JGA is strictly regulated, and 
controlled by a variety of factors. 
1.1.4.1 Macula densa mechanism 
The macula densa cells, named by Zimmermann (30), are situated in 
the distal tubule. They appear, under light and electron microscopy, to 
have an intimate anatomical contact with the JG cells (37, 47), separated by 
an incomplete basement membrane, with cytoplasmic bridges between 
them (47). It has been postulated that this relationship might permit 
sampling of the macula densa fluid or transferal of information 
concerning its composition to the granular cells (48, 49). The MD plays a 
major role in regulating renin release for each individual nephron, and is 
responsible for the modulation of renin release in response to changes in 
dietary sodium, known as the tubuloglomerular feedback mechanism. 
Vander and Miller (50), observed that renin release was inversely 
proportional to the sodium delivered to the MD. Skott and Briggs (51) 
observed a dramatic increase in renin release when macula densa cells, 
still connected to the JGA, were perfused with a low sodium solution but 
not when isotonic saline was used. 
The mechanisms by which the MD senses the sodium chloride 
concentration is unclear, although sodium chloride transport is believed 
to be important (52). Various messenger systems have been postulated as 
the signal from the macula densa, which stimulates release of renin from 
the granular cells (reviewed in (39, 53). These include: Ca 2 regulated by 
cAMP (54, 55); AngIl which is co-localised with renin in the granular cells 
(56-58) and adenosine (52) 
1.1.4.2 Renal baroreceptors 
The baroreceptor theory was first hypothesised by Tobian (32, 59) 
who suggested that since the JG cells are located in the media of the 
afferent arteriole, they are subject to the same changes in stretch that affect 
the wall of the afferent arteriole, and could thus act as stretch receptors 
(see (49) for review). An increase in blood pressure would stretch the 
granular cells and inhibit renin release, whereas low blood pressure 
would reduce granular cell distension and release renin. This theory is 
compatible with the observation that renin release was affected by small 
decreases in mean arterial pressure (lOmmHg), irrespective of changes in 
pulse pressure (50, 60-62). Blaine and colleagues developed the non 
filtering kidney model, which had no detectable glomerular filtration 
rate, but did have blood flow. Partial constriction of blood flow caused an 
increase in renin levels, indicating a renal arterial pressure-dependent 
mechanism (63). Kiil and co-workers suggest that the intrarenal 
baroreceptor is an emergency reaction stimulated at the limit of 
autoregulation, since the JG cells are located at the most distal portion of 
the renal arterial tree which will only undergo vasodilation at low 
arterial pressures (64, 65). Fray and Lush have directly demonstrated the 
function of the renal arteriolar baroreceptor (66). JG cells were layered on 
a latex grid and stretched by 112%. Renin secretion fell, but increased 
again when the stretch stimuli was removed, indicating that individual 
JG cells are able to change their rate of renin release in response to stretch. 
1.1.4.3 Angiotensin II and the hormonal control of renin release 
Circulating hormones are believed to regulate renin expression and 
its release. There is evidence to suggest that Angil negatively regulates its 
own production (49, 67-69), independent of a functional MD (70). Menard 
et a! (69), have also shown that a decrease in Angil was the major 
stimulator of renin release in humans given a renin inhibitor. 
Additionally, administration of ACE inhibitors, which prevent the 
conversion of AngI to Angli, results in an increase in renin secretion (41). 
7 
The inhibitory effects of Angli are thought to be mediated by increased 
permeability of JG cells to Ca 2 (71). 
Endothelial cells are in close contact with the renin expressing cells, 
and are known to release endothelin-1, a potent vasoconstrictor (72), 
prostaglandins, (mainly PCI2), and the endothelin-derived relaxing factor, 
nitric oxide (73-77). Endothelin-1 is thought to inhibit renin release, PCI 2 
is thought to relax SMC and stimulate renin release, whilst the role of NO 
is controversial (78-81). NO is also thought to play a role in metaplastic 
differentiation, since NO inhibition blunted the increase in renin 
immunostaining usually observed after Angli inhibition (82), implying 
that NO and Angli have opposing actions on renin release. Co-cultures of 
JG cells and bovine arterial endothelin cells, indicated that endothelial 
cells attenuate renin secretion induced by cAMP (83). Renin release 
stimulated by adenylate cylase (Forskolin treatment), is prevented when 
NO production is inhibited (84) indicating that endothelial cells might 
regulate cAMP stimulation of renin release in JG cells by NO. 
Increases in intracellular calcium are thought to cause a decrease in 
renin release from the JG cells, by tightening the sublemmal myofilament 
network, and decreasing the likelihood that the granules will pass 
through and be released (85). This is supported by the influx of Ca 2 into 
JG cells caused by an increase in arterial stretch (86). However renin 
release can be stimulated in primary JG cell cultures, by increasing the 
Ca 2 concentration in the culture medium (81). This phenomenon was 
also observed in permeabilised JG cells (87), suggested to be a result of a 
change in chloride concentration and that calcium's inhibitory effect on 
renin secretion might be due to a decrease in chloride concentration 
mediated through activated chloride channels (87). 
Additional hormones believed to effect renin release include: atrial 
natriuretic peptide, released from cardiac myocytes in response to atrial 
distension, which causes general vasodilation, and inhibits the release of 
aldosterone (88, 89), and renin from primary JG cultures (90); dopamine 
stimulates renin release (91, 92); acetylcholine is also thought to increase 
renin release mediated through NO (93). Bradykinin has been shown to 
have a stimulatory effect on renin secretion. However this is believed to 
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be indirect, since bradykinin stimulates the release of prostaglandins and 
nitric oxide (33). In addition kallikrein is thought to be a potential 
physiological activator of prorenin (94). 
1.1.4.4 Adrenoceptor and cardiopulmonary receptor control of 
secretion 
The afferent and efferent arterioles are highly innervated (95), and 
Vander (50) demonstrated that direct stimulation of the renal nerves 
caused renin secretion, which correlated with increased circulating 
catecholamines. This has also been demonstrated in renal slices (91, 96). 
This is thought to be effected through -adrenoceptors, since -agonists 
induce renin release (91, 96). Furthermore there is evidence to suggest 
that external cxl and 01-adrenoceptors are involved indirectly in renin 
secretion (97, 98), although whether the effect of cxl adrenoceptors is 
inhibitory (99) or stimulatory (100) is unclear. 
Cardiopulmonary receptors have been implicated in the stimulation 
of renin release (101), since a decrease in left or right atrium pressure 
increases renin secretion (102-104). However whether the atrial stretch 
induces renin secretion by activating cardiopulmonary receptors through 
the vagal nerves, (105) or through atrial natriuretic factor is unclear (39, 
106). 
1.2 The Mouse Renin Locus 
1.2.1 Organisation of the mouse renin locus 
The isolation of renin was facilitated by the fortuitous discovery that 
some inbreä mouse strains express reñin at high levels in the granulated 
ducts of the submaxillary gland (SMG) (107-109). SMG renin was purified 
to homogeneity and appeared indistinguishable from kidney renin, 
immunologically and physicochemically (11, 110-112). However this 
fraction was found to be heterogeneous with respect to isoelectric 
focusing, with molecular weights ranging from 36-43KDa (108). 
High SMG renin expression was believed to be due to a single 
genetic locus, a renin regulator (Rnr), located on chromosome 1 (109, 113, 
114), the expression of which was influenced by androgen and thyroxin 
(108, 115-118). Differences in the thermostability of SMG and kidney renin 
indicated that different isoforms may exist (119, 120). The presence of a 
second renin gene on chromosome 1, was identified by utilising cDNAs 
to SMG renin, to screen genomic libraries (121-125). This second gene was 
predicted to be the product of a recent gene duplication (122, 123, 125-127). 
Molecular cloning techniques led to the isolation of two distinct 
renin genes from genomic libraries derived from DBA/2J and C57BL/6J 
mouse strains. These two genes were subsequently designated Ren1d  and 
Ren1c respectively (122, 123, 125-129), with the duplicated gene called 
Ren-2 (120). The human and rat renin genes were also isolated from 
genomic libraries utilising the mouse renin cDNA as a probe (130, 131). 
Mapping of the duplication junction (132), indicated that a 21Kb 
fragment, comprising the ancestral gene flanked by 4.1Kb of 5' sequences 
and 7Kb of 3', was duplicated, thus separating the two genes by 11Kb. 
Subsequent insertions have occurred which have increased this distance - 
to 21Kb: a 3Kb fragment consisting of a deleted Intra-cisternal A particle 
(lAP) genome (a non infectious retrovirus-like structure) (133), which lies 
1Kb down stream of Ren-2; and a 7Kb Ml (mouse insertion) element, 
located 3.8Kb 5' of Ren-l" (134). Additional insertions which have 
occurred include: a Ren-2 specific B2 repetitive element located within 
the M3 element, situated 80bp 5' of the transcriptional start site; a 143bp 
M2 insertion which is also specific for the 5' of Ren-2; and a M4 insertion 
dspecific for RenV, which lies 400bp 3' of Ren-V. These insertions 
correspond to the lack of homology observed between the 5' sequences of 
Ren-1 and Ren-2 (118, 135, 136);.(Figure 1.3). Finally a Bi element, located 
within the 5' sequences, has been found to be conserved between all three 
mouse renin genes, and also located within the 5' flanking sequences of 
the rat and human renin genes (118, 135-137). 
The duplication event is thought to have occurred after speciation 
between rats and mice about 13 million years ago, followed by a 
subsequent deletion, which may have occurred between 1.2 million years 
ffel 
ago (126, 128, 133), and 2.75-5.5 million years ago (127,. 128, 131). 
Comparison of the renin locus of DBA/2J and a wild mouse strain Mus 
hortulanus, which has both Ren-1 and Ren-2 but lacks the subsequent 
insertion events, would suggest that the duplication occurred prior to the 
divergence of these two strains. Since the only difference in expression 
profiles between these two strains is the lack of expression of renin in the 
adrenal gland in Mus hortulanus the insertions do not influence renin 
expression in the SMG (138). 
The mouse and rat renin genes span approximately 10Kb and are 
comprised of nine exons separated by eight introns. The human renin 
gene has an additional exon which codes for 3 amino acids, termed 
exon5A. Comparisons of the three mouse renin genes revealed that Ren-
1 and Ren-1" are 99% homologous within the coding regions, whereas 
Ren1d and Ren-2" are only 97% homologous. The three renin proteins 
are approximately 97% homologous at the amino acid level (139), the 
major difference being the loss of three potential asparagine linked 
glycosylation sites in renin-2 (126, 135, 139, 140), which may account for 
the differences in thermostability between the proteins (119). Rat renin 
has the same three potential glycosylation sites whereas human renin 
only has the first two (130, 141). As a result of the insertion events, several 
restriction fragment length polymorphisms have been identified which 
can be utilised to distinguish between the renin genes (125, 142). 
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Figure 1.3. A comparison of the organisation of the renin locus from 
C57BL/6J,Mus hortulanus and DBA/2J 
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1.2.2. Structure of renin 
• Renin is an aspartyl protease and a comparison of the amino acid 
sequence of renin-2 with pepsin shows approximately 42% homology 
(126, 143). Aspartyl proteases are bilobal structures, related by a two-fold 
axis of symmetry (144), believed to have evolved after duplication and 
fusion of an ancestral gene (145) Two aspartyl residues at positions 32 and 
215 have been conserved in renin, which are essential for catalytic activity 
(146). However renin is unique since it has little protease activity at an 
acidic pH, with optimal activity observed at pH 7.0. 
Renin is synthesised as a single chain precursor, pre-prorenin, which 
is 1,600 amino acids long, and approximately 45KDa, identified and 
isolated by renin antibodies and purified Fab-fragments (112, 147). This 
45KDa protein is degraded to 43KDa in the presence of dog pancreatic 
microsomal membranes (148), the cleaved 2KDa peptide representing a 
'pre' or signal' peptide thought to be essential for secretion (149). In vivo 
the signal peptide is cleaved once the protein has been directed to the 
endoplasmic reticulum. The 43kDa pro-renin is either rapidly secreted in 
its pro form through the constitutive pathway, or packaged into 
immature granules and processed. Once stored, the 43KDa protein is 
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rapidly processed to a 38KDa protein followed by a slow intracellular 
process, converting the single-chain renin into a two-chain form. The 
heavy chain consists of 288 amino acids and the light chain 48 amino 
acids, which are held together by a single disulphide bond (11, 122, 140, 
148, 150). This two-chain form is 1/6th as active as the single-chain renin. 
In mice, both SMG renin and kidney renin are believed to be slowly 
hydrolysed to give a two chain form with a 33KDa and a 5KDa subunit 
(1481  149), with equivalent cleavage postulated to occur in the rat (131, 
151). Human renin has been shown to be hydrolysed to give 22KDa and 
18KDa subunits (152, 153), with cleavage occurring after the amino acids 
encoded for by the unique 5A exon, although no di-suiphide bridges have 
been identified (152, 153). The two-chain form of renin-2 is known to be 
secreted (154), however whether the two-chain form of renin-1, rat renin 
and human renin is secreted or represents a product of intracellular 
degradation is unclear. 
A 200KDa HMW renin has been observed in plasma, which has been 
identified as renin complexed to the renin binding protein (RnPB). The 
binding of active renin to the RnBP greatly reduces renin activity (111) 
and is thought to 'mop-up' excess plasma active renin. The cDNA 
encoding the RnBP has been isolated from human, porcine, and rat 
kidney cDNA libraries (117, 155, 156), and has a leucine zipper motif 
essential for renin-RnBP binding (117, 157). 
Inactive prorenin and active renin are both released from the JG 
cells. Prorenin is constitutively released via clear secretory granules, 
whilst renin release from mature granules is regulated. Renin activation 
has been localised to the immature granules by immunohistochemistry 
(36, 158), antibodies raised against the profragment were only observed to 
hybridise to the immature granules. Cathepsin B is believed to be the 
enzyme responsible for this activation, since it co-localises in the 
immature granules (159). Mature granules contain the 38KDa active renin 
protein which is believed to be slowly hydrolysed to the two chain form. 
Cathepsin D is believed to regulate the quantity of renin available for 
secretion, since cathepsin D was located in the mature granules by 
immunohistochemistry (160). The processing enzyme in the SMG has 
been identified as epidermal growth factor-binding protein, type B (mouse 
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kallikrein gene 13), which cannot process renin-1 (161). The role of 
secreted prorenin is unclear, though might act as a source of renin for 
tissue RASs. 
The 3D protein structure of the SMG renin and human renin were 
initially inferred from homology to other aspartyl proteases (126, 162, 163), 
but have subsequently been determined by X-ray crystallography which 
shows the profragment lying in the active site and thus inhibiting 
substrate access (164-166). Substrate specificity is achieved by residues on 
the surface of the enzyme adjacent to the active site. Subtle differences in 
subsites, between mouse and human renins, could account for species 
specificity. 
1.2.3.Expression profiles of renin 
Renin is first observed in the kidney of embryos at day 14.5 post 
coitus, associated with the newly developing vasculature. As the renal 
artery develops renin-expressing cells are restricted towards the more 
distal arteries, until after birth when renin expression is restricted to the 
classical JGA position (167-170). 
Renin expression is also observed in the adrenal gland at day 14.5p.c. 
peaking at day 15.5p.c., after which expression steadily declines in 
newborns until it reaches undetectable levels in the adult mice of one 
renin gene strains. In two renin gene strains, expression becomes limited 
to the developing inner cortex (169, 170). In addition, renin expression has 
been observed in subcutaneous tissue following the generation of 
subcutaneous tumours in transgenic mice harbouring the 5V40 TAg 
under the transcriptional control of the Ren-2 promoter (171-173). Renin 
expression has also been observed in the mouse foetal testes, male sex 
accessory tissue (170), and in the developing vasculature of the human 
foetal lung (174). 
Expression in the adult mouse displays differential tissue specific 
expression profiles despite the close physical linkage between Ren-1' and 
Ren2d and the close homology with Ren1c  (175, 176), see table 1.1). 
RNase protection (177), and primer extension (142, 178), which utilise 
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nucleotide differences between the three genes, have shown that all three 
mouse genes display almost equivalent expression in the kidney. 
Additionally it was observed that Ren1c  is expressed moderately in the 
SMG, highly expressed in the coagulating gland but not in the adult 
adrenal gland. Ren-2 is expressed highly in the SMG whilst Ren1d  is 
undetectable. Neither protein is detected in the coagulating gland, whilst 
both are identified in the adrenal gland. Expression has been shown to 
cycle between the zona fasiculata and the X-zone in DBA substrains 
during oestrous (170, 175). All three genes are expressed in the leydig cells 
of the testes (179), with Ren-1'1 being more highly expressed. Renin 
expression has been detected in the brain, hypothalamus, lung, liver, and 
heart, by RT-PCR and immunohistochemistry (176, 180). Renin mRNA 
was also observed to cycle during oestrous in the theca cells of the ovary 
(181-184). 
Table 1.1 Expression of mouse renin genes in various tissues, indicating 
the number of renin expressing cells in each tissue 
Tissue Ren1C Ren-id Ren-2 
Kidney  +++ +++ 
SMG + 
Adrenal  
Zona fasiculata - + + 
X-zone - + + 
Testes + + + 
Sex accessory gland + + - - 
Ovary + + + 
1.2.4. Tissue RAS 
The expression of renin and other components of the RAS in extra 
renal tissues suggests that a localised RAS, with paracrine and autocrine 
functions may exist (185-188). Renin, angiotensinogen and ACE mRNA 
and proteins have been found in several tissues by RT-PCR and 
immunohistochemistry (176, 180, 189, 190), including: the kidney, in 
which locally produced Angli might regulate glomerular filtration rate 
(191), stimulate sodium reabsorption (192, 193), and control vascular tone 
and/or hypertrophy (9, 189, 194, 195); the adrenal gland, for regulation of 
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aldosterone and catecholamine release (57, 196); the brain, contributing to 
arterial pressure and total body fluid homeostasis (197); the heart, where 
Angil has been found to stimulate cardiac myocyte hypertrophy (14, 17, 
20); and in the theca cells and the lutinized granulosa cells of the ovary to 
facilitate follicle development, ovulation and luteal function during 
pregnancy (184). AngIl is also thought to play a role in foetal development 
since an abundance of Angli receptors can be observed throughout the 
foetus prior to birth (173, 198). 
Ninety percent of the total circulating renin is prorenin, the function 
of which is unknown. Prorenin can be activated by various proteases, acid 
treatment and cold (199, 200), and found to be reversibly activated in 
human plasma (201). The discovery of a prorenin binding protein 
(ProBP), associated with various tissues suggests the functional 
importance of circulating prorenin (202), and supports the hypothesis that 
prorenin is taken up by tissues (203, 204). Relative binding capacities are 
different for various tissues indicating that prorenin uptake can be 
regulated in a tissue specific manner. However there is no evidence to 
suggest that prorenin can be activated once intemalised, so the relevance 
of the ProBP is unknown. 
1.3. Renin angiotensin system and its 
involvement in hypertension 
Hypertension is the pathological elevation of blood pressure and is a 
multifactorial or complex genetic trait, characterised by a gradual, 
persistent increase in normal resting BP (205). Human essential 
hypertension accounts for 90% of all hypertensives, and is a general term 
for hypertension of unknown origin. Clinically a patient is categorised as 
hypertensive if their systolic blood pressure (SBP) is ~! 140mmHg and 
diastolic blood pressure (DBP) is ~! 90mmHg. Additionally there are three 
stages of severity: stage 1, patients have a SBP of 140-159mmHg, and a DBP 
of 90-99mmHg; stage 2, SBP 160-179mrnHg, and a DBP 100-109mmHg and 
stage 3, patients usually have a SBP 180mmHg, and a DBP> llOmmHg 
(206). Since the RAS is involved in blood pressure regulation it has been 
suspected of being involved in hypertension. 
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1.3.1. Genetic linkage analysis 
All components of the RAS have been studied to identify whether 
they are linked to the hypertensive phenotype. Evaluating the 
contribution of a given gene to a disease, can include mapping 
polymorphisms within a given gene to see whether it is linked to the 
disease phenotype, by using genetic linkage analysis or quantitative trait 
loci, (QTL) (207, 208). 
Renin was thought to be the most likely candidate to be linked to the 
hypertensive phenotype since its release is strictly regulated, and 
intravenous doses of renin induce high blood pressure in dogs. Equally 
intravenous injections of renin specific antibodies into salt deplete dogs 
(14), Goldblatt hypertensive dogs (14, 209), spontaneously hypertensive 
rats (210), and hypertensive patients (211) reduces blood pressure. 
The spontaneously hypertensive rat is an animal model of primary 
hypertension in humans (212, 213). A stroke prone line, SPSHR has been 
studied, and structural observations have been observed (214, 215). 
However, no human equivalent to these polymorphisms have been 
associated with human hypertension, since they occur with similar 
frequency in both hypertensive and normotensive patients (216) 
Furthermore it has been shown that mutations in the prosegment of 
renin affects its activation, although human studies indicated no 
correlation of these mutations with hypertension (217). An 
insertion/deletion in intron A of the renin gene in Dahi rats has been 
found to co-segregate with increased blood pressure, although it is 
theoretically possible that a linked gene is responsible (218). 
Linkage analysis of angiotensinogen, the only known substrate for 
renin, has identified that certain molecular variants of the 
angiotensinogen gene are linked to hypertension (219-221). The 
angiotensin converting enzyme has also been strongly linked with 
hypertension. QTL analysis identified genetic evidence that a gene located 
on chromosome 10, closely linked to the ACE locus, plays a major role in 
blood pressure homeostasis (222), with a possible variant of ACE linked 
with hypertension using a PCR screen (223). A genetic linkage between 
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malignant phase hypertension and a gene closely linked to ACE on 
chromosome 10 has also been identified in a sub group of the 
TGR(mRen2)27 rats (224, 225). Additionally no linkage has been found 
between the AT 1 receptor polymorphisms and human essential 
hypertension (226). 
1.3.2. Transgenic studies 
Transgenic animals are generated when exogenous DNA is 
integrated randomly into the host's chromosome, often in multiple 
copies. Transgenic studies are used to observe the effects of over-
expression of a gene of interest on the development of the animal, or to 
delineate those sequences necessary for correct developmental and tissue 
specific expression. 
Transgenic studies to identify the function of Ren-2 have been 
performed by two independent groups. Mulims and co-workers used a 
24Kb transgene consisting of the entire renin gene with 4.6Kb of 5' and 
9Kb of 3' flanking sequences (175). Seven out of the seventeen transgene 
positive animals expressed Ren-2, the expression of which was tissue-
specific although not at a level comparable with wild type expression, 
indicating position effects. The transgene utilised by Tronik et a! (227) 
consisted of only 2.5Kb of 5' flanking sequence, and they also claimed 
tissue specific as well as quantitative expression of their transgene in the 
SMG and kidney only, although not copy number dependent (227). A 
similar transgene to that used by Tronik et al was utilised by Gross and 
colleagues to generate additional transgenic animals, however tissue 
specific expression of this transgene was not obtained (Dr Gross personal 
communication). These experiments would suggest that all the required 
elements for tissue specific expression reside within the 4.6Kb sequence 
flanking Ren-2,. However since neither group observed copy number 
dependent expression, additional sequences are required to counteract 
position effects. 
Subsequent experiments used 4.6Kb of Ren-2 promoter sequences to 
direct expression of the SV40 T-antigen (SV40 Tag) (228). SV40 Tag is a 
viral oncogene and was used to induce neoplastic growth in renin 
expressing cells. The expression of SV40 Tag was restricted to renin 
expressing cells and resulted in tumours in the kidney, subcutaneous 
tissue, the adrenal gland and the testis. Renin expressing cell lines have 
since been derived from these tumours (see 1.5.1. for details) (228). 
However a similar transgene using 2.5Kb of Ren-2 promoter sequences 
showed inappropriate expression, indicating some essential cis-ac ting 
element located upstream (229). Additional transgenics generated using 
Ren-2 promoter and coding regions have been used to express the 13-Geo 
reporter construct (230). However none of the transgene positive animals 
displayed specific p-Gal activity in the kidney (Mullins personal 
communication). 
There is species specificity between renin and its substrate as 
identified by in vitro studies (231). When the 24Kb Ren-2 transgene (175) 
was introduced into rats these animals (TGR(mRen2)27) developed 
fulminant hypertension, due to over expression of the transgene in the 
adrenal gland (12), leading to increased circulating prorenm. Since mice 
carrying the same transgene were normotensive (175), the hypertension is 
probably due to the increased reactivity between mouse renin and the rat 
substrate (232). Hypertension was also observed in transgenic mice 
expressing the rat angiotensinogen gene (233), although Ohkubo and 
colleagues only noticed an 25mmHg increase in mean arterial blood 
pressure when both the rat renin and angiotensinogen genes were 
present (234). The latter result is possibly due to the overexpression of the 
rat angiotensinogen gene in the brain, as a result of expression from the 
mouse metallothionein I promoter used to drive expression of the rat 
substrate in these lines. The introduction of either human renin or 
human angiotensinogen genes independently into mice or rats does not 
induce hypertension, indicating the specificity of human renin with its 
substrate. However if these two transgenic lines are crossed, the progeny 
do exhibit hypertension (235-238). 
These studies show that the overexpression of components of the 
RAS does induce hypertension, supporting the hypothesis that the RAS is 
an important regulator of blood pressure. 
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1.3.3. Gene targeting 
Gene targeting allows the ablation or mutation of a given gene 
which can be used to dissect its contribution towards development, 
disease or biological pathways. This technology involves either the 
deletion or insertion of DNA sequences into a gene, by homologous 
recombination between a targeting vector and its endogenous gene 
located within totipotent embryonic stem (ES) cells derived from pre-
implantation mouse embryos (239, 240). Targeting vectors are generally 
prepared from isogenic DNA to the strain from which the ES cells were 
derived, to increase the chance of obtaining targeted ES cells. Successfully 
mutated ES cells are then returned to a recipient blastocyst of strain 
C57BL/6J, where they can contribute to the germ-line of the resultant 
chimeric mouse (241). The strain used for breeding should be the same 
strain from which the ES cells were derived, so that any phenotypic 
changes observed can be directly related to the gene disrupted rather than 
a co-segregating linked gene. However this is not always feasible as 129 
mice are renowned for their low fertility and reduced fecundity. Gene 
targeting has been utilised to knockout various components of the RAS 
to identify their individual contribution to the system. 
ES cells derived from a two renin gene mouse strain (129.01a) have 
been used to disrupt both Ren1d  and Ren-2. Ren-1't was knocked out 
(Miller et al 1992), and germ-line transmission achieved by two 
independent groups (242, 243). Clark and colleagues identified a sexually 
dimorphic hypotension and lack of granulation in the JG cells in addition 
to an altered morphology of the macula densa. Bertaux however did not 
observe any significant difference in blood pressure, and did not report 
any morphological changes in the kidney. Disruption of the Ren-2 allele 
did not significantly alter mean arterial, blood pressure, although a slight 
increase in plasma active renin and a decrease in circulating prorenin was 
observed. Furthermore no morphological changes were identified (244). 
These two results indicate that Ren-2 cannot fully substitute for Ren-1" 
whilst the Ren-2K0 animals display no observable phenotype, however 
the evolutionary conservation of Ren-2 suggests an important function. 
Other components of the RAS have been knocked out, most of 
which resulted in hypotensive phenotype. The angiotensinogen gene and 
the ACE gene knock out animals both had hypotension, and severe 
morphological changes in the kidney (245-247). The male homozygote 
ACE knockout also showed a reduced fertility, thought to be due to the 
males inability to fertilise the ova. Disruption of the AT1A and the AT 2 
receptors did not cause any outwardly visible abnormalities (248-250). The 
AT1A null animals were hypotensive, but without the observed 
alterations in kidney morphology seen with the angiotensinogen and 
ACE knockouts, whereas Ichiki and colleagues detected a significant 
increase in blood pressure in their AT 2 null animals. Additionally AT1 A 
KO animals had a depressed pressor response to Ang-Il, with the AT2 KO 
animals having an elevated response, indicating that AT2 has a depressor 
effect, which antagonises AT 1 pressor effects. Both sets of animals 
displayed an impaired drinking response to water deprivation and a 
reduction in spontaneous movement. 
The three isoforms of nitric oxide synthase have been knocked out: 
inducible NOS (iNOS) knockout mutants displayed a reduced resistance 
to microorganism infection (251, 252); neuronal NOS (nNOS) mutant 
mice had dilated stomachs associated with constricted pyloric sphincters 
(253-255); endothelial NOS (eNOS) null animals had .no EDRF activity 
(256), and were significantly hypertensive, indicating a role in blood 
pressure regulation. When eNOS mutant mice were treated with L-
nitroarginine they showed a decrease in mean arterial pressure, 
indicating that another NOS isoform is involved in blood pressure 
control, believed to be nNOS. NO vasodilatory actions are thought to 
counteract the vasoconstriction activities of Angli, and the resultant 
hypertension observed in eNOS knockout animals support this role (256, 
257). Hypertension was also observed in animals with a disrupted 
endothelin-1 gene (258), with homozygotes dying at birth. Endothelin-1 
knockout mice were expected to have a reduced blood pressure. However 
these results indicate that endothelin has vasodilatory activity, believed 
to be mediated through NO, confirming the observation that NO released 
from endothelin cells stimulates vasodilation and inhibits renin release. 
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Gene targeting experiments have shown that the components of the 
RAS are intimately involved in blood pressure regulation, and that 
generally a disruption in one of the components causes hypotension 
(apart from the AT2R mutant), which corroborates the proposal that the 
RAS may have evolved to protect against hypotension (256) 
1.4. Cell culture 
1.4.1. Cell lines 
Experiments investigating renin secretion and processing have been 
performed in cell culture. The isolation of primary JG cells is hindered 
since these cells make up less than 0.1% of the total kidney (259). 
However it is possible to enrich for JG cells by utilising Percoll gradients 
(90), although is should be noted that JG cells represent only 80-90% of the 
cells cultured, so care must be taken when analysing data. Primary JG cells 
express renin initially, but intracellular renin activity declines and within 
3 weeks of culture only small quantities of renin activity are observed 
(259). Recently protocols to isolate primary JG cells have yielded 95% pure 
cultures, identified by immunohistochemistry (260). In addition a method 
of isolating JGA is to perfuse the kidneys with magnetic iron particles, 
which become wedged in the glomerular capillaries and are harvested 
through a strong magnetic field (261). 
Since primary cultures lose their ability to produce renin after three 
weeks in culture, the development of renin expressing cell lines was 
paramount. The As4.1 cell line was derived from transgenic mice 
expressing the SV40 TAg under the transcriptional regulation of the Ren-
2 promoter (228). SV40 can immortalise cells by forcing the cell to cycle 
from GO or Gi to S phase, thus maintaining cell cycling. A renin 
expressing cell line was isolated from these mice by propagating a primary 
kidney tumour in nude mice. The resultant tumours were then seeded in 
culture and a clonal cell line derived. Similarly a human renin expressing 
cell line has been generated by transfecting a human JG cell tumour with 
SV40 mutants (262). After twelve months of culture the cells were 
responsive to cAMP stimulated renin release (263). An additional renin 
expressing cell line is HEK293, derived from human embryonic kidney 
cells. These cells express human renin and have been proposed as a 
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model system with which to study transcriptional regulation of renin 
genes (264). 
Additional cell lines are utilised to characterise renin transcription: 
the JEG-3 line, derived from a human choriocarcinoma (265), does not 
express renin though it is assumed to contain cell specific trans-acting 
factors involved for renin regulation, since the choriodecidual cells are 
known to express high levels of renin mRNA; the mouse pituitary 
corticotrophe line, AtT20 (266, 267) which does not express renin. This cell 
line can store active renin, the secretion of which can be regulated 
through the action of 8-bromo-cAMP, and secrete prorenin through the 
constitutive pathway. Other cell lines which can only utilise the 
constitutive pathway include the BTG9A, a mouse hepatoma cell line 
(267), the Chinese hamster ovary (CHO) cell line (268, 269) and COS-1 
cells, which are mouse fibroblasts, which have been transformed by 
polyoma virus (270). Non-renin expressing cell lines can be used to 
identify factors responsible for regulating renin expression. However, 
since tissue specific trans acting factors, required for renin expression in 
various tissues, may not be expressed in these cells, the results probably 
do not reflect the in vivo situation. 
1.4.2 cis-acting control elements regulating renin 
expression 
1.4.2.1 The cyclic AMP and the negative responsive element 
cAMP is known to stimulate renin release in cultured JG cells, with 
a putative role in increasing renin mRNA stability rather than protein 
synthesis (271, 272). Deletion analysis has identified a cAMP responsive 
element (CRE) located 5' of the mouse renin promoter (273), denoted as 
the RP-2 element, cAMP enhances the binding of transcription factors to 
RP-2 (274). A similar element is found in the human promoter region 
although located further 5' (265, 275). A negative regulatory element 
(NRE), has been identified which overlaps the CRE (276, 277). This NRE is 
orientation dependent and active in Ren-1 only, since Ren-2 has a 160bp 
insertion inactivating this element. Removal of this insertion reactivates 
the NRE (276, 278). 
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Renin expression in the mouse kidney and submaxillary gland is 
differentially regulated by cAMP (276). In the kidney cAMP induces a 
nuclear protein, CREB, which complexes with the CRE, thus activating it. 
In the SMG this nuclear protein is prevented from binding, indicating the 
presence of an inhibitory CREB protein. This inhibitory protein termed 
NREB, has also been identified in the testis, liver, brain and heart, but not 
the kidney, indicating a trans-acting protein that interacts with the CREB, 
which might contribute to the tissue specific regulation of renin 
expression by cAMP (279-281) 
1.4.2.2 The renin enhancer 
An enhancer element has been located 2.6Kb upstream of the Ren1C 
promoter, which has been found to stimulate reporter activity 80-fold in 
As 4.1 cells (282, 283). A similar element has been found in the human 
renin promoter located 12Kb from the transcriptional start site. It has 65% 
homology with a 650bp region of the minimal enhancer from Ren-1'. 
However the human enhancer failed to stimulate human renin 
promoter activity in As 4.1 cells, although a 220bp region, highly 
conserved with the mouse sequence, did induce a 47-fold increase in 
reporter activity (283). The function of this enhancer in vivo is yet to be 
established, although previous transgenic studies indicate that it might be 
required for proper tissue-specific and cell-specific expression (175, 229). 
1.4.3 Transcription factors 
The renin promoter has many putative binding sites for a multitude 
of transacting factors, though how many of these actually regulate renin 
expression is, at this time, unknown. The RP-2 element also contains a 
Pit-i like binding site, which is required for full cAMP induction in mice 
and humans (274, 284). Pit-i is a pituitary specific factor, not thought to be 
expressed in the kidney (285) However other members of the POU family 
of transcription factors are expressed, Brn-1 in the kidney, and Tst-i in the 
testes (286). 
Additional sequence motifs identified within the renin promoter, 
include a near consensus activator protein-i (AP-1) binding site. 
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Transacting factors which bind to this region are comprised of either c-Jun 
homodimers or c-Jun/c-Fos  heterodimers. The binding of these 
transcription factors to AP-1 is stimulated by activators of protein kinase 
C, such as phorbol esters, which have been found to be necessary for the 
activation of the renin promoter by c-Jun (287). c-Jun activates the renin 
promoter in JG cells, mediated through the renin core promoter region in 
human embryonic kidney cells (288). This list is far from exhaustive, but 
does indicate additional elements which might be involved in the tissue 
specific expression patterns of renin, and the isolation of renin expressing 
cells from various tissues would facilitate the identification of such 
factors. 
1.5 Position effects 
As previously mentioned the Ren-2 transgene was not expressed in 
all transgene positive animals, and as with several transgenes such as cx-
actin, -globin, and insulin, it gave correct tissue specific and 
developmentally specific expression but not at a level which is 
comparable with the endogenous gene (289). Transgene expression can be 
highly variable, does not correlate with the copy number, and appears to 
be affected by the site of integration, a phenomenon known as position 
effects (290, 291). Furthermore transgene expression can vary within a line 
giving a variegated pattern, a phenomenon known as position effect 
variegation (292). A variety of studies have demonstrated that the ability 
of trans-acting elements necessary for transcription, to access cis regions is 
dependent upon the structure and organisation of chromatin (293, 294). 
To achieve quantitative and qualitative expression of a given 
transgene it has been shown that intronic sequences (295, 296), and 
flanking sequences (290, 297) should be included in the transgene. The 
quantity of flanking sequences required varies from gene to gene, with 
regulatory elements associated with regions of DNasel hypersensitivity 
(thought to indicate the disassociation of nucleosomes) (298, 299). 
Elements found to be involved in site independent expression include 
locus control regions (LCRs), matrix attachment regions (MARs), and 
scaffold attachment regions (SARs). 
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1.5.1 Locus control regions 
Certain transgenes, such as -globin and chicken lysozyme, show a 
high degree of consistency between independent mouse lines, with regard 
to cell specificity, level of expression and copy number dependent 
expression. The latter feature indicates the ability of the transgene to 
autonomously form and regulate an active domain. Such elements have 
been termed locus control regions (LCR) However LCRs do not act 
independently and require cis and trans-acting factors to open chromatin 
(300, 301), and mediate the position independent expression, which is 
comparable to endogenous levels. LCRS are dominant positive activators 
and may act by forming a transcriptionally active domain spanning the 
whole locus (302-304). LCRs may have enhancer activity and are usually 
associated with multiple factor binding sites which might be critical for 
their action (303). 
1.5.2 -Globin LCR 
The first LCR to be identified was associated with the human 13-
globin locus (reviewed in (303, 305-308), where it was observed that a 
deletion of sequences 50Kb upstream of the 13-globin gene was associated 
with human thalassemias. The locus was found to be resistant to DNase I 
digestion in both erythroid and non-erythroid tissue, indicating 
untranscribed DNA (309, 310). 
The 13-globin locus is comprised of an embryonic (e), two foetal (G 
and A)  and two adult (8 and 13) globin genes, which undergo 
developmental stage related switching (311). The e gene is expressed in 
the early embryo, the foetal genes during most of foetal life and the 8 and 
13 genes during adulthood (312). Regions located 50-65Kb upstream of the 
13-globin gene, and 20Kb 3' were found to contain DNase I hypersensitive 
sites specifically in erythroid cells (310, 313), present in all developmental 
stages. Additionally there are DNase I sensitive sites associated with the 
individual globin genes, which are only observed during specific stages of 
development (291). Four DNase-I hypersensitive sites have been mapped 
5' and one 3' which make up a general DNase I sensitive chromatin 
region (310); Figure 1.4). Erythroid specific transcription factor binding 
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sites, GAlA-i, along with ubiquitous AP-1 and Sp-1 binding sites, have 
been located to HS IV, suggesting that erythroid specific and ubiquitous 
nuclear proteins might be required for LCR action (314). 
Figure 1.4 The f3-Globin locus 
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• Deletion studies of the -g1obin LCR have identified that individual 
HS sites (II, III and IV) are sufficient to direct high level erythroid specific 
expression in transgenic mice (315) and in cell culture studies (316, 317). 
HS II placed upstream of the human -globin gene, confers site 
independent expression, with 40% as much human globin to mouse 
globin expressed per gene copy (318, 319). The addition of HS III and IV 
boost this expression to 100% per copy (317). 
1.5.3 Mechanisms of action 
The developmental profile of the globin genes is in part due to 
developmental stage specific expression of various transcription factors, 
which both repress and stimulate specific gene expression (320). Correct 
gene expression is dependent upon the LCR being unable to bind to 
promoters which are silenced, due to the interaction of repressors (303, 
321). The LCR is thought to mediate its effects by looping round and 
complex with specific gene promoters, interacting with transacting factors. 
The means by which the LCR is able to maintain an open structure is 
unknown, although HS IV and V. located at opposing ends of the 0-
globin locus are coincident with scaffold attachment regions (SARs). An 
alternative model suggests that the -globin locus is replicated during 
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early S phase in erythroid cells forming a specialised chromatin structure 
for subsequent globin gene expression (322). 
Transgenic mice generated with a human -globin minilocus, 
comprised of the entire LCR and the -globin gene, exhibited position 
independent and copy number dependent expression (290). This indicates 
that the LCR elements can overcome position effects. The same position 
independence is observed when heterologous cDNA's are inserted 
between the promoter and the second intron of the -g1obin gene, placed 
downstream of the LCR (323, 324). 
Several LCR elements, able to confer site independent and copy 
number dependent expression upon a transgene have been identified for 
a number of genes; they can be located upstream of the gene, such as the 
mouse class II major histocompatibility complex Ea , (325), -myosin 
heavy chain gene (326), and the human opsin genes (327); or placed 
downstream of the gene as observed for the human CD2 gene (328); or 
both 5' and 3' as observed with the mouse metallothionein gene (329). 
Although this list is not exhaustive it does indicate that LCRs are 
involved in the regulation of different genes. 
1.5.4 Insulator elements 
LCRs require additional elements to confer site independent 
expression. Additional insulators include, scaffold attachment regions 
(SAR), or matrix attachment regions (MAR), which are thought to 
insulate the gene from neighbouring chromatin. 
The chicken lysozyme gene has elements both 5' and 3' which can 
mediate integration site independent expression (330). These elements 
have been termed 'attachment' or 'A' elements and have been 
characterised as a subset of matrix attachment regions (MARs), located at 
the boundary of the gene locus generating a chromosomal loop of active 
chromatin (331). Additionally the human adenosine deaminase (ADA) 
gene (332) has HS sequences 5' and 3' required for site independent 
expression, called 'facilitators'. These elements do not act as enhancers 
and are thought to be an additional requirement for correct expression of 
the transgene. Furthermore the Apolipoprotein B gene is flanked by 
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matrix attachment sites which function as insulator elements, shielding 
transgene expression from effects of neighbouring chromatin domains 
(333). 
An open chromatin structure is necessary for the expression of 
transgenes, whether this be conferred by MARs, attachments sites, 
facilitators or LCRs. Once in an open structure, trans acting factors can 
direct high level expression. The only distinction between these elements 
is that LCRs possess enhancer activity (303), whereas MARs and 
facilitators appear to be ioop anchorage points, which require additional 
sequences within the gene locus to enhance gene expression. 
The observed lack of quantitative expression of the 25Kb renin 
transgene (175) implies that further cis-acting control elements are 
required. DNase-I hypersensitive sites have been located within a 5Kb 
fragment 5' of Ren-2, however this sequence is insufficient to express the 
transgene at a level comparable to the endogenous gene (282). Further 
study is therefore necessary to identify those sequences required for site 
independent expression. 
1.6 Genomic cloning vectors 
Identification of problems associated with position effects have 
resulted in the need to isolate genomic clones which span the entire locus 
with extensive flanking sequences. Lambda and cosmid libraries have 
average inserts of 20 and 45Kb respectively, which is probably sufficient 
for isolating small genes. However for the isolation of genes in excess of 
10-20Kb these vectors are being superseded by genomic cloning strategies 
which can accommodate larger inserts, such as yeast artificial 
chromosomes, P1 vectors and bacterial artificial chromosomes. 
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1.6.1 YACs 
The first artificial chromosome was created from the budding yeast 
Saccharomyces cerevisiae, by combining the origin of replication, 
telomers and centromere sequences (334-338). Second generation vectors, 
comprising left and right telomers, two selectable yeast markers, TRP1 
and URA3, a yeast origin of replication (ARS autonomously replicating 
sequence), and a yeast centromere, were capable of accommodating large 
DNA inserts, at least ten fold larger than those of bacteriophage lambda or 
cosmids (339). YACs are generally used for physical mapping and 
positonal cloning projects, and have enabled the physical mapping of a 
variety of genome projects from bacteria, plants, Drosphilia, 
caenorhabditis elelgans (340), mouse and human (341). Because of the 
large insert size less clones are required, and YACs give better coverage of 
the genome than previously achieved. 
YACs have more recently been used in expression studies. They 
have been transferred from yeast to mammalian cells by spheroblast 
fusion (342), and via liposomes (343), and have also been used to generate 
transgenic mice by pronuclear injection, (for example a 35Kb YAC, 
encompassing the mouse tyrosinase minigene (344). The efficient 
introduction of mutations into YACs through homologous 
recombination, and selection for yeast specific genes, makes it possible to 
introduce any mutation into YACs to identify regulatory elements in any 
given gene (345-348). 
Despite the important contribution of YACs to the physical mapping 
projects and their usefulness in transgenic projects, there are several 
major problems associated with YACs. A high percentage (40-60%) of 
clones, particularly in the human YAC libraries, are chimeric, containing 
two unlinked segments of human DNA in the same clone. Another 
problem associated with YACs is that the inserts can be unstable leading 
to large deletions of the internal sequences, problematic for constructing 
accurate physical maps or in gene isolation. Chimerism and deletions can 
be decreased by transferring YACs into a recombination deficient host 
strain (349, 350). However the third problem is that YACs cannot be 
readily distinguished from the 15Mb yeast chromosome by simple 
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methods, and can only be isolated in very small quantities. Isolating YAC 
DNA requires the use of pulse field gel electrophoresis (PFGE), or 
subcloning of the YAC insert into cosmid vectors (351) to increase yields. 
Recently new cloning vectors, such as P1 and bacterial artificial 
chromosomes (BACs), have been developed which have a lesser degree of 
chimerism, a higher, transformation efficiency in generating libraries, and 
which are easier to purify away from the host genome. The only drawback 
is that the insert size is smaller than that obtainable with YAC vectors. 
1.6.2 The P1 cloning vector 
P1 vectors were established as an intermediate between cosmids and 
yeast artificial chromosomes (YACs). Cosmid vectors have a high cloning 
efficiency and a small insert size of 45Kb, whereas YACs are able to sustain 
inserts of hundreds of kilobases (352). This increase in size lowers the 
cloning efficiency as well as decreasing the quantity of DNA purified. The 
P1 vector was designed to permit efficient recovery of insert DNA and to 
minimise recombination of the insert during isolation and subsequent 
amplification steps (353). The original vector pAd 10 was constructed so 
that it could accept fragments up to 100Kb. 
The plasmid replicon maintains the vector at one copy per cell, due 
to the action of the laclq repressor. During propagation, amplification of 
the copy number is achieved by the addition of the lac inducer, isopropyl-
-D-thiogalactopyranoside (IPTG). IPTG over-rides the laclq repressor, 
thereby activating the P1 lytic replicon and increasing the number of 
copies within the cell (353). The pAdlO vector was used for generating 
genomic libraries and it was noted that a high percentage of recovered 
clones did not contain inserts (354). A SacB negative selectable marker 
was introduced into the unique BamHI site, under the control of an E. 
coli promoter, together with unique cloning sites flanked by Sp6 and T7 
promoters, to aid mapping and analysis of cloned DNA. SacB encodes for 
the exoenzyme levansucrase. Levansucrase synthesises levan, in the 
presence of sucrose, which accumulates in the periplasmic space of cells, 
resulting in cell death (355). Thus cells expressing sacB will die in media 
containing greater than 2% sucrose. Ligated DNA will disrupt the 
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presence of sucrose, which accumulates in the periplasmic space of cells, 
resulting in cell death (355). Thus cells expressing sacB will die in media 
containing greater than 2% sucrose. Ligated DNA will disrupt the 
transcription of SacB, permitting growth on agar plates containing sucrose 
and kanamycin. The E. coli promoter was regulated by the P1 repressor, 
ci, since the vector could not be isolated due to leaky expression of SacB 
causing cell death (354). pADlOsacBII (Figure 1.5) has subsequently been 
used to generate human and mouse genomic libraries (356, 357), Mullins 
U unpublished data). 
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1.6.3 E. coli genetics 
The E. coli strain NS3529 has the following characteristics which 
make it suitable for the generation of P1 clones: constitutive expression of 
cre recombinase; a defective recA gene which is normally responsible for 
the major homologous recombination system of bacteria, (recA 
mutations prevent rearrangement of homologous sequences within the 
inserted DNA); mutations in the methylation restriction system mcrABC, 
to prevent degradation of foreign, methylated genomic DNA; and the 
laclq repressor to inactivate the multicopy P1 lytic replicon (353). 
Constitutive expression of cre recombmase is a handicap because it leads 
to reduced recovery of DNA. It is therefore necessary to transfer P1 
plasmids to a more appropriate host strain (such as DH10B, (358), by either 
conjugal transfer or electroporation (359-362). 
1.6.4 P1 based artificial chromosomes 
The size of the DNA cloned into pAdlOsacBII is restricted to between 
80 and 100Kb because of the headful limitation and the requirement of 
two loxP sites, necessary for circularisation of the clone in the bacterium. 
A new vector has been developed, pCYPAC-1 (360), which is already 
circularised, leaving the unique BamHI restriction site and the sacB 
selectable marker gene intact. The pCYPAC-1 vector has been used to 
generate P1 libraries (360) with inserts ranging from 130-150Kb, without 
any observed insert instability. The E. coli strain DH10B has been 
identified as being beneficial for P1 maintenance. A deoR mutation 
permits the maintenance of large DNA fragments, whilst an endAl 
mutation increases the recovery of DNA by alkaline lysis, since it 
prohibits the endonuclease attack of supercoiled DNA (Dr Leach personal 
communication). 
P1 clones have been widely used in physical mapping projects (356). 
More recently P1-derived DNA has been expressed in a rat hepatoma cell 
line and used to generate transgenic mice, following the removal of the 
17Kb vector sequences to prevent any adverse effects in these animals 
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(359). Stably transformed cell lines were derived by the use of a cationic 
lipid reagent, Lipofectin (Gibco), and transgenics by microinjection. Both 
systems expressed the DNA fragment at high levels. 
1.6.5 Bacterial artificial chromosomes 
BACs are based on the F. coli's plasmid F factor (363). The F plasmid 
is strictly controlled (364), and maintained at one or two copies per cell, 
thus reducing the potential for recombination between DNA fragments 
carried by the plasmid. Additionally the F plasmid is capable of 
maintaining inserts as large as 1Mb (365). Individual clones containing 
inserts of 125Kb and 175Kb have been observed to be stable after 100 
generations of serial growth indicating that human DNA inserts are quite 
stable within these vectors. 
The BAC vector is 7.3Kb and is comprised of the oriS and repE genes, 
which mediate unidirectional replication of the F factor, as well as parA 
and parB which maintain the copy number at one or two copies per F. coli 
genome, by the exclusion of extraneous F factors. These genes along with 
a chloramphenicol resistance gene marker and a cloning segment make 
up the pBeloBAC vector. The cloning segment contains bacteriophage 
XcosN and a P1 loxP site to allow site specific cleavage by either ? 
terminase or cre recombinase respectively, two unique restriction sites, 
Hindlil and BamHI, and several CG rich restriction enzyme sites, NotI, 
EagI, XmaI, SmaI, BglI and Sf11, for potential excision of inserts. The 
cloning site is flanked by T7 and SP6 promoters which allow the 
generation of RNA probes for chromosome walking and for DNA 
sequencing the ends of the insert (see Figure 1.6). 
BAC clones are efficiently transformed by electroporation into E. coli 
strain DH10B (363), with approximately 108  clones per tg of DNA 
recovered, 10-50% of which contained inserts, which is 10-100 times more 
efficient than yeast spheroblast transformation. Clones with inserts in 
excess of 300Kb have been isolated, with chimerism observed in 1 out of 
28 clones examined (352). Furthermore out of 300 clones analysed none 
contained multiple BACs within a single cell, indicating their strict 
regulation. Finally, since F plasmids are maintained as supercoiled 
circular DNA, BACs can be easily isolated and manipulated in solution 
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Figure 1.6 The BAC vector pBe1oBAC 
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P1 and BAC clones are ideal for studying the genetic regulation of 
closely linked genes. However manipulating these clones by traditional 
molecular cloning techniques is highly inefficient, primarily due to the 
decrease in cloning efficiency, but also because unique cloning sites are 
rare in DNA fragments of this length. Therefore an alternative technique 
is required. 
1.7 Mutagenesis of large genomic clones 
Large genomic clones, which contain all the necessary cis-acting 
elements for site independent and copy number dependent expression, 
can be utilised to direct expression of mutated genes or reporter constructs 
to endogenous sites of expression within transgenic animals. In order to 
35 
introduce such modifications into P1 or BAC clones, in vivo techniques 
are required, such as those used to mutate YACs (366, 367). 
Homologous recombination between the E. coil chromosome and 
circular plasmids or linear fragments of DNA has been widely 
investigated (368-372), as has intra molecular recombination within a 
plasmid (373-378). Additionally, intermolecular recombination between 
two linear fragments of DNA has been observed (379, 380). These reports 
suggest that homologous recombination may be an efficient and effective 
way of introducing mutations in vivo in bacteria, however these 
methods require the use of E. coli strains with specific alterations in the 
recombination pathways. 
1.7.1 E. coli recombination machinery 
The recombination system in E. coil is complex and involves a host 
of recombination pathways (for a review see (381). RecA is essential for all 
pathways of homologous recombination in the bacterial cell, apart from 
RecET mediated pathways, and mutations in recA generally leave the cell 
recombination deficient. Hence recA strains are usually used for 
molecular cloning purposes, where recombination is undesirable. 
Mutations in the recBCD genes have various consequences: bacteria 
with recB mutations generally have no dsDNA-dependent nuclease or 
ATPase activity (382) and cannot unwind DNA. This phenotype suggests 
that RecB has essential helicase activity; recC mutations leave a bacteria 
moderately recombination proficient, although they are unable to 
undergo recombination at X sites (383), suggesting that the X recognition 
domain resides within RecC; Mutations in recD produce strains which are 
hyper-recombinogenic and which have undetectable ds-ssDNA nuclease 
activity, although they still maintain the helicase activity (384-388). 
Generally recBC strains are not recombination proficient and are often 
associated with mutations in sbc (suppressor of recBC), which reinstates 
recombination. 
sbcA mutation induces the RecET recombination pathway (389-391). 
Mutations in both sbcB and sbcC require the products of recF, recO and 
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recR, which are thought to work together to initiate recombination. RecF 
is necessary for inter and intramolecular recombination between circular 
plasmids in a wild type background (392, 393) and for intramolecular 
recombination of circular and linear plasmids in a recBC sbcBC 
background (391, 394), but not in strains containing recD mutations (395, 
396). 
1.7.2 In vivo inter and intramolecular recombination 
The E.coli recombination system has been extensively investigated, 
and numerous mutant E. coii strains have been produced to identify the 
contribution of each gene. Some of these strains have been found to be 
hyper-recombinogenic and promote recombination within the E. coil 
genome or within plasmids. In a wild type strain the introduction of 
linear DNA would result in its degradation (397), due to exonuclease V 
activity (398). Mutations in recBC and sbcA or sbcB, were found to stop 
this degradation and allow linear DNA to enter the cells and be involved 
in either intermolecular recombination with the E. coil genome (369-372), 
or intramolecular recombination within the linear plasmid (373-375, 377, 
378). 
Conley and colleagues observed that when linearised pBR322 was 
introduced into E. coil strains with various mutations in the rec genes, 
circularised plasmids were recovered (373-375). Linear DNA is generally 
transformed with 102  to io fold less efficiency than covalently closed 
circular (ccc) DNA in wild type E. coil strains (378, 399)An additional 10-40 
fold reduction was observed in E. coli strains with recA, recBC and recF 
mutations, whereas the transformation efficiency of ccc DNA was 
unchanged. When pBR322 was cut with Sail, which leaves sticky ends, 
23% and 5.6% of the transformants obtained showed deletions of various 
lengths, in recBC (JC5519) and recBC,sbcA (JC8679) strains respectively, 
compared to 9% in wild type strains (373, 378). Dephosphorylated or blunt 
ended linear DNA, decreased transformation efficiency whilst increasing 
the deletion rate. Conley and colleagues proposed that the majority of 
transformants did not reanneal by ligating the two Sail sticky ends but by 
intramolecular recombination between short, 4-10bp, of directly repeated 
sequences, and that perfectly recirularised monomers arose primarily by 
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intramolecular recombination between head to tail linear pBR322 dimers, 
which are formed during preparation of linearised plasmid. 
Additionally, intramolecular recombination has been shown to be 
involved in double stranded gap repair, using a recBC, sbcA strain, JC8679. 
Kobayashi and Yamamoto (376, 377) introduced a plasmid which had two 
copies of the neomycin phosphotransferase gene in an inverted 
orientation, one of which had a 248bp deletion of the neo gene. 
Approximately 80% of the transformants recovered had two functional 
copies of neomycin, indicating the efficiency of gene conversion with and 
without crossing over. This proves that recBC, sbcA strains can participate 
in gap repair. 
Comparisons of the efficiency of intramolecular recombination in 
strains with recBC,sbcA and recBC,sbcBC mutations, indicated that both 
strains were highly recombinogenic, inducing recombination between 
homologous sequences within a linear plasmid. Additionally 
recombination was also observed within a ccc plasmid in the recBC,sbcBC 
strain. Chau and Oliver also demonstrated that transformation 
efficiencies with linear DNA are dependent upon efficient 
recircularisation on entry into the bacteria (378). 
Several studies have utilised homologous recombination in bacteria 
for intermolecular recombination between a linear fragment and a 
plasmid or the E. co/i chromosome (222, 369, 372), using the strain JC7623 
which has recBC, sbcBC mutations. Generally the reporter construct was 
flanked a with sequences homologous to the desired mutation site. 
Winans and colleagues used this technique to introduce the 
chioramphenicol resistance gene into the chromosomal recA gene. They 
introduced a 10Kb linear plasmid into JC7623, and identified 
recombination-deficient strains. Although this technique was not 
particularly efficient it was successfully used to introduce mutations into 
the E. co/i chromosome (369). The introduced DNA does not have to be 
linearised, as intermolecular recombination has been observed between a 
circular plasmid and the E. co/i genome, with and without utilising a 
temperature sensitive origin of replication to select for double crossover 
events (368, 400). 
The utilisation of E. coli to recombine two exogenous, linear DNA 
fragments has been published by two different groups (379, 380). 
Sequences homologous to a plasmid vector were introduced onto the 
ends of PCR products, and transformed into either DH5a or 
electroporated into JC8679 cells, along with the linearised plasmid. 
Transformants were obtained which had correctly recombined the two 
fragments, without any duplication of the homologous sequences. 
These experiments indicate that modifying genomic clones by in 
vivo recombination in bacteria is a practical solution to the problems 
associated with molecular cloning. 
1.8 Experimental Outline 
The differential regulation of Ren-1 and Ren-2 is intriguing, as is the 
physiological role of Ren-2. Many regulatory regions have been identified 
within the 5' flanking sequences, but the lack of site-independent and 
copy number-dependent expression of the 25Kb Ren-2 transgene indicates 
that additional cis-acting control elements are necessary to overcome 
position effects, which are located outwith those sequences. These might 
include a locus control region, as observed for many genes, or alternative 
insulator elements which maintain the correct chromatin configuration 
required for expression. Renal as well as extra-renal sites of renin 
expression might utilise different cis regions, which would account for 
the different level of renin expression in different cells. The generation of 
transgenic animals expressing a reporter gene in renin expressing cells 
may well answer some of these questions, either in vivo or in cell 
culture. 
The aim of this project was to direct expression of a reporter gene to 
renin-1 expressing cells. To achieve this aim the reporter gene was 
introduced into renin sequences within a large genomic clone which 
might confer site independent and copy number dependent expression of 
the renin genes, and hence the reporter. The introduction of a reporter 
gene, under the transcriptional control of the renin promoter, but 
independently translated, would create a tool, in which renin gene 
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expression could be visualised or assayed for. Genomic clones spanning 
both renin genes are required, since cis-acting elements involved in Ren-
1d regulation might lie upstream of Ren-2. YAC clones were not used due 
to the difficulty in isolation and characterisation, in addition to the 
problems associated with chimerism, and so P1 and BAC libraries will be 
screened to find such a clone. 
Introduction of the reporter gene into the renin locus located in a P1 
or BAC clone would not be practical by molecular cloning, and so 
intermolecular recombination will be utilised. Since it would be difficult 
to linearise a P1 clone at a specific site, it was proposed to induce 
homologous recombination between a circular P1 /BAC and a linearised 
recombination fragment. Successfully recombined clones will be 
introduced into cell culture to ensure expression of the reporter construct 
and subsequently used to generate transgenic mice. 
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Chapter 2 
Materials and Methods 
2.1 Materials 
2.1.1 Chemicals and Solutions 
Analytical grade chemicals were obtained from BDH Laboratory 
supplies (Merc Ltd, Lutterworth, UK), with Stock solutions were prepared 
using reverse osmosis purified (ROP) water (Elgastat Prima Reverse 
Osmosis Water Machine; Elga Ltd, High Wickham, UK), filtered (0.22mm 
cellulose acetate membrane), treated with 0.01% diethyl pyrocarbonate 
(DEPC; Sigma-Aldrich Company Ltd, Poole, UK), and autoclaved as 
necessary. 
Acids, alcohols and solvents were purchased from BDH Laboratory 
Supplies or Fisons Scientific Equipment (Loughborough, UK), except for 
absolute ethanol (Hayman Ltd, Litham, UK). Phenol was supplied, 
redistilled and buffered with Tris-HC1, from Fisons Scientific Equipment 
(code T/P633/05). Analytical grade agarose was purchased from Gibco BRL 
Life Technologies (Paisley, UK), and NuSieve low melting point Genetic 
Technology grade agarose from FMC (Flowgen, Sittingbourne, UK). Luria-
Bertani medium and agar capsules were supplied by BlO 101 Inc (Vista, 
CA, USA), with Bactoagar, Bactotryptone, and yeast extract bought from 
DIFCO Labs (Detroit, Michigan, USA). Radioisotopes were supplied by 
Amersham International PLC (Little Chalfont, UK), and Kodax XOMAT 
XAR-5 film was purchased from IBI Ltd (Cambridge, UK). Oligonucleotide 
primers were synthesised by OSWELL DNA Service (University of 
Southampton, UK) or MWG Biotech UK Ltd., Milton Keynes, UK). 
Random hexamers and dNTP's were purchased from Pharmacia Biotech. 
2.1.2 Enzymes 
All restriction enzymes were bought from Boehringer Mannheim 
(Lewes, UK), except for AscI and BsmBI (New England Biolabs, Hitchin, 
UK). UlTma DNA polymerase and the Amplitaq FS dye terminator 
sequencing kit (Applied Biosystems, Warrington, UK), T4 DNA ligase and 
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T4 polynucleotide kinase (Gibco-BRL). Cre recombinase a gift from Dr 
Andrew Bates, Department of Biochemistry, Liverpool University, UK) 
2.1.3 Bacterial strains 
Small plasmids, less than 20Kb, were maintained in the Escherichia 
coli strain DH5 (Hanahan 1985) (Genotype: supE44 hsdRl7 recAl endAl 
gyrA96 thi-1 relAl deoR F- 1-). P1 clones and BACs were maintained in E. 
coli strain DH10B (Grant et a! 1990) (Genotype: F- mrcA A(mrr-hsdRMS-
rnrcBC) 480dlacZM15 AlacX74 deoR recAl endAl araD139 z\(ara, leu)7697 
galU galK A.- rpsL vuitG). Intermolecular recombination was performed in 
strain JC8679 (Gillen et a! 1974) (Genotype: recB21 recC22 sbcA23 his-328 
thr-1 ara-14 1euB6 E(gpt-proA)62 lacYl tsx-33 g1nV44(AS) galK2 rpsL31 
kdgK51 xylA5 mt1-1 argE3(0c) thi-1 Lam- Rack Qsrl+). TA cloning was 
performed in strain TOP10F' (Invitrogen, Leek, The Netherlands), 
(Genotype: F'{laclq TnlO (TetR)} mcrA E(mrr-hsdRMS-mcrBC) 
4801acZAM15 DlacX74 recAl araD139 z\(ara-leu)7697 galU galK rpsL (StrR) 
endAl nupG). 
2.1.4 Cloning vectors, plasmids and probes 
pSP72polyl and pSP72poly2 are derived from pSP72 (Promega), and 
constructed by removing the original polylinker and exchanging it for 
complementary oligodeoxynucleotides, prepared by Oswell (Figure 2.1 
and 2.2 respectively; Dr S. Morley et al unpublished data). pIRES3-Geo, 
the original reporter cassette used (Figure 2.3), was a gift from Dr Austin 
Smith (University of Edinburgh, Edinburgh, UK) and pKL53 from which 
the final reporter construct was derived (Figure 2.4), a gift from Dr Ken 
Lee (University of Edinburgh). pZeoSV (Figure 2.5), and the pCR®2.1, TA 
cloning vector (Figure 2.6), were purchased from Invitrogen. pR1KO 
containing the Ren-id homology arms (Figure 2.7), a gift from Dr Allan 
Clark (University of Edinburgh), and pSVlrecA temperature sensitive 
suicide vector (Figure 2.8), a gift from X. Yang (The Rockefeller 
University, New York, NY, USA). A key for all the plasmid maps can be 
found in Appendix 2. 
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Figure 2.1 Diagramatic representation of pSP72polyl 
XbaL 	PstI 	 Hindill 	Smal 
XhoI Miul PmU 	BamHI 	Sail 	MunI 	Bgffl KpnI 	EcoRI NotI 
LAB! I.D. No. JJM-60 
VECTOR pSP72PL1 a pSP72 (Promega) based vector containing an altered 
polylinker. 
COMMENTS : The polylinker of pSP72 was excised via the XhoI and Bglll sites and 
replaced with a pair of self complementary 83mer oligonucleotides with 4 base 
overhangs at the 5' ends designed to recreate the XhoI site, but to block the BgIII site of 
the original vector. The new polylinker contains the novel EcoRI compatible enzyme 
MunI and is flanked by SF6 and 17 promoter sites which can be used for sequencing 
through insert fusion points. 
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Figure 2.2 The vector pSP72.poly2 
NotI 
XhoINotI MunI Kasi AscI 	Bcil EcoRI BamHI Sail 	BgilI NaeI 
LAB I.D. No. JJM-94 
VECTOR: pSP72,poly2 is a pSP72 (Promega) based vector containing an altered 
polylinker. 
COMMENTS : The new polylinker was created by XhoI/BglII digestion of 
pSP72,polyl (JJM-60) and inserting a pair of self complementary 81bp oligonucleotides 
with 4bp overhangs at the 5 ends designed to recreate the XhoI site and destroy the 
BgllI site. The sequence is flanked by SP6 and 17 primer binding sites and also 
sequencing primer binding sites at 213-196 and 2391-2408. Correct insertion and 
presence of restriction sites verified by sequencing. Construction and sequencing by 
Steve Morley, Matt Sharp and Allan Clark. 
Figure 2.3 Diagramatic representation of pIRESI3-Geo 
5' BamHI-SmaI-Ps tI-EcoRI-EcoRV-HindIII-ClaI-SalI-XhoI-KpnI 3' 
SV40 PolyA*. 	
Promoter Sequence 






3' EcoRI-XbaI-NotI-SacII-SacI 5' 
IRES 
Sequence 
LAB/I.D. No. JJM-126 
INSERT: A 5.1kb NotI/Sall fragment containing the Encephalomyocarditis Virus 
hiternal Ribosome Entry Site (IRES) sequence (1) positioned upstream of a 
-Gal/neomycin fusion (2) and SV40 polyA signal 
VECTOR:. pBluescript KSII(-) (JJM-107) 
COMMENTS : pIRES.-13-Geo is a promoterless g-Geo reporter construct designed for 
gene targetting after addition of 5' and 3' flanking exon sequence homologous to the 
targeted gene. Targeting into an exon results in the expression, under the control of the 
targeted gene promoter, of a dicistronic mRNA in which on which translation of the 
reporter gene (LacZ) is under the control of the internal ribosome entry site (IRES). 
The same principle can be exploited in building transgene constructs, thus enabling 
IRES mediated translation of a reporter product from within the gene of interest. 
Note that the IRES is stopped in all three reading frames, thus preventing 
readthrough from 5 coding sequences. pIRES--Geo was constructed by Peter 
Mountford and the JRES-g-Geo cassette including polyA signal can be excised by a 
NotI/SalI double digest. 










INSERT: A 7Kb Sail fragment containing the engrailed splice acceptor in front of the 
encephalomyocarditis virus internal ribosomal entry site, 3-Ceo fusion and the SV40 
poly A tail 
COMMENTS: pKL53 is an optimal promoterless f-geo construct which was designed 
as a gene trap vector. The engrailed splice acceptor is included so that 3-Geo is 
expressed if the vector integrates into an intron. The 5 IRES has an extra three stop 
codons in all three reading frames, and includes a more optimally located ATG to 
initiate transcription. 3-Geo expression is direct to the nucleus via the nuclear 
localisation signal which had been included. The construct can be utilised for gene 
targeting constructs enabling IRES mediated translation of the reporter product from 
within the gene of interest. The splice acceptor, IRES-Geo construct is excised from 
pKL53 by a Sail digest. 
Figure2.5 The mammalian expression vector pZeoSV 
Asp7l 81 
Kpnl 	AsuIl 

















COMMENTS: pZeoSV is a mammalian expression vector to express genes in 
mammalian cell lines. The gene of interest is introduced inbetween the SV40 
promoter and the SV40 polyA tail. Bacterial constructs are selected for by zeocin 
resistance, mediated through a modified T7 promoter, and in mammalian cells 
by the cytomegalo virus promoter 
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Figure 2.6 The PCR cloning vector pCR 2.1 from Invitrogen 
EcoRI 	 EcoRI 
o3AATIGGcTr 	 GCCGPAIWICT 
crrAAGC 	 TrCGGCTTAAGA 
M13 reverse primer 	 ,.....-17 promoter 
000"
~
N LacZ alpha 







COMMENTS: The pCR 2.1 vector is bought linearised within the TA cloning kit from 
Invitrogen. PCR fragments are generated with deoxyadenosine residues, introdcued by 
the PCR polymerase, and ligated with the linearised vector which has 
complementary deoxythymidine residues on the ends. Inserts are screen ed for white 
colonies when grown on X-gal plates. The PCR product can be sequenced using teh M13 
reverse primer and the 17 promoter and can be cleaved from teh vector by a EcoRI digest 
Figure 2.7 A diagramatic representation of the pR1K0 vector 
5' HindIII-EcoRI-Bdll-AscI-KasI 3' 
ii 3' 
LAB/I.D. No. JJM-175 
INSERT: Renid 129 genomic sequences. 5' homology arm= intron A to Exon 3 (Partial) 
3' homology arm= Exon 4 (Partial) to intron G 
VECTOR: pSP72,polyl (flM-60) 
COMMENTS: pR1KO is an intermediate plasmid in the construction of Renid 
targeting constructs. This construct was generated by cloning 2 PCR amplified 
homology arms on either side of a new polylinker insert. The homology arms were 
PCR amplified using ULTma DNA polymerase from a P1 template. Between the 
homology arms is a new polylinker sequence for the insertion of selectable 
markers.Reporter constructs can be introduced into the unique Sail and NotI sites, with 
the construct excised by a AscI/)(hol framgement. 
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from 	 (11090bp) 
pSC1O1 
Tet 
COMMENTS: The temperature sensitive suicide vector has been generated to 
participate in homologous recombination with bacterial artificial . The ori of 
repolication was derived from a temperature senstive mutant of pSC101, which was 
derived from a R plasmid, and is maintained at very low copy number. The plasmid is 
tetracyline resistant and also carries the E. coli RecA gene to induce recombination. The 
recombination fragment is introduced within the unique Sail site shown. 
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The 5' probe used for mapping P1 clones was a 0.35Kb XbaI-PstI 
fragment from plasmid pRn34 kindly provided by D. Burt and W. 
Brammar. The 3' probe was a 0.8Kb XbaI-Ecoffl fragment derived from the 
3' flanking sequences of Ren -2 from pRen2X/R (401). External probes used 
for identifying recombination events were derived from clones 
containing either Ren - 1 or Ren -2 sequences. A 297bp PvuII-BamHI 
spanning exon 1 was derived from pR2D8 (K. Gross), with the 746bp 
Hindlil- NcoI fragment spanning exon 8 and part of exon 9 was prepared 
from plasmid pRen12 (D. Burt and W. Brammar). The IRES oligo probe is 
a 20mer designed against the reverse strand of the IRES element from 
pIRES3-Geo, and the primers used to identify in vivo recombination with 
small plasmids were designed against sequences located in pSPZeo. 
2.1.5 Cell culture 
All cell culture work was performed in a Class II microbiological 
safety cabinet (Gelair ICN Flow Hood (Class 2), ICN Pharmaceuticals Ltd, 
Thame, UK). The cells were grown in tissue culture grade plastics 
manufactured by Corning and Iwaki (supplied by Bibby Sterilin, Stone, 
UK), and gassed with CO2 (BOC, Glasgow, UK),before placing in a 
humidified incubator (Heraeus; model No. B5060 EC/CO 2), with 5% CO2 
at 37°C. All surfaces, including hands and arms, were sprayed with 70% 
methylated spirits (BDH), before working in the flow hood, to prevent 
bacterial or fungal contamination. 
2.1.6 Mouse strains and Housing 
The mouse strain Fl, which is a CBA-057/BL6 cross, was used for the 
generation of transgenic lines. Mice were maintained in a stabilised 
environment with 14hours of light/lOhours darkness, (midpoint being 12 
O'clock, midnight), at a constant temperature of 21 0C±2°C, and at a 
constant humidity (50%±10%). The mice were supplied food and water ad 
libitum. All animals were housed and bred within the Centre for 
Genome Research, Edinburgh, UK, according to the provisions of the 
animals (Scientific Procedures) Act (UK) 1986. 
I~Iv 
2.1.7 Computer analysis 
DNA analysis was performed using the DNAstar Lazergene 1.60 
package (Lazergene, London, UK), ABI PrismTM  377 DNA Sequencer Data 
Collection 1.1 or ABI PrismTM  DNA Sequencing software 2.1.1 (obtained 
from Applied Biosystems). Plasmid diagrams were created using 
GeneConKit v2 (Textco Inc. West Lebanon, New Hampshire, USA). 
2.2 Methods 
2.2.1 Molecular Biology techniques 
Standard molecular techniques were performed as described in 
Sambrook et a! ((402) 
2.2.1.1 Bacterial cultures 
Bacterial liquid cultures were generally grown in Luria-Bertani 
medium (L. broth; lOg/i Bactotryptone, 5g/l yeast extract, lOg/i NaCl; pH 
7.2), supplemented with the following antibiotics when appropriate; 
Ampicilin (Amp) lOOj.tg/ml, Chioramphenicol (Cm) 12.5ig/ml, 
Kanamycin (Kan) 25jtg/ml, Tetracycline (Tet) 12.5tg/m1 all obtained from 
Sigma-Aldrich company Ltd. Low salt L-broth (log/i Bactotryptone, 5g/l 
yeast extract, 5g/1 NaCl; pH 7.2), was used for bacterial cultures grown in 
the presence of lOOjig/mi Zeocin (Zeo) antibiotic (Invitrogen). SOB 
medium was used to grow cells to be made electrocompetent (SOB; 20g/l 
Bactotryptone, 5g/l yeast extract, 0.584g/l NaCl and 0.186g/1 KC1), SOC 
medium was produced by adding lOml/l 2M Mg2 (lM MgC12.6H20, 1M 
MgSO4.6H20), and 10ml/1 2M glucose (w/v). Cultures were incubated for 
16-20 hours at 37°C, in an orbital shaker at 225-250rpm. Large cultures, > 
lOOmis, were seeded, (1:100 dilution), from a 5m1 starter culture, 
inoculated from a single colony from an agar plate. Cultures grown from 
a frozen stock were initially streaked onto a fresh agar plate, a single 
colony of which was used to start the cultures. Where appropriate the 
cultures were streaked onto a fresh agar plate and grown overnight at 
37°C. Stock cultures were prepared by inoculating 5mls of freezing 
medium (L- broth containing 8.25g/1 K2HPO4.3H20,  1.8g/l KH2PO4, 
0.45g/l sodium citrate, 0.09g/1 MgSO4 and 44g/l glycerol (Gergen 1979)), 
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with 0.1ml of an overnight culture, incubated at 37°C with shaking for 8 
hours. Aliquots of 1.8m1 were frozen on dry ice and stored at -70°C. 
Agar plates were prepared by the addition of 15g bactoagar to 1 litre L-
broth. The agar was then autoclaved and allowed to cool to 60°C or below 
before the addition of the relevant antibiotics. Using aseptic techniques, 
the antibiotics were added and mixed by swirling the bottle, the plates 
were poured quickly, and air bubbles removed by sweeping a bunsen 
flame over them. The plates were allowed to set before turning over, 
stored at room temperature over night, to harden, and then subsequently 
stored at 4°C until required. Before use the plates were dried in a 37°C 
oven for 1 hour. 
2.2.1.2 Competent cells and transformations 
a) Electrocompetent cells 
Highly competent electrocompetent cells with an efficiency of 1010 , 
with small plasmids can be achieved by the following method. A 5m1, 
SOB, overnight culture was prepared from a fresh agar plate, streaked 
from a frozen glycerol stock. Generally, 2 ml of this overnight culture was 
used to inoculate 500m1 of SOB, including any appropriate antibiotics. 
Cultures were grown to an optical density at 550 (OD550) of 0.8, usually 3-4 
hours, and allowed to cool, to 4°C in the cold room, for approximately 10 
minutes. To ensure highly competent cells, all subsequent steps were 
performed at 4°C, and all reagents, and surfaces which came into contact 
with the cells were at 4°C, including tips, eppendorfs and pipettes; the 
500m1 culture was split between two 500m1 Sorvall GC3 rotor buckets and 
harvested by centrifugation at 4°C for 10 minutes at 2,700g (5000rpm, 
using the Sorvall rotor GS3, in the Sorvall centrifuge RC5C), and the 
supernatant discarded. The cells were washed twice in an equal volume, 
250m1, of 10% glycerol (v:v), with the cells harvested as previously 
described. After the last spin the supernatant is discarded, leaving a 
residual 2m1 of 10%, glycerol in the bottom. The cell pellet was then 
resuspended in this 2m1 and stored in pre-cooled 500pi eppindorfs in 
220i1 aliquots, rapidly frozen on dry ice, and stored at -70°C. 
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Electroporations were performed as described in Dower et a! 
(403)using a Biorad Gene Pulser, with a capacitance expander; the cuvettes 
and the holder were chilled on ice for 20 minutes before the DNA was 
added to the cuvette, lOng of plasmid DNA or 2t.tl  of ligation mix, dialysed 
against 1xTE (10mM Tris-HC1; pH8, 1mM EDTA). Subsequently an aliquot 
of frozen cells was thawed, with 40tl of cells added to the DNA sample, 
the bottom of the cuvette was tapped to bring the solution to the bottom 
and to get rid of any bubbles. The cuvette was then placed in the cuvette 
holder and placed between the electrodes, to let the electrical current pass 
through the cuvette (2.5Volts, 25jiF 250).The cells were mixed with lml 
SOC, and transferred to a 2059 Falcon tube (supplied by Beckton 
Dickinson) and incubated for 45 minutes to 1 hour at 37°C with shaking. 
Plasmids were diluted 1:100,000 in SOC medium, whilst lOOp.l of ligations 
were spread onto L-agar plates containing the relevant antibiotics and 
incubated at 37°C overnight. 
b) Chemical competent cells 
The following method was developed by Hanahan (404), and used to 
generate competent cultures of the E. coli strains DH5 and DH10B. 
Simply; five isolated colonies, from a freshly streaked plate from a frozen 
glycerol stock, were inoculated into 5m1 SOB containing 20mM MgSO 4 . 
The bacteria were dispersed by vortexing at a moderate speed and used to 
inoculate lOOml SOB containing 20mM MgSO4 in a 1 litre flask. The cells 
were grown until an OD600 of 0.6 was reached. The cells were split, 
aseptically, between 2, ice cold, 50m1 centrifuge tubes and cooled on ice for 
10 minutes. Cells were recovered by centrifugation, 4°C for 10 minutes at 
approximately 2,200g (3,200rpm in the Hereaus Varifuge 3.2R). The 
supernatant is decanted and allowed to stand upright to ensure all 
residual media drained. The pellets were resuspended in 20m1 (per 50ml 
tube), of FSB medium (lOml/l KPO4 pH7.5, 8.91g/l MnC1 2.4H20, 1.47g/l 
CaC1 2 .2H 20. 7.46g/l KC1, 0.8g/L Hexamminecobalt chloride, lOOml/l 
glycerol), by gentle vortexing, stored on ice for 10 minutes, and then cells 
were harvested as before. The supernatant was drained and the cells 
resuspended in 4ml ice cold FSB, with 140p.l DMSO added per 4ml of 
resuspended cells. The cells were stored on ice for 15 minutes, and an 
additional 140p.l of DMSO was added, which was gently mixed and 
54 
returned to the ice bath. The cells were split into 200pl aliquots and frozen 
on dry ice before storing at -70°C. 
Transformations were carried out as described by Sambrook et al 
(402); competent cells were thawed in iced water, and 200j.tl of cells were 
placed in a 2059 Falcon tube. Ten nanograms of plasmid DNA or 2jil from 
a ligation reaction were added, and kept on ice for 30 minutes. The tubes 
were then placed in a 42°C water bath for exactly 90 seconds, and then 
quickly placed on ice, and allowed to chill for 1-2 minutes. Eight hundred 
mircoliters of SOC was added to the cells and incubated at 37°C with 
shaking for 45 minutes to an hour. The cells were then plated onto fresh 
agar plates plus antibiotics, 100tl of a 1:1,000 dilution of plasmid DNA, or 
100p1 of the ligation reaction, and incubated at 37°C overnight. 
2.2.1.3 Quantitation of nucleic acids 
DNA and RNA concentrations were determined by measuring the 
optical density at 260nm (OD mo) on a spectrophotometer (Pharmacia 
Biotech; model No 80-2092-26). Plasmid preparations were diluted in TE, 
at 1:100, and 1:200, and measured in a lOOpi capacity cuvette. The optical 
densities were measured after zeroing at 260nm and 280nm with TE, with 
the cuvette rinsed with TE between samples. Concentrations were 
calculated by multiplying the OD at 260 by the dilution factor, by 50 for 
DNA samples, and 40 for RNA samples, and finally by 1000 to give the 
concentration in p.g/pi. 
2.2.1.4 Nucleic acid precipitation 
Typically DNA precipitations were performed by the addition of 0.5 
volumes of 6M ammonium acetate, and 2 volumes (final) of cold 
isopropanol and stored at -20°C for 30 minutes. DNA was pelleted by 
centrifugation at maximum speed (15,000rpm) for 20 minutes, followed 
by a 150pi wash in 70% ethanol. If the DNA pellet was dislodged, a 
subsequent centrifugation step was included before removing the 
supernatant, and repeating the wash step. Finally the DNA pellet was 
allowed to dry, and resuspended in a suitable volume of TE. 
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2.2.1.5 Plasmid isolation 
The following techniques were used to isolate plasmid DNA from 
multicopy plasmids, unless otherwise stated. 
Rapid alkaline lysis mini preps 
This protocol is based on the method of Birnboim and Doly (405). 
Single bacterial colonies were inoculated into 3mls of L-broth plus the 
appropriate antibiotics, and grown overnight at 37°C with shaking. 1.5mls 
of this culture was then used for analysis, the remainder kept at 4°C. The 
cells were harvested by centrifugation, full speed, 15,000rpm, for 20 
seconds, in a microfuge, the supernatant was aspirated from the cells, and 
the pellet resuspended in 100p1 of freshly prepared lysis buffer (25mM 
Tris-HC1 pH 8, 10mM EDTA pH 8, 10% (w/v) glucose and 10mg/mi 
lysozyme (Sigma-Aldrich; code L-7651)) and left at room temperature for 
10 minutes. Then 200.t1 of fresh sodium hydroxide/SDS solution (0.2M 
NaOH, 1% (w/v) SDS) was added, mixed gently and left on ice for exactly 
5 minutes, followed by 150tl potassium acetate solution (3M potassium, 
5M acetate), which was mixed and left on ice for 5 minutes. Tubes were 
spun for 1 minute at high speed, and the supernatant transferred to a 
fresh tube, containing 0.9m1 of isopropanol. The tubes were placed at 
-20°C for 15 minutes, followed by a 2 minute spin at high speed. The DNA 
pellet was resuspended in 20tl 6M-ammonium acetate and 120p1 
isopropanol, and stored at -20°C for a further 5 minutes. The tubes were 
spun for 2 minutes, and the pellets washed with 180pl 70% ethanol, and 
resuspended in 20tl TE containing 50 jig/rn1 DNase free RNase (RNase A, 
(Sigma-Aldrich; code R-4875), made DNase free by boiling a lOmg/ml 
solution, made up in 10mM Tris-HC1; pH7.5, 15mM NaCl, for 10 
minutes), to destroy any contaminating RNA. This procedure usually 
recovers 5-8jig plasmid DNA, which was then used for restriction enzyme 
digestion, usually 2 jil per reaction. 
Pi/BAC minipreps 
As P1 and BAC's are maintained at 1-2 copies per cell an increased 
volume of bacterial culture was used to obtain sufficient plasmid DNA 
for restriction digest analysis. A modified alkaline lysis protocol was used. 
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The cells from a lOmi overnight culture, without IPTG induction, were 
harvested by centrifugation, 10 minutes at approximately 2,200g (3,200prm 
in the Heraeus Varifuge 3.2R). Pellets were resuspended in 180p.l of lysis 
buffer and transferred to an Eppendorf tube. After incubating at room 
temperature for 10 minutes, 0.4ml of sodium hydroxide, SDS solution 
was added, mixed and placed on ice for 10 minutes. Three hundred 
microliters of neutralising solution was added and left on ice for 20 
minutes, before pelleting the cells for 10 minutes at 4°C at maximum 
speed in a microfuge. The supernatant was transferred to a fresh tube 
containing an equal volume of phenol, the contents mixed and spun for 3 
minutes to separate the phases, the aqueous phase was carefully removed 
and put into a fresh tube containing an equal volume of "chloroform" 
(chloroform:iso-amyl alcohol (24:1)), spun as before, and the aqueous 
phase removed into another fresh tube, containing an equal volume of 
isopropanol, and stored at -20°C for 30 minutes. The tubes were then spun 
for 20 minutes in a microfuge, washed with 200tl 70% ethanol, allowed to 
dry and then resuspended in 50jil TE with 0.5j.tg/ml RNaseA. Usually 1-
31g of DNA is recovered. 
P1asmidPURETM DNA MINIPREP KIT 
The P1asmidPURETM DNA MINIPREP KIT is a rapid plasmid 
purification system from Sigma-Aldrich (code P-MINI). It is based on a 
rapid alkaline lysis procedure, which precipitates chromosomal DNA, 
followed by the specific binding of plasmid DNA to the PlasmidPURE 
spin filter. Impurities are washed away, with the plasmid eluted in either 
TE or deionized water. All solutions are included in the kit which can 
harvest 15jig of plasmid DNA from 1-3ml overnight culture. 
Qiagen DNA preps 
This method involves the separation of plasmid DNA from 
chromosomal DNA, followed by binding of the plasmid DNA to the resin 
in a QIAGEN column. RNA and proteins are removed by wash steps in 
medium salt buffer, followed by p!asmid DNA elution in a high salt 
buffer, and precipitation to yield high quality DNA. This kit can be used to 
obtain 500p.g DNA, using a QIAGEN-tip 500 (QIAGEN Maxiprep; code 
12162), or lOOjtg using a QIAGEN-tip 100 (QIAGEN midiprep; code 12143). 
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The DNA concentration is determined by spectrophotomeric analysis 
(section 2.2.1.3) and the identity of the plasmid confirmed by restriction 
digests. 
QIAGEN columns were used to isolate DNA from low copy 
plasmids such as pSC101, or P1 or BAC clones. QIAGEN tip-100 were used, 
doubling the quantity of the buffers P1, P2 and P3, to ensure chromosomal 
degradation. Additionally to elute the plasmid, the buffer QF is heated to 
50°C to improve yield, (QIAGEN product information). 
Alkaline lysis Maxipreps 
This protocol is a large scale version of the rapid alkaline lysis 
method, isolating DNA from cultures > 500m1. A 500m1 culture was 
inoculated from a single bacterial culture (section 2.2.1.1). Cells are 
harvested by centrifugation for 10 minutes at 4°C, 2700g (4,000 rpm using 
the Sorvall GS-3 rotor, in a Sorvall RC5C centrifuge), and resuspended in 
4mls lysis buffer, left on ice for 10 minutes, before adding lOml of sodium 
hydroxide, SDS solution. After 10 minutes on ice, 7.5m1 of neutralising 
solution was added, and the cells left on ice for a further 10 minutes. The 
solution was centrifuged for 15 minutes at 4°C 24,000 x g (13,000rpm, 
Sorvall SS34 rotor, in a RC5C centrifuge), and the supernatant added to a 
50ml tube containing an equal volume of isopropanol and stored at -20°C 
for 1 hour. The plasmid DNA was harvested by centrifugation, 
approximately 2,200g (3200rpm, in the Heraeus Varifuge 3.2RS), and the 
pellet resuspended in 9m1 of TE. The samples were centrifuged again, to 
pellet any insoluble material. This supernatant was then used for 
Caesium chloride / ethidium bromide equilibrium centrifugation. 
Triton lysis 
This protocol was based on the Clewell and Helinski (406) method. 
An overnight culture, 500mls, was centrifuged, for 10 minutes at 4°C, 
2,700g (4000rpm Sorvall GS-3 rotor in the RC5C centrifuge). The cell pellet 
from each 500m1 was resuspended in 7.5ml of ice cold sucrose solution 
(50mM Tris-HC1, pH8.0, 25% (w/v) sucrose), and 1.225ml of fresh 
lysozyme solution (10mg/mi), and left on ice for 15 minutes. Then 2.5m1 
of 0.5M-EDTA pH8.0 was added, mixed gently and left on ice for 15 
minutes, followed by the addition of lOml triton solution (50mM Tris, 
pH8.0, 62.5mM EDTA, pH8.0, 2% (v/v) triton X-100). The solution was 
swirled until it became viscous and transferred to a 30m1 Sorvall round 
bottomed tube. The samples were then centrifuged for 30 minutes at 4°C 
at approximately 27,000g (15,000rpm, SS34 Sorvall rotor in the RC5C 
centrifuge), and the supernatant carefully poured into a 50m1 conical tube 
(Corning; supplied by Bibby Sterilin). If the pellet appeared 'fluffy', the 
cells had over lysed and were boiled for 5 minutes and respun for 30 
minutes at 4°C at approximately 27,000g (15,000rpm, SS34 Sorvall rotor in 
the RC5C centrifuge). The DNA is precipitated by the addition 0.1 volume 
of 3M sodium acetate, pH5.5, and 1 volume cold isopropanol, then at 
-20°C for 30 minutes. The DNA is pelleted by centrifugation, for 10 
minutes at approximately 2,200g (3,200rpm in the Heraeus Varifuge 3.2R), 
and all traces of supernatant removed before the pellet was resuspended 
in 9ml TE, pH8.0, this solution was warmed to 37°C for 30 minutes to aid 
resuspension. Insoluble material was removed by centrifugation as above, 
and used for caesium chloride gradient purification. 
g) Caesium Chioride/ethidium bromide equilibrium centrifugation 
This method was used to isolate covalently closed circular DNA, 
similar to the technique described by Radloff et a! (407), and Sambrook et 
al (402). To 9mls of plasmid solution, 9.9g of caesium chloride (Sigma-
Aldrich; code E-8751), and 0.45m1 of a lOmg/ml, ethidium bromide 
solution was added. The solution was then transferred to an llml 
Beckman polyallomer Quickseal tube (Beckman RIIC Ltd, High 
Wycombe, UK; code 342413). The tubes are topped up with mineral oil, 
balanced, and then sealed by heating. The tubes are then spun for 16 
hours at 20°C at 55,000rpm, (approximately 260,000g; Beckman L-60 or L7 
ultracentrifuge, with rotor NVT-65), with the brake set to slow. After 
centrifugation, the tubes are observed under a longwave UV lightsource. 
There are generally two bands observed, the upper band being, 
chromosomal DNA and nicked plasmid DNA, whilst the bottom band is 
covalently closed circular DNA. To retrieve the band, a syringe needle, 19 
gauge (Becton Dickinson), was pushed into the top of the tube, to allow 
air in. Another 19 gauge needle, attached to a 5m1 syringe (Becton 
Dickinson) was pushed in to the side of the tube, (through opaque scotch 
tape to prevent leakage), bevelled edge upwards, just below the plasmid 
band. The plasmid band was removed from the tube and transferred to a 
15m1 falcon 2059 tube. 
The ethidium bromide was removed by repeated extraction with an 
equal volume of water saturated isobutanol. Briefly the solution was 
mixed, and centrifuged for 3 minutes at approximately 2,200g (3200rpm, 
in a Heraeus Varifuge 3.2R). The isobutanil layer was removed and 
exchanged for fresh water saturated isobutanol, until the bottom solution 
cleared, and traces of isobutanol were evaporated in a flow hood. The 
solution was made up to 2.5m1 with TE and loaded on to an exclusion 
chromatography column (NAP-25 column; Pharmacia Biotech; code 17-
0852-02 25), to remove the caesium chloride. The NAP-25 column was 
equilibrated with TE, before loading the plasmid solution. Plasmid DNA 
was eluted by the application of 3.5 ml TE to the column, and then 
precipitated by ammonium acetate/isopropanol (section 2,2,1,4). DNA 
was pelleted for 30 minutes at 4°C at 12,000g (8,550rpm in the Sorvall 
rotor HB-4 in the Sorvall RC5C centrifuge), and washed with 70% 
ethanol. The DNA pellet was resuspended in 200-1000ml TE, and the 
concentration determined by spectrophotometry (section2.2.1.3). The 
identity of the plasmid was confirmed by restriction mapping. 
2.2.1.6 Genomic DNA isolation 
a) Agarose plugs for pulse field gel analysis 
High molecular weight DNA is required for genomic DNA 
restriction endonuclease mapping, and for isolating DNA fragments in 
excess of 50Kb. Spleens from 129/01a or DBA/2J mice were homogenised, 
washed in PBS (137mM NaCl, 2.7mM KC1, 4.3mM Na 2HPO4 and 1.4mM 
KH2PO4), and resuspended at a concentration of 2x107 cells/mi in L buffer 
(0.1M EDTA, 0.01M Tris.HCi; pH7.6, 0.02M NaC1). An equal volume of 1% 
low melting temperature agarose, in L buffer, cooled to 42°C, was added 
and the cell suspension allowed to set in imi syringe barrels (nozzles 
removed). The agarose/cell samples were then cut into 0.5cm plugs, 
which contained 1x10 6 cells and yielded approximately 5-10ig of DNA 
(Current Protocols in Molecular Biology). The plugs were treated with 
Proteinase K and 1% sarkosyl for 48hr, at 50°C, changing the buffer after 24 
hours. The plugs are then incubated in rinse buffer (TE containing 
40 jig/mi phenylmethylsulfonyl fluoride; Sigma; code P7626), at 50°C for 2 
hours, changing the solution after 1 hour, and subsequently equilibrated 
in 1xTE for 24 hours. The samples are then stored in 0.5M EDTA at 4°C. 
High molecular weight DNA extracted from bacterial cells 
This protocol was performed as described in Current Protocols in 
Molecular Biology ((408)). Cell wall debris, polysaccharides and other 
proteins are removed by their selective precipitation with CTAB, leaving 
the HMW DNA in solution. 
The bacterial cells of a 1.5m1 overnight culture were harvested by 
centrifugation for 2 minutes in a microfuge. The cells were resuspended 
in 567j.tl TE buffer, 30pi of 10% SDS (w/v), and 3jil of a 20mg/ml 
Proteinase solution, mixed and left at 37°C for 1 hour. Then lOOjil of 5M 
NaCl was added and mixed thoroughly, followed by 80jil CTAB/NaC1 
solution (2% (w/v) cetyltrimethylammonium bromide (CTAB), 100mM 
Tris-HC1; pH8.0, 20mM EDTA; pH8.0, 1.4 M NaCl), the samples were 
mixed and incubated at 65°C for 10 minutes. An equal volume of 
"chloroform's solution was added, mixed and centrifuged for 5 minutes, 
to remove the CTAB/protein complex. The aqueous phase was removed 
and placed in a fresh tube containing an equal volume of PCI. The 
samples were mixed and spun for 5 minutes, the aqueous phase 
transferred to a fresh tube, and the DNA precipitated with 0.6 volumes of 
isopropanol. After thorough mixing a stringy precipitated formed, which 
was carefully recovered and washed in 70% ethanol, to remove any 
residual CTAB. The DNA was collected by centrifugation for 5 minutes 
and redissolved in 100j.il TE. The concentration was determined (section 
2.2.1.3) and the DNA visualised on an agarose gel. 
Genomic DNA isolated from cultured cells 
Genomic DNA was isolated from cultured cells grown to confluence 
in a T25 flask by a modification of the method of Laird et a! (409). Flasks 
were washed with PBS and 600 jil of Lysis buffer (100mM Tris-HC1;pH8.5, 
5mM EDTA, 0.2% (w/v) SDS, 200mM NaCl and 100mg/mi Proteinase K 
(Boehringer Mannheim; code 745723)) was added to the flask, which was 
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stored at 37°C overnight. The suspension was then transferred to a screw 
capped tube and precipitated with 600fl isopropanol. Samples were mixed 
by rotating for 10-15 minutes and the DNA collected by centrifugation for 
15 minutes. The DNA pellet was washed twice with 70% ethanol, air 
dried and resuspended in 100p1 TE, the tubes were stored at 65°C to aid 
resuspension. 
d) Mouse tail, tissue DNA preparation 
The method used to extract high molecular weight DNA from tail 
clips or embryonic tissue, was based on the method of Hanahan (Cold 
Spring Harbour cloning course protocol Jan 1984), adapted from various 
standard methods for preparing high molecular weight DNA ((402)). The 
tail clips, (1cm in length) were obtained from 4-5 week old mice, 
following the application of local anaesthetic (ethyl chloride BP; Syntex 
Pharmaceuticals Ltd, Maidenhead, UK), and stored in screw capped tubes 
at -20°C until needed. The stump of the tail was sealed with Vet Seal 
tissue glue (B. Braun, Malsungen, Germany), and the mouse ear tagged 
for subsequent identification. Placentas were taken from 13.5 p.c. embryos, 
embryonic liver and tail tissues from day 16.5 p.c. embryos, and treated as 
for tail DNA. 
The tail tip was minced using sterile, sharp, stainless steel scissors in 
600 p1 of tail buffer (50mM Tris-HC1; pH 8.0, 100mM EDTA, 100mM NaCl, 
1% (w/v) SDS and 35p1 10mg/mi Proteinase K (Boehringer Mannheim; 
code 1092-766), and incubated at 55°C overnight, with rotation. 
Subsequently, 20pi  of a 10pg/ml DNase free RNase solution was added 
and incubated at 37°C for 1 hour. After the addition of 37.5p1 2M - 
mercaptoethanol and 600iil of phenol the tubes were rotated on a vertical 
rotor for 15 minutes. The tubes were then spun for 2 minutes at full 
speed, and the aqueous phase removed, using "cut-off" blue tips, to avoid 
shearing, and put into a fresh screw capped tube containing 300j.tl phenol, 
and 300p1 T'chloroform". The tubes were rotated as before for 5 minutes, 
and the phases separated by centrifugation at full speed for 2 minutes. The 
aqueous phase was placed in another fresh tube, containing 600jil 
"chloroform", and rotated for another five minutes. The phases were 
then separated by centrifugation and the aqueous phase transferred to a 
62 
fresh tube containing 600pi isopropanol. The DNA was precipitated by 
inverting the tube a few times, until a stringy precipitate was observed. 
The tubes were spun at full speed for 2 minutes, and the supernatant was 
removed, the pellets were resuspended in 200il TE, overnight at 4°C. The 
DNA's were precipitated by ammonium acetate isopropanol (section 
2.2.1.4), and pelleted by centrifugation, then washed in 70% ethanol. The 
DNA pellets were air dried, and resuspended in 100pl TE, and the DNA 
concentration determined (section 2.2.1.3). Embryonic tissue, was very 
'gluey', and required repeated pip'peting before being quantitated. 
2.2.1.7 RNA preparation 
a) From tissues 
RNA was extracted from whole tissue using guanidine 
isothiocyanate/phenol extraction (410). The solutions were freshly 
prepared; Stock solution A (4M guanidine thiocyanate, 25jiM sodium 
citrate; pH7.0, 1% (w/v) sarcosyl, 0.1M -mercaptoethanol, made up to 
50m1 with DEPC treated water, adjusted to pH 7.0 with 1M NaOH), 
RNAzo1 stock solution (1 volume Stock Solution A, 1 volume of phenol 
and 1.0 volume of 2M sodium acetate; pH4.0). 
Tissues were homogenised in 2m1 of RNAzol solution for each 
100mg of tissue, using a Janke and Kunkel Ultra-turrex T25 homogeniser 
(supplied by Sartorious Ltd, Epsom, UK). Samples were placed on ice for 
5-15 minutes before the addition of 200il chloroform per sample, and 
mixed by vortexing for 15 seconds. Samples were left on ice for a further 
15 minutes then centrifuged, at 4°C for 5 minutes at 2,200g (3200rpm in 
the Heraeus Varifuge 3.2R). The aqueous phase was carefully removed, 
avoiding the interface, which contains protein and DNA, and transferred 
to a 2m1 screw cap tube. RNA was precipitated by the addition of 1 
volume cold isopropanol stored at -20°C overnight. The RNA was 
collected by centrifugation at full speed in a microfuge for 10 minutes. 
The sample was washed twice with 70% ethanol, made from DEPC water, 
dried and resuspended in lOOjil deionised formamide (inhibits 
degradation of RNA by RNase). RNA concentration is determined by 
spectrophotometry and for quality by analysis on an agarose gel. 
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b) Cultured cells 
The isolation of RNA from cultured cells used a slightly modified 
protocol, (Colleen Kane personal communication); the cells from a 
confluent T25 culture flask were lysed in the flasks by the addition of 
600pi of Stock Solution A. The cell suspension was recovered from the 
bottom of the flask using cell scrapers (Falcon; code 3085; supplied by 
Becton Dickinson), and placed into a screw capped eppendorf tube. Then, 
50ji1 2M sodium acetate was added along with 700 jil phenol, and mixed by 
vortexing until the solution clears. The samples were then placed on ice 
for 30-40 minutes and then microfuged at 4°C for 10 minutes. The 
aqueous phase was then transferred to a fresh tube containing 200il 
"chloroform", mixed and incubated on ice for 30 minutes, followed by 
centrifugation for 10 minutes. The aqueous phase was recovered and 
added to an equal volume of cold isopropanol and stored at -20°C 
overnight. The pellet was collected by centrifugation for 20 minutes, 
washed twice with 70% ethanol and resuspended in lOOpJ deionised 
formamide. 
2.2.1.8 Restriction digests 
Plasmid digestion 
Restriction digests were performed as described by,  Sambrook et 
al(402). DNA was digested at concentrations of 0.1-0.5mg/ml using less 
than 10% (v/v) enzyme (5% (v/v) glycerol) in the solution. Small 
plasmids were left from 1-5 hours, at the appropriate incubation 
temperature, whilst large plasmids and genomic DNA was left overnight. 
Restriction digests were stopped by the addition of 10mM EDTA; pH8.0 (in 
excess Of Mg2 concentration), followed by denaturation at 65°C for 15 
minutes, unless the whole digest was run on the gel, as for mini prep 
digests or fragment isolations. 
Pulse field plug digestion 
DNA plugs were stored in 0.5M EDTA; pH8.0, and so before 
digestion all traces of EDTA were removed, by 3x 20 minute incubations, 
with agitation, in 20m1 of TE. This was followed by 2x 1 hour incubations 
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in the relevant lx restriction buffer, before the DNA plugs were digested 
in a 100tl volume, (1 x restriction buffer) with 1.tl of a lOmg/ml BSA 
solution and 10 units of enzyme, overnight. The next day the tubes were 
placed on ice, to cool for 15 minutes, and the reactions stopped by 
immersing the plugs in 200m1 stop buffer (0.5x TAE, 10mM EDTA) for 20 
minutes on ice, prior to loading on a gel. 
2.2.1.9 Fragment separation 
Nucleic acids are separated by an electrical current being passed 
through an agarose gel, with smaller nucleic acids moving quicker than 
larger fragments. The type of apparatus used depends upon the size of the 
DNA to be resolved (see Figure 2.9). 
Horizontal submerged gel electrophoresis 
DNA fragments are loaded onto a 0.8% agarose gel, submerged in 
0.5xTAE buffer (402), containing 0.5mg/mi ethidium bromide. The DNA 
fragments were separated on small mini gels at 60V for 1 hour, whereas 
the longer 20 cm gels were left for 2-3 hr at 75-1Oy, or overnight at 25V, 
with the electrical current flowing in a constant direction. The DNA size 
markers used are normally X DNA digested with HindIll (23,130, 9,416, 
6,557, 4,361, 2,322, 2,027, 564, 125bp), HindIII/EcoRI (21,226, 5,148, 4,973, 
4,268, 3,530, 2,027, 1,904, 1,584, 1,375, 947, 831, 564, 125bp), or pRri2IRESI3-
Ceo digested with BamHI (4,964, 3,808, 2,678, 1,851, 1,262, 936, 788, 571, 
380bp). DNA fragments up to 15Kb can be effectively separated using this 
protocol, which was routinely used for mapping small plasmids. 
Field inversion gel electrophoresis 
These gels are used to separate DNA fragments ranging from 10-
250Kb, depending on the pulses applied. The electrophoretic current is 
switched linearly to facilitate the separation of larger fragments. Generally 
1%GTG agarose gels, are run in 0.5x TBE buffer using a BIORAD gel tank 
and a SWITCHBACKTM  pulse controller, (supplied by Hoefer Scientific 
Instruments) to control the switching times,. The pulse conditions were 
from 0.6 to 6 second pulses, increasing linearly for 24 hours. The DNA 
markers used were the Midrange I and 11 pulse field gel markers (New 
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England Biolabs; codes 355-1 and 355-2 respectively). The sizes of the 
fragments were; Midrange Marker I (in Kb); 291.0, 276.0, 257.5, 242.5, 227.5, 
209.0, 194.0, 179.0, 160.5, 145.5, 130.5, 112.0, 97.0, 82.0, 63.5, 48.5, 33.5, and 15; 
Midrange Marker II (in Kb); 291.0, 267, 266.5, 24.5, 218.5, 218.0, 194.0, 170.0, 
169.5, 145.5, 121.5, 121.0, 97.0, 73.0, 72.5, 48.5, 24.5 and 24.0. 
Figure 2.9 A comparison of the different types of submerged 
electrophoresis. 
A) Horizontal, B)Switchback, C) Pulse field gel electrophoresis 
+ve 
-ye 
A) Horizontal gel electrophoresis 
current runs in one direction. 
B) Switchback gels 
current switches linearly. 
+ve 	 +ve 
-ye 	 -ye 
C)Pulse field gel electrophoresis 
The current switches from a northwest to 
southeast, to a northeast to southwest 
direction. Switching times are changed 
depending on the DNA fragments to be 
separated. 
c) Pulse field gel electrophoresis 
Pulse field gels are routinely used to distinguish between megabased 
fragments of DNA, and the switch times can be optimised to separate 
fragments of any given size In the CHEFDRII system which has a 
hexagonal electrode array. The current switches from a north/east - 
south/west direction to a north/west - south/east direction, with the 
larger fragments taking longer to react to the change in switching times 
than the smaller ones. DNA plugs are loaded before the gel is submerged 
in the buffer, and sealed in the wells with 1% low melting point agarose, 
to stop the plugs coming out of the wells. Liquid samples are mixed with 
low melting point agarose before being loaded. The Midrange markers I 
and II are used as molecular weight standards. Initial analysis were carried 
out using a purpose built kit made by the workshop at the Western 
General MRC unit. Subsequently a CHEFDRII system was purchased from 
BIORAD. 
2.2.1.10 Gel purification of DNA fragments. 
DNA digests were loaded on to a 0.8% agarose gel and subjected to 
horizontal gel electrophoresis. Gels were then observed under longwave 
(366nm) UV light (UVP Inc,; model UVGL-58). The band of interest was 
excised from the gel and recovered by one of three methods. 
a) Electroelution 
Fragments of DNA were recovered from gel slices by electroelution. 
The gel slice, containing the DNA fragment was put inside a short length 
of dialysis tubing. This was secured at one end with a hydrogen peroxide 
treated clip. The gel slice was surrounded by 0.5-1ml of 0.5x TAE buffer 
solution and the tubing secured with another clip, ensuring that there 
were no air bubbles in the bag. The dialysis tubing containing the gel slice 
was then placed into an electrophoresis tank and subjected to 100V for 1-2 
hours, or until the ethidium bromide had migrated out of the gel slice. 
The tubing was then turned round, and a 15 second pulse of current was 
applied, to detach any DNA from the dialysis tubing (see Figure 2.10). The 
gel fragment was then removed and the buffer placed into a 2ml screw 
capped tube. The dialysis bag was rinsed with 200il of 0.5 x TAE buffer and 
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added to the 2m1 tube. Impurities were removed by the addition of an 
equal volume of PCI mixed and separated by centrifugation, at full speed 
for 5 minutes. The aqueous phase was removed and placed in a clean tube 
containing an equal volume of "chloroform", mixed and spun as before. 
The DNA was then recovered by precipitation with 6M ammonium 
acetate and isopropanol (section 2.2.1.6). DNA concentration was 
determined by spectrophotometry and integrity was checked on a small 
scale agarose gel. 
Qiaex purification 
This technique involves dissolving the gel slice in sodium 
perchiorate, followed by the selective absorption of DNA onto the QIAEX 
silicagel particles (QIAGEN Ltd., Crawley UK; code 20020). The gel slice 
was incubated in buffer QX1 (3M NaCl, 4M sodium perchiorate, 10mM 
Tris-HC1; pH7.0, 10mM sodium thiosulphate), and the DNA bound to 
QIAEX beads. The beads were repeatedly washed in QX2 buffer, (8M 
sodium perchiorate, 10mM Tris-HC1;pH7.0), to remove any traces of 
sodium thiosuiphate, and then in QX3 wash buffer (70% ethanol (v/v), 
100mM NaC1, 10mM Tris-HC1; pH7.5), to remove the sodium perchiorate. 
The DNA was recovered by eluting in 2x20p.1 TE, and the two 
supernatants pooled. DNA was quantitated (section 2.2.1.6), and 
visualised on an agarose gel. 
Gene clean 
The gel slice was melted into a 4M NaI solution at 45°C and the 
DNA selectively bound to the specially formulated silica matrix. The 
beads are washed in NEW wash, and eluted in 2x lOp! TE or water. DNA 
concentration is determined (section 2.2.1.6) and visualised on an agarose 
gel. 
Figure 2.10 The isolation of DNA by gel electroelution. 
A) The DNA fragments are separated by horizontal gel electrophoresis and the fragment 
of interest removed from the gel, under long wave UV light, using a sterile scalpel. B) The 
gel slice is then placed into a length of dialysis tubing and surrounded by lml 0.5x TAE 
running buffer and secured at both ends with a clip. The gel slice, in dialysis tubing, is then 
returned to the electrophoresis tank, and subjected to an electrical current for 1-2 hours, 
until the ethidium bromide has left the gel slice. Before collecting the DNA the dialysis 
tubing is rotated 180 degrees and a quick 20 second pulse of current is applied, to dislodge 
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2.2.1.11 Ligations 
T4 DNA ligase was used to subclone DNA sequences into plasmid 
vectors. The plasmid vector was digested with restriction enzymes which 
either generate ends compatible with the DNA sequences to be 
introduced, or blunt ends. The plasmid vector was usually treated with 
calf intestinal phosphatase after digestion to dephosphorylate the ends, 
preventing self ligation (see below). The linearised vector and DNA 
fragments are then incubated together in the presence of T4 DNA ligase 
which joins the compatible ends together. Ligation reactions were set up 
with vector:insert molar ratios of 2:1 or 5:1, using bOng of vector DNA, in 
a lOjfl reaction, using the manufacturer's lOx ligation buffer (50mM Tris-
HC1; pH7.6, 10mM MgCl2, 1mM ATP, 1mM DTT and 5% (w/v) 
polyethylene glycol-8000; GIBCO-BRL). Ligations were incubated at 15°C 
overnight, and dialysed against TE for 30 minutes before introduction 
into bacteria (section 2.2.1.2). 
Ligations of large DNA fragments are inefficient and so an 
additional 10% PEG (polyethylene gylcol) was added to the ligation mix 
(making it up to 15% PEG), which acts as a molecular crowder, increasing 
the chance of recovering the expected plasmid. 
2.2.1.12 Calf intestinal phosphatase 
CIP treatment removes the terminal phosphatase, which is necessary 
for re-ligation, from the plasmid vector. By dephosphorylating the vector 
it increases the probability that clones recovered will contain the required 
insert. Briefly, after restriction digests, lunit of CIP (Boehringer 
Mannheim; code 713023) was added per .tg of DNA, and incubated at 37°C 
for. 30 minutes. CIP cannot be heat inactivated and was removed by 
mixing with an equal volume of PCI, which was centrifuged at maximum 
speed for 5 minutes, followed by precipitation (section 2.2.1.6). 
2.2.1.13 Polymerase chain reaction 
a) DNA template 
The polymerase chain reaction (PCR) involves the selective 
amplification of specific DNA sequences, by a three step process which 
cycles approximately 30 times. Simply the duplex DNA is separated at 
94°C, the PCR block rapidly cools to a temperature which allows the 
specific annealing of the primers to the DNA template, then the 
temperature is raised to 68°C to allow extension of new DNA strand by 
thermostable Taq polymerase (purchased from Promega). The 
concentration of primers in the buffer are vastly in excess, since for each 
cycle new templates are generated and so the quantity of product doubles 
after each round. This technique is highly sensitive, and steps must be 
taken to prevent sample contamination. Such precautions include; using 
a separate set of pipettes, or cleaning them before use in 1M HC1, followed 
by rinses in deionised water; using plugged tips and mineral oil and 
reverse osmosis purified (ROP), water which has been treated with UV 
light, (wavelength 302nm) for 20 minutes. Additionally to prevent 
amplification of non specific products Taq polymerase can be added once 
the sample has reached 94°C, termed 'hot start'. 
!11] 
PCR primer pairs are designed so that the melting points are similar, 
there is limited secondary structure, especially at the 3' end, and that runs 
of three or more of the same nucleotide are avoided. The PCR conditions 
need to be optimised for each set of primers; the annealing temperature is 
crucial, since the specific amplification requires that the primers only bind 
to the selected DNA sequence. The optimal annealing temperature is 
determined over a range of temperatures starting from 5 degrees below 
the melting temperature (Tm) of the primer pair, and is increased until a 
single specific product is amplified. Since the Mg2 ion concentration is 
also important and can affect the quantity and specificity of product, it is 
optimised over a range of concentrations between 1-3mM. Additionally 
the DNA template should be free of impurities, and can be extracted with 
an equal volume of PCI and precipitated as described (section 2.2.1.4). 
Generally a cocktail of the PCR components are mixed together, in 
sufficient quantity for the number of reactions, and an alliquot added to 
each sample, so that they are treated similarly. PCR reactions are 
performed in either a 25, 50 or lOOjil volume, topped with 30j.tl of mineral 
oil and placed in a Hybaid Omnigene Thermal cycler (Hybaid, 
Teddington, UK; code TR3 CM220). PCR products were analysed by gel 
electrophoresis. 
b) Isolation of PCR products 
Subsequent manipulations of PCR products require the removal of 
primers, template DNA and the high salt buffer. The PCR clean-up kit 
(Boehringer Mannheim) has been designed for this purpose. The PCR 
product is removed from the tube, leaving the oil behind, and placed on a 
piece of parafilm, by rolling the sample down the film, the last traces of 
mineral oil can be removed. The sample was then mixed with 500ml of 
the supplied binding buffer, and applied to a column. The column binds 
DNA products greater than 100bps and less than 5Kb, so can generally 
remove template, and primers from the reaction. The column was 
washed twice with 500ml of wash buffer, to remove impurities, before the 
PCR products were eluted from the column by lOmi TE or ROP water. 
The DNA could then be used for restriction digests. 
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Cloning PCR products 
Taq polymerase and ExpandTM add deoxyadenosine residues to the 
ends of PCR products. This phenomenon has been utilised in the TA 
Cloning® kit, (Invitrogen; code K2030-01). A linearised plasmid is 
supplied which has complementary deoxythymidine residues, so that the 
PCR product can be ligated to it. The PCR product is specifically amplified 
and added to the ligation mix, containing the linearised plasmid. The 
ligation is allowed to proceed at 16°C overnight and used to transform 
TOP1OF' competent cells, supplied with the kit. The cloned PCR products 
can be identified by blue/white selection of the bacterial colonies grown 
on agar plates, spread with 40jtl of both 100mM IPTG, and 40mg/mi X-gal. 
White colonies indicate an insert has been incorporated into the plasmid, 
which can be confirmed by subsequent restriction mapping. 
Reverse transcriptase- polymerase chain reaction 
RT-PCR, was used to show the presence or absence of specific RNAs, 
within a tissue or expressed in cultured cells. By generating a single strand 
cDNA from the RNA, which was subsequently used as a template for 
PCR. Single stranded DNA was synthesised using the ExpandTM reverse 
transcriptase enzyme (Boehringer Mannheim), which is a genetically 
manipulated version of the Maloney murine leukaemia virus RI 
enzyme. It is engineered to have reduced RNaseH activity, and generates 
single stranded DNA from an RNA template using a random hexamer as 
the primer. A specific DNA product was amplified using the ExpandTM 
Long Template PCR system (Boehringer Mannheim), using specific PCR 
primers, with the products analysed by gel electrophoresis. 
2.2.1.14 Nucleic acid transfer 
There are several methods for transferring nucleic acids onto a 




Southern blotting was performed as described in Sambrook et a! 
(402), a modification of the original method by Southern (411). 
Restriction digests, of small multicopy plasmids, were separated by 
horizontal gel electrophoresis. The gels were then denatured by gentle 
agitation in 1.5M NaCl, 0.5M NaOH, for 30minutes, briefly rinsed in ROP 
water, followed by neutralisation in 1.5M NaCl, 1mM EDTA, 0.5M Tris-
HC1; pH7.2, for an additional 30 minutes. Restriction digests of P1 / BAC 
or genomic DNA's were similarly separated by electrophoresis, however 
the gels were depurinated in 0.25M HC1 for 30 minutes, before 
denaturation. 
The Southern apparatus was set up as follows: a glass plate was 
placed on top of a Pyrex dish containing 20xSSC (3M NaCl, 0.3M 
trisodium citrate), 2 sheets of 3mm Whatmann paper was placed so that it 
covered the glass plate and was submerged in the 20xSSC, to act as a wick. 
Air bubbles were removed and the gel was then placed on top and 
surrounded in parafilm. A piece of nylon membrane (Boehringer 
Mannheim; code 1417240), was cut to the size of the gel and soaked in 
6xSSC before being placed on top of the gel. Air bubbles were removed by 
rolling a sterile glass pipette over the top. Six pieces of 3MM Whatmann 
paper, slightly larger than the gel were then soaked in 6xSSC and placed 
on top of the nylon membrane. Finally paper towels were placed on top, 
followed by a glass plate with the whole apparatus covered in cling film 
(Saran wrap). An 800g weight was placed on top, and the gel left to blot 
overnight. The next day the apparatus was dismantled and the nylon 
membrane baked at 120°C for 30 minutes to an hour, whilst the gel was 
stained in lmg/ml ethidium bromide for 30 minutes, to determine the 
efficiency of the transfer. Pulse field gels were blotted for 48 hours. 
Northern blotting 
The protocol used is based on Sambrook et a! (402). Equal amounts of 
each RNA sample were precipitated (section 2.2.1.4), and resolubilised in 
3.7jfl of DEPC treated water. Subsequently 12.3pl of fresh glyoxal mix (80j.tl 
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DMSO, 16p.l 0.1M sodium phosphate; pH7.0, and 27j.tl deionised glyoxal), 
was added and the samples heated to 50°C for 1 hour, cooled, and loaded 
onto a fresh 1.2% agarose gel, containing 10mM sodium phosphate 
buffer(pH7.0) The gel was then run in 10mM sodium phosphate running 
buffer (pH7.0). Whilst the RNAs were separating the buffer was circulated 
using a peristaltic pump, to maintain the pH. The RNA was transferred 
onto nylon membrane as described for the Southern method. 
c) Bacterial colony lifts onto nylon membranes and lysis of colonies 
Plasmid analysis of low copy plasmids, or screening a large number 
of colonies was simplified by colony hybridisation. A 9cm diameter, nylon 
membrane (Schleicher and Schuell; code 77500), was placed on top of the 
bacterial colonies. The colonies had been cooled on ice, and the filter 
orientated by placing a set of holes round the outside of the membrane 
(see figure 2.11), using a 19 gauge needle, flaming between use. Using 
sterile forceps, the filter was lifted carefully from the plate, and placed 
colony side up onto a dry piece of 3MM Whatmann paper. Four pieces of 
3MM Whatmann paper are then cut to fit inside the lids of four plastic 
trays. One is soaked in 10% SDS, the second in denaturation solution, the 
third in neutralising solution (1.5M NaCl, 0.5M Tris-HC1; pH7.4), and the 
forth in 2x SSC.Any residual solution was removed, to avoid wetting the 
bacterial side of the filter. The filters were placed in the first tray for 3 
minutes, which increases the sharpness of the hybridisation signal, then, 
using sterile forceps, the filters were transferred to the second tray for 5 
minutes, to lyse the cells. They were then transferred to the third tray for 
5 minutes and the final tray for 5 minutes. The filters were then placed on 
a dry piece of 3MM Whatmann paper for 30 minutes to dry, then placed 
between two pieces of paper and baked for 30 minutes to an hour at 120°C. 
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Figure 2. 11 Diagramatic representation of bacterial colony lifts. 
The bacteria are cooled on ice for 10 minutes, and then covered with a 9cm diameter nylon 
filter. The filter is orientated by placing holes around the outside of the filter using a 
sterile syringe needle. The filter is then carefully removed from the plate and the 
bacterial colonies lysed on the filter before hybridisation. 
2.2.1.15 Hybridisations 
a) Southern blots 
Once the nucleic acids have been bound to the filter, specific 
sequences can be identified by hybridising with a 32P-labelled probe. The 
radiolabelled probe binds to the complementary sequences and can be 
identified by exposing the filters to X-ray film. Specifically Southern blots 
were initially wetted in 2xSSC for 10 seconds, before being placed in a 
Hybaid hybridisation bottle (supplied by Hybaid, Middlesex, UK). Then 
25ml of prehybridisation solution was added (5xSSC, 5x Denhardts 
solution, 0.5% SDS (w/v), 1mM EDTA), and 100j.il of 10mg/mi denatured, 
sonicated salmon sperm DNA. The blots were incubated in a Hybaid dual 
hybridisation oven for 2 hours at 68°C, before adding the probe, which 
was left to hybridise overnight. Pulse field blots were left hybridising for 
48 hours. The hybridisation solution was then discarded, and the blot 
washed once at room temperature in Wash 1 (2 x SSC, 0.1% SDS (w/v)). 
This was then followed by 2x 20 minute washes in Wash 1 at 68°C 
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followed by a further wash for 30 minutes at 68°C, and a final 10 minute 
wash at 68°C in Wash 2 (0.1xSSC, 0.1% SDS (w/v)), depending on the 
activity of the blot. The blots were then air dried for a couple of minutes 
and placed in saran wrap, before exposing to X-ray film, in a cassette with 
two enhancement screens. The cassettes were placed at -70°C for a suitable 
length of time, and the film developed in a X-OGRAPHY Compact x2 
developer, supplied by X-OGRAPHY LTD UK. 
Northern blots 
The prehybridisation solution used for RNA blots was 50% (v/v) 
deionised formamide, 5x SSPE, 5x Denhardts solution, 0.5% (w/v) SDS, 
1mM EDTA. These were washed in Wash 1; 2x SSPE, 0.1% (w/v) SDS, and 
Wash 2; lx SSPE, 0.1% (w/v) SDS. 
Randomly labelled hybridisation probes 
This method was based on the Hodgson (412) modification of the 
Feinberg and Vogelsteins method (413, 414) A gel purified template DNA 
(50ng), was mixed with 250ng random primer (1xg/ml), in a screw capped 
eppendorf, made up to 10p1 with TE, and denatured by boiling for 5 
minutes at 100°C. The tube was placed on ice, and the following were 
added, 5il lOx oligodeoxynucleotide labelling buffer (0.5M Tris-HC1; 
pH6.9, 0.1M MgSO4, 1mM DTT, 1mM dATP, 1mM dGTP, 1mM dTTP), 5xl 
a32P-dCTP (3000Ci/mmol), 24j.il ROP water, lixl  10mg/mi nuclease free 
BSA (GIBCO-BRL; code 15561-012), and 2j.tl (2units per/jtl) Klenow 
enzyme. The reaction was then placed at 37°C for 2-4 hours before 
purifying the labelled probe from unincorporated nucleotides by passing 
through a NAP-5 column (Pharmacia Biotech), according to 
manufacturers instructions. The specific activity of the probe was 
calculated by the addition of 2.5j.tl of probe into 2.5mls of Ultima gold 
scintillation fluid (supplied by Packard) and counted in the Liquid 
scintillation counter, (supplied by Packard). Aliquots of probe containing 
2.5-5xlO7cpm were added per 20cm2 blot. 
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d) Oligo labelling 
Oligo's were labelled using a 5' end labelling system. Simply, <5pmol 
of an oligo was added to a screw capped tube, denatured by boiling for 
5minutes, and placed on ice. Subsequently 2.5fl lOx kinase buffer, 5j.il y -
32P-ATP, ijil polynucleotide kinase was added, and the solution made up 
to 25j.tl with ROP water. The reaction was incubated at 37°C for 2 hours, 
before purifying the labelled probe from unincorporated label by passing 
through a NAP-5 column. Oligo hybridisations used the prehybridisation 
solution described by Church and Gilbert (415)(0.25M Na 2HPO4; pH7.2, 7% 
SDS, 1mM EDTA), with the temperature dependent upon the length of 
the oligo. Generally 22 mers were hybridised between 50-55°C, whilst 30-
40 mers, were hybridised at 60°C. The wash solutions used were Wash 1; 
20mM Na2HPO4 ; pH7.2, 1mM EDTA; pH8.0, 5% SDS, and Wash 2; 20mM 
Na2HPO4; pH7.2, 1mM EDTA; pH8.0, 1% SDS. 
2.2.1.16 Sequencing 
Sequencing was performed using the Amplitaq FS Kit from Applied 
Biosystems, which is a modification of the dideoxynucleoside chain 
termination procedure designed by Sanger et a! (416). The new DNA 
strand was synthesised, from the oligonucleotide primer, and was 
terminated once a 2',3'-dideoxynucleoside 5' triphosphate (ddNTPs) was 
incorporated. Each ddNTP is covalently linked to a fluorescent dye, so 
that only one tube was necessary to generate the whole sequence. The 
products were separated on a denaturing polyacrylamide gel, and the 
sequence detected by laser (ABI 377 Automatic Sequencer) which 
distinguishs between the four dyes. Amplitaq FS uses a Taq based enzyme, 
with template extension performed at 60°C, and cycles similar to a PCR 
reaction. Cycle sequencing can provide a higher quality of sequence data 
than normal dideoxysequencing using T7 DNA polymerase, since the 
higher temperatures used decreases the amount of secondary structure, 
allowing the enzyme to proceed along the template. 
Sequencing reactions were performed as described by the 
manufacturer, using 100-200ng of high quality, CsC1 gradient, or Qiagen 
prepared DNA for plasmids, or gel purified fragments, isolated by 
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electroelution, followed by two PCI extractions. The reactions were only 
lOml, to economise on materials. Thirty six samples (resuspended in 3i1 
gel loading buffer), were denatured for 5 minutes at 100°C, and cooled 
rapidly on ice before being loaded. The gel was 0.2mm thick, and 
comprised of 1.0x TBE, 6M urea and 5% (29:1 acrlyamide:bis-acrylamide) 
polyacrylamide gel. This was cast in frames supplied with the ABI 377 
automatic sequencer. Gels were run overnight for 10 hours at 150W at a 
constant temperature of 51°C. Other parameters were limited to 1680V 
and 5OmA. After the run the samples were scanned by the computer to 
check for the correct tracking of the 36 samples, before extracting the 
sequence information. 
2.2.1.17 Linearising P1 and BAC clones 
The generation of transgenic animals requires a linear transgene, to 
increase the chance of integration. This method was based on Linda 
Mullins (417) protocol, using the unique loxP site located within the P1 
and BAC vectors. 
loxP oligos were annealed through a touch down lift off protocol, the 
reaction mix (0.776j.il of B16 (51.6 pmoles/jil), 1.056pi of B17 (37.9 
pmoles/pi), 7.5p1 20x SSC and 15.668i.tl dH20) was placed in a PCR block 
and subjected to the following conditions:- 98-60°C for 1 minute, 
alternating with 60°C for 2 minutes. Excess salt was removed using a 
SpinX column as per the manufacturers instructions (Costar; supplied by 
Sigma-Aldrich; code F-6642). The Cre-lox reaction was performed by the 
addition of 30j.tg P1 or BAC DNA in a volume of 159p1 TE, 21pi  of lOx Cre-
lox buffer (50mM Tris;pH 7.5, 33mM NaCl, and 5mM spermidine; Andy 
Bates; Liverpool University, UK), and 20i1 cre recombinase (kindly 
provided by Andy Bates). The reaction was incubated at 37°C for 1 hour, 
then heated to 70°C for 5 minutes, and cooled on ice. The sample was 
then gently extracted with an equal volume of fresh PCI, incubated for 1 
hour with gentle rocking, before the phases were separated by 
centrifugation for 3 minutes at full speed. The aqueous phase was 
carefully removed and placed into a fresh tube with "chloroform", which 
was left rocking for 20 minutes, before phase separation. The aqueous 
phase was placed on a strip of parafilm to evaporate residual chloroform. 
The sample was subsequently loaded onto a 0.8% agarose gel, in 0.5xTBE, 
in the CHEFDRII pulse field apparatus, and subjected to 1-20 second 
pulses for 22 hours at a constant 6V/cm. 
The marker tracks, and a small sample of the linearised BAC was 
stained in ethidium bromide (1 jig/mi in ROP water), for 30 minutes, and 
the fragment representing the linearised clone was excised, and placed in 
an H202 treated small gel tray, at a 900  angle to original orientation. This 
was surrounded by 4% Nusieve low melting point agarose, and subjected 
to electrophoresis, 30V, at 4°C overnight. The BAC/Pi DNA became 
concentrated in the 4% agarose, and was subsequently isolated from the 
agarose by agarase treatment (-agarase; New England Biolabs). The gel 
slice containing the concentrated DNA was equilibrated in 2 volumes of 
lx agarase buffer, at 4°C overnight. The buffer was changed and left on ice 
for a further 30 minutes. The gel plug was weighed, after removing the 
buffer, and the sample heated to 68°C for 5-10 minutes, to melt the 
agarose. The tube was then spun for 10 seconds, at high speed, and heated 
for a further 2 minutes. The DNA was cooled to 40°C for 10 minutes and 4 
units of -agarase was added for each lOOj.tg agarose (the enzyme was 
warmed before it was added to ensure that the agarose did not set). The 
tube was then incubated at 40°C for 2 hours. The tubes were cooled on ice 
to ensure that the agarase treatment was successful, and the tubes spun 
for 10 minutes at maximum speed. The DNA was then transferred to a 
clean tube and stored at 4°C. 
An aliquot of the linearised DNA was analysed by pulse field gel 
electrophoresis, using the same conditions as before. The sample was 
dialysed against injection buffer (10mM Tris-HC1;pH7.5, 0.1mM EDTA 
with an additional 0.1M NaCl), for 2 hours. The concentration was 
determined by spotting 2p.l  onto a microscope slide, covered in 1% 
agarose, in 0.5x TAE, and containing lp.g/ml ethidium bromide, which 
was previously spotted with a range of concentrations of A. DNA from 
25ng to 0.5ng. The DNA is diluted to give a concentration of 1-2ng/ml 
and used for microinjection. The DNA was introduced into fertilised 
pronuclei, derived from the Fl mouse line (CBA-057/BL6 cross, which is 
Ren-ic ), and reintroduced to a pseudopregnant mother of the same line. 
Gillian Brooker and Morag Meikle were responsible for the animal 
handling, day to day care, and microinjections. 
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2.2.2 Cell culture 
All cell culture work was performed with the As.4.1 cell line 
(Sigmund et a! 1990), which was grown in a 1:1 ratio of DMEM:F12 
medium, with Hepes (15mM), bought in powdered form (code 42400-010; 
GIBCO-BRL). The medium was prepared using UHP water (Elgastat Prima 
reverse Osmosis Filter followed by an Elgastat UHP water purifier), 1.125g 
was added to the solution before filtration through 0.22mm falcon bottle 
top filter (code 7111; supplied by Becton Dickinson). Foetal calf serum 
(Sigma batch number 3364), at a concentration of 10%, was added to the 
media. 
2.2.2.1 Maintaining the As 4.1 cell line 
The As4.1 cell line was maintained as follows; a frozen vial of cells 
was thawed in a 37°C water bath and placed in lOml of DMEM:F12 
medium containing 10% foetal calf serum. This dilutes the DMSO used in 
the freezing medium. The cells were harvested by centrifugation at 220g 
(1,200rpm, Denley BS400 bench top centrifuge, supplied by Life Sciences 
Intl. (UK) Ltd., Basingstoke, UK)) for 5 minutes, the supernatant aspirated 
and the cells resuspended in lOml of fresh medium. The cell suspension 
was placed in a 125 flask, gassed for 10 seconds with CO2 and placed in a 
37°C incubator. The medium was changed 8 hours later to remove any 
traces of DMSO which could inhibit cell growth. Within 3 days the cells 
were confluent, and were passaged. Cells were washed twice in lOml PBS, 
and then trypsinised by the addition of lml TVP (0.025% trypsin ( GIBCO-
BRL; code 25090-010), 1% chicken serum (GIBCO-BRL; code 16110-033), 
0.5M EDTA dissolved in PBS) to the flask. The cells were incubated at 
room temperature for 30 seconds. to 1 minute and then dislodged by 
hitting the side of the flask with the side of your hand. Then lOml of 
medium was added to neutralise the trypsin. The cell suspension was 
repeatedly pipetted to generate a single cell suspension. This was 
harvested by centrifugation, as described previously, then resuspended in 
lOml of medium. The cell count was determined using a hemacytometer, 
5x 10 cells were seeded into a 125 flask in lOmi of medium, or 2x 106  cells 
were used to seed a T75 in 20m1 of medium. Flasks were gassed as before, 
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and the medium changed every two days until confluent, usually within 
5-6 days. 
2.2.2.2 Freezing cells 
Cells were routinely frozen to maintain frozen stocks, as follows; 
once the cells were confluent, they were trypsinised as before, with 10% 
(v/v) DMSO added before centrifugation. The cells were then 
resuspended in freezing medium containing 10% DMSO. A T75 flask was 
spilt into 8-10 vials of 0.5m1 per vial, whilst a T25 was split between two 
vials, and stored at -80°C overnight. The vials were then transferred to 
the liquid nitrogen freezer (Minnesota Valley Engineering Cryogenics; 
code XLC110; Supplied by Cryotechnics, Edinburgh, UK). 
2.2.2.3 Introducing exogenous DNA into mammalian 
cells 
Plasmid DNA was introduced into the As 4.1 cell line by 
electroporation or lipofection. 
a) Electroporations 
The electroporation method was performed as instructed by Colleen 
Kane, (Roswell Park, Buffalo, NY, USA). Briefly, a confluent As4.1 T25 
flask, was trypsinised as described above, apart from Optimem I medium 
(low serum medium Gibco; code 11058-021) was used to stop the trypisin 
reaction. One sixth of the cells were used to seed a fresh T25 flask, and 
grown in Optimem I medium (with 2% FCS and 1 x A1buMAXTMII (Gibco; 
code 11020-013)). They were grown to confluency and then trypsinised. 
The trypsin reaction was stopped with the addition of 5m1 of Optimem 
medium and stored on ice. They were then spun for 5 minutes at 220g 
(1200rpm in the Heraeus bench top centrifuge), and resuspended in 5 ml 
of HeBS buffer (70mM NaCl, 2.5mM KC1, 0.375mM Na 2HPO 4, 3mM 
dextrose and 12.5mM Hepes). The cells were respun as before and 
resuspended in 500R1  of HeBS buffer. The cell suspension was then placed 
in the cuvette along with 35p.g plasmid DNA. A BIORAD Gene Pulser 
electroporator was used with a capacitance expander, the condtions were 
960 jiFd, 300 or 250Volts. The cells were subjected to an electrical current 
and immediately added to prewarmed medium, DMEM:F12 plus 10% 
FCS, and placed into a fresh T25 flask. The cells were left in an incubator 
for 2 days before the cells were fixed and analysed for -Ga1actosidase 
activity. 
b) Lipofection 
The lipid transfections were performed as the manufacturers 
instructions. A confluent T25 flask was trypsinised and the number of 
cells counted. Each well of a 6 well plate (Corning or Iwaki, supplied by 
Becton Dickinson) were seeded with 2.5 x 10 5 cells and incubated at 37°C 
overnight. The next day 2p.g of plasmid DNA was mixed with 98jt1 of 
Optimem I medium and placed in a universal tube. Additionally 12pg 
Lipofectin reagent (Gibco; code 18292-011) was made up to 10Op.1 with 
Optimem I medium. The two solutions were mixed together and left at 
room temperature for 15 minutes. The cells, which were 60% confluent, 
were washed twice with PBS and 0.8m1 of Optimem I was added to each 
well. The DNA/lipid complex was then dropped onto the medium and 
incubated for 6 hours at 37°C. After this time the DNA/Lipid solution was 
aspirated from the cells and 2m1 of normal medium added and the cells 
were incubated for 2 days at 37°C. The cells were then fixed and analysed 
for -Galactosidase activity. The Perfect Lipid kit (code K925-01) from 
Invitrogen, used the same conditions. 
2.2.2.4 3-Ga1actosidase assay 
Cell monolayers were washed twice with 5 ml of PBS, and the cells 
subsequently fixed for 15 minutes in glutaraldehyde solution (0.1M 
sodium phosphate buffer;pH 7.3, 1.0mM MgC12,0.2% glutaraldehyde). The 
cells were then washed three times in 5m1 PBS, then stained with 1.5m1 
X-gal solution (0.1M sodium phosphate buffer;pH7.3, 150mM NaCl, 
1.0mM MgCl2, 3.3mM K4Fe(CN) 6, 3.3mM K3Fe(CN) 6, 0.2% X-gal), and 
incubated at 37°C overnight. The X-gal stain is removed, the cells washed 
twice with PBS, covered in fresh PBS and observed with a light 
microscope. 
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2.2.2.5 Explant cultures 
As a means to derive conditionally immortalised cell lines, an 
explant culture method was used, as instructed by Katrina Gordon, 
(Roslin Institute, Midlothian, Edinburgh, UK). 
Transgenic mice expressing the temperature sensitive TAg (A58 
mutation), were sacrificed and the kidneys removed and placed into 
Dissection medium (50mls M199 medium; supplied by Gibco code 22340-
020, lOmis antibiotic/antimycotic; Gibco code 15240-039, 5mis of a 
lOmg/ml gentamycin solution; Sigma, code G1272). The tissue culture 
flasks were treated with 5m1 of collagen solution (0.1% collagen type 1 
(Sigma code C18919) diluted in 0.1M acetic acid) which was left on the 
plates stored at 4°C overnight, and washed three times with 5m1 PBS 
before use. The kidneys were decapsulated and cut into 1mm3 blocks, and 
placed gently onto the collagen coated flasks. One and a half millilitres of 
growth medium (SOOml M199 medium with 500p.l of 5mg/ml bovine 
insulin (Sigma code 11882), 500pil 5mg/mi hydrocortisone (Sigma code 
H4881), 500j.tl of lOp.g/ml epidermal growth factor (Sigma code E4127), 
1.1ml 45% glucose solution and 2.5m1 of 10mg/mi gentimycin) was placed 
around these explants, which were subsequently gassed and placed in an 
incubator at 33°C, 5% CO2. The medium was replaced daily and after two 
weeks the explants were removed and normal growth medium was used 
(DMEM;F12 plus 10% fetal calf serum, 5ng/ml EGF, lOng/ml insulin, 
5jig/ml Linoleic acid and 50jtg/mi gentimycin. The cells were maintained 
as previously described and analysed for renin expression. 
2.2.2.6 Prorenin and renin protein assays 
The As4.1 cell line secretes prorenin into the supernatant. In order to 
measure the prorenin secreted, supernatants were analysed, by the 
method of Peters et a! (418). To prevent prorenin activation serum-free 
medium was exchanged for normal medium one day after passaging. 
This was left on the cells for two days before being collected for analysis. 
Total renin concentration was calculated by activating 2x 20j.il 
aliquots of supernatant with 40tl trypsin solution (400 units/ml trypsin, 
dissolved in TES buffer (0.1M N-Tris(hydroxymethyl)methyl-2-
aminoethane-suiphonic acid; pH7.2, 0.01% neomycin, 10mM EDTA)). 
Samples were left on ice for 10 minutes, and the activation stopped by the 
addition of 40pi  of soybean trypsin inhibitor (600 units/mi, in TES buffer). 
Active renin was measured by the addition of 80pi of TES buffer (without 
trypsin), to 20jxl of supernatant. Each pre treated sample was split into 
three tubes, (6 tubes per original supernatant sample), and incubated with 
lyophilised renin substrate (angiotensinogen). This was isolated from 
nephrectomised rat plasma (final concentration; 80mg/mi, 0.11% 2,3-
dimercapto-1-propanol, 1.15mg/ml 8-hydroxychinolin in TES buffer), for 
1-3 hours at 37°C. The reaction was stopped bythe addition of RIA buffer 
(0.1M Tris-acetate; pH7.4). The AngI generated by renin in the supernatant 
was measured by radioimmunoassay (419, 420). The 6 measurements 
were averaged (for each assay), to gave a value with an error of 15%. The 
prorenin activity in the supernatant was determined by the difference 
between total renin activity and active renin activity. 
2.2.3 Physiological analysis 
The expression of lacZ in transgenic positive animals was 
determined by staining kidneys from day 15.5p.c through to two week old 
pups. Embryos taken at E13.5 and E14.5 were decapitated and frozen in 
OCT fluid. Due to endogenous 0-galactosidase activity, all staining 
procedures were performed at pH8.5, at room temperature for 48 hours to 
prevent the conversion of X-gal by endogenous -galactosidase like 
enzymes. 
2.2.3.1 Whole mount staining 
Animals were sacrificed by vertebral dislocation after carbon dioxide 
anaesthesia, and kidneys and adrenals were extirpated immediately from 
embryo's and pups. One kidney, plus adrenal, was placed in fixative (0.1M 
sodium phosphate buffer;pH8.5, containing 0.2% (w/v) gluteraldehyde, 
5mM EGTA and 2mM MgCl2), for 1 hour at room temperature, followed 
by 3x 20 minute washes (1M sodium phosphate buffer;pH8.5, containing 
2mM MgCl2, 0.01% (v/v) deoxycholate and 0.02% (v/v) nonidet-P40). 
Adult kidneys were fixed over night due to the size of the tissue. The 
kidneys were then stained in X-gal solution (lmg/ml 5-bromo-4-chloro-3-
indoly1-3-ga1actoside in 0.1M potassium phosphate buffer; pH8.5, 0.4 M 
K4Fe(CN)6.3H20), for 48 hours at room temperature. The staining was 
stopped by rinsing the kidneys for 3x 20 minutes in PBS containing 3% 
(v/v) DMSO. Finally the tissue was rinsed three times in 70% ethanol, 
prior to storage at 4°C in 70% ethanol. The kidneys were observed 
through an Olympus SZX binocular light microscope, and pictures taken 
with Kodak Ektachrome 64T film. 
2.2.3.2 Kidney sectioning and staining 
The second kidney, and adrenal, from each of the above animals, 
were mounted in OCT compound embedding medium (Tissue Tek; Miles 
Inc, Diagnostic Division, Elichort, IN USA; code 4583), followed by rapid 
freezing on dry ice. OCT blocks were kept at -70°C until required. Frozen 
sections were prepared using Cryotomb 650 (supplied by Anglia Scientific, 
UK). The blocks were kept inside the chamber for 1 hour before use, to 
equilibrate with the temperature of the chamber, -18°C. Frozen sections, 
(20mm) were mounted into polysine coated slides (purchased from BDH; 
code 406/017/00), and fixed for 1-2 minutes, as above. The slides were 
then washed 3x 5 minutes in wash solution (as above, but without the 
deoxycholate and nonidet-P40), and then stained for 48 hours at room 
temperature. The sections were then rinsed in wash solution, before 
counter staining with Haemallum (BDH; code 35060), for 30 seconds, 
followed by rinses in ROP water until clear, and further staining in Eosin 
for 90 seconds (0.1% (w/v) eosin in 70% (v/v) ethanol, and 0.5% (v/v) 
glacial acetic acid; eosin Y powder, Sigma-Aldrich; code E-6003). This was 
followed by successive dehydration in 95% and 100% ethanol, and 100% 
isopropanol, cleared in histoclear (National Diagnostics; code HS-200), 
and briefly air dried before mounting (Histomount; National Diagnostics; 
code HS103) and covering with coverslip. The slides were dried 
overnight, to let the mountant set. Sections were observed through a 
Leitz Laborlux 5, binocular light microscope, and pictures taken using 
Kodax Gold 100 film. 
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Chapter 3 
Renin expressing cell lines 
3.1 Introduction 
The molecular organisation and structure of the renin genes can be 
investigated through traditional molecular techniques (123, 124, 132, 134, 
139). However to identify regulatory elements governing renin 
expression, appropriate reporter constructs can be used to generate 
transgenics, or be introduced into mammalian cells where the level of 
renin or reporter gene expression can be compared. Initial transgenic 
studies (175, 227, 228) and deletion constructs expressed in cell culture 
have identified several elements regulating renin expression (274, 276, 
278,421). 
JG cells either constitutively secrete prorenin, or can be stimulated to 
release stored active renin into the circulation, to maintain mean arterial 
blood pressure (3, 4). Extra renal sites of renin expression are believed to 
release prorenin which may be involved in autocrine or paracrine RAS. 
Some inbred mouse strains have a single renin gene Ren1c,  which in JG 
cells can either be constitutively secreted as prorenin or stored as active 
renin, whilst the situation in two renin gene mouse strains is 
hypothesised to be slightly different, with renin-2 secreted as prorenin 
and renin-1 stored in granules. Renin release maybe differentially 
regulated in JG cells from different strains and between cell types, 
suggesting that care should be taken when choosing a cell line with which 
to work with. Since we are interested in studying Ren-1" and Ren-2 
expression and trafficking in modified smooth muscle cells we require a 
mouse derived JG cell line. 
Primary JG cell cultures have been used to investigate renin 
secretion (90, 259), but the isolation of this cell type is difficult since these 
cells make up less than 0.1% of the total cells of the kidney. It is possible to 
enrich for JG cells by utilising Percoll gradients (90), however once in 
culture they lose the ability to express renin within three weeks (259). The 
As 4.1 line (228), is the best model system available to characterise murine 
renm expression to date. 
3.2 The As 4.1 cell line 
The As 4.1 cell line was derived from a kidney tumour, in a 
transgenic mouse harbouring the SV40 Tag fused to the Ren-2 promoter 
(228). (SV40Tag can induce tumours, by stimulating cell proliferation. The 
oncogenicity is due, in part, to the ability of SV40Tag to bind and sequester 
p53 and Retinoblastoma (Rb), simultaneously. This association results in 
p53 being unable to act as a transcription factor, or bind to transcription 
factors, with Rb no longer able to interact with the proteins by which it 
negatively regulates growth (422). Transgene positive mice developed 
tumours in the kidney, subcutaneous tissue, adrenal gland and testes. The 
kidney tumours were extirpated and propagated in nude mice. The 
resultant tumours were seeded into culture dishes and established as 
continuously growing cultures. These non clonal cell lines were analysed 
by Northern blot analysis for endogenous renin, and transgene 
expression. All culture lines expressed Ren1C at levels as great as 25% of 
the total tumour, and subsequent clonal cell lines were isolated by serial 
dilution. Clone 4.1 was chosen because it had equal quantities of renin 
and prorenin within the cell and ultrastructure analysis identified storage 
granules morphologically similar to those in kidney JG cells. This cell line 
was initially responsive to 8- bromo cyclic AMP, releasing 2.3 fold more 
active renin after 4 hours, and 4.6 fold after 15 hours of treatment. This 
response subsequently diminished (personal communication George 
Hadjucek, SUNY, Buffalo, NY, USA), indicating that these cells had lost 
their ability to respond to external stimuli. 
3.2.1 Maintaining the As 4.1 cell line 
As 4.1 cells can be identified by the dense secretory granules located 
in the cytoplasm, and constitutive secretion of prorenin into the 
supernatant. The amount of prorenin these cells secrete depends upon 
the growth conditions, so initial experiments to establish these cells 
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within the Centre for Genome Research Tissue Culture facility, were 
performed to identify the optimal growing conditions. 
3.2.1.1 Serum batch testing 
Four companies were asked to send samples of their European foetal 
calf serum (FCS), Harlan Sera-lab LTD (Dodgeford lane Loughborough, 
UK), Globepharm (Esher, Surrey, UK), Gibco and Sigma, (see Table 3.1). 
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A vial of As 4.1 cells, Passage 12, was thawed and pipetted into lOmls 
DMEM:F12 medium (Gibco), with 10% FCS, to dilute the DMSO present 
in the freezing medium, (initial culture conditions used the 'in house' 
FCS, GP batch number 4120). The cells were harvested by centrifugation, 
220g for 3 minutes, and the supernatant aspirated off. The cell pellet was 
resuspended in lOmis of fresh medium, then seeded into a 9cm tissue 
culture dish and placed in a 37°C incubator with 5% CO2. The medium 
was changed after eight hours to ensure that all traces of DMSO had been 
removed. 
After four days the cells reached 100% confluency. The cells were 
trypsinised as described in section 2.2.2.1 and counted using a 
haemocytometer. The counting square represents 1pl of cell suspension, 
and cells are counted within the 25 smaller squares using the north/west 
faces, (see Figure 3.1). The cell count was calculated by averaging the 
number of cells within the two counting squares. This number was then 
multiplied by 10, then again by the number of mis in the cell suspension 
to give the total number of cells. A 9cm dish generates approximately 
4x10 6 cells. Nine 9cm dishes were seeded with 4x105 cells per dish, one 
dish for each serum sample. The cells in the different sera were grown to 
confluency, passaged and used to seed an additional two 9cm dishes, 4x10 5 
cells per dish. The medium from one of these dishes was collected and 
Ef 
cells located within 
the 25 counting 
squares and any 
placed on the 
north/west faces are 
counted 
analysed for prorenin content, by radioimmuno assay, ((418)Dr Jorg 
Peters, University of Heildberg), whilst the cells from the other dish were 
used to maintain the cells in the different sera. 
Figure 3.1 Haemocytometer to count cells 
cell susnension 
Constituents of serum affect the prorenin assay, and so the cells were 
grown in serum-free medium for three days before collection. The 
medium was spun at 220g for five minutes, and duplicate samples were 
treated as follows:- 800jil of medium was added to 200p.l glycerol and lOpi 
0.1M DTT and frozen on dry ice, and sent to Dr Peters. See Table 3.2 for 
the results. 
Table 3.2 The effects of different sera on prorenin release 




Gibco 	3840 70% 4496 1.25% 
9244 80% 6678 0.67% 
Globepharm 2855 80% 9135 0.95% 
4120 70-80% 7069 1.2% 
4123 60% 2768 0.7% 
Seralab 	001038 90% 7498 2% 
201101 60-70% 10272 1.16% 
301101 90% 7661 1.4% 
Sigma 	3364 60-70% 11263 0.75% 
The results of the prorenin assay show the wide variation in 
prorenm released and indicated that the FCS from Sigma induces the 
highest prorenin secretion into the supernatant. This FCS was 
subsequently used in all future cultures. The various levels of confluence 
reached (Table 3.2.) was thought to reflect the change in growth due to the 
addition of the different batches of sera. 
3.3.1.2 Additional factors 
The confluency of the cells might have affected prorenin release, to 
give the results in Table 3.2. Additionally Passage number and the type of 
plastic the cells are grown on might also effect the production and release 
of prorenin. TC flasks are treated to alter the charge of the plastic allowing 
cells to attach. Companies use various methods, Corning (Acton, MA, 
USA) use UV light exposure whereas Falcon use plasma gas. Cells were 
grown on both Corning and Falcon flasks to identify whether the type of 
plastic had any effect on renin expression. RNA was isolated from cell 
cultures at different Passages and at various confluences to compare renin 
expression. Twenty micrograms of RNA was used from each sample and 
compared to 20ig liver and 5p.g submaxillary gland RNA, (obtained from 
a pubescent male; 129/01a mouse strain). The Northern blot was 
hybridised with the renin cDNA probe, and with GAPDH as a loading 
control (see Figure 3.2). 
The results of this analysis indicate that the Passage number, (lanes 8 
and 9 compared to lanes 1 and 5), and the type of TC flask used, (lanes 6 
and 7 compared to lanes 5 and 3), has no effect on the amount of renin 
expressed in these cells. However the confluency of the cells has a 
dramatic effect. The lower percentage confluency had very little renin 
within the cells, but as the confluency increased so did the amount of 
renin. The blot was also probed with GAPDH, which is ubiquitously 
expressed in all cells, to ensure that the observed difference was not due 
to variation in the amount of RNA loaded for each sample. 
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Figure 3.2 The effect of confluency, Passage number and tissue 
culture flask on renin expression in the As4.1 cell line. 
All cells were grown on Coming flasks unless otherwise stated, and represent 
20ig of RNA. The upper panel shows the blot probed with the renin cDNA, 
whilst the bottom panel represents GAPDH as a loading control 
lane 1, P13 100%cfl; lane 2, P14 100% cfl; lane 3, P14 807o cfl; lane 4, P15 1007o cfl; 
lane 5, P15 60% cfl; lane 6, P15 60% cfl (falcon); lane 7, P15 80% cfl (Falcon); 
lane 8, P27 607o cfl; lane 9, P29 100% cfl; lane 10, liver RN; lane 11, Sjig SMG RNA 







The morphology of the cells was observed to change depending on 
whether the cells were grown in dishes or flasks. The incubators used for 
these experiments are in continuous use and so CO2 levels are 
continually fluctuating. Cells grown in 9cm dishes are susceptible to 
changes in the CO2 level, as they are not sealed, whereas TC flasks are 
relatively resilient to change since they are gassed and sealed. Cells grown 
in dishes are small with thin protrusions radiating from the cells, whilst 
in tissue culture flasks they are rounded, without any protrusions, (Figure 
3.3). Differences in the CO2 level alters the pH balance in the culture 
medium which is thought to be the reason for the altered morphology. 
All subsequent experiments were performed in flasks where appropriate. 
3.3 Introducing exogenous DNA into the 
As 4.1 cell line 
To compare the renin expression from different constructs they have 
to, be introduced into the cell by transfection. There are various 
techniques available, and some of these were used to optimise the 
transfection conditions for this cell line which is known to be difficult to 
transfect. 
3.3.1 Electroporation 
Electroporation has been used to introduce DNA constructs into this 
cell line (282, 283, 423); Colleen Kane personal communication, Buffalo 
USA), so this was the first method tried. The reporter gene construct 
pSVJ3Ga1 (Figure 3.4), was utilised to identify transfection efficiencies, 
whilst pRen2-IRESI3—Geo construct, (Figure 3.5), was used to show that 
the Ren-2 promoter is active in these cells. Two different Passage 
numbers were used to identify whether efficiency is affected by long term 
culture. 
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Figure 3.3 The As 4.1 cells in culture. 
40% confluent, grown in 9cm dishes, the cells are thin, with long protrusions radiating 
from them. 
90% confluent grown, in T25 flasks, the cells are more rounded. 
Pictures were taken at xlO magnification 
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Figure 3.4 A diagramatic representation of pSV-Ga1actosidase 
plasmid from Promega. 
SV40 promoter and 
enhancer 
.. 





COMMENTS: This plasmid was designed by Promega, as a positive control for 
monitoring transfection efficiences of mammalian cells. The SV40 early promoter 
and enhancer drive transcription of the bacterial lacZ gene which in turn is 
translated into the [-galactosidase enzyme. -Ga1actosidase activity can be 
assayed quickly and directly by fixing and subsequent staining with the substrate 
X-gal, or by spectrophotomeric assay. 
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Figure 3.5 A diagramatic representation of the pRen2 IRES f3-Geo 
plasmid. 









Exon 3 Ren2 promoter 
Exon 2 
Exon 1 
LAB I.D. NO. JJM-125 (construct generated by Hazel Clarke). 
INSERT: A 9.7kb XhoI/KpnI Ren2 promoter fragment fused to a 5.1kb NotI/Sall 
IRES-fi-Geo reporter cassette including poiy A signal. 
COMMENTS: pRen2 IRES-fl-Geo is a mouse DBA/2 Ren2 gene promotér-fl-Geo 
reporter fusion construct designed to direct 1-galactosidase and neomycin resistance 
activities to sites of Ren2 expression in transgenic animals, or transfected into 
mammalian cells which express renin. This plasmid was constructed by insertion of 
an approx. 5kb NotI/Sail fragment from pIRES-J3-Geo (JJM-126), which contains an 
internal ribosome entry site upstream of aJ3-gai/neomycin fusion and 5V40 poly A 
signal,downstream of a DBA/2 Ren2 genomic 9.7kb XhoI/KpnI promoter fragment 
extending from the XhoI site positioned 5.6kb upstream of the transcription 
initiation site to the KpnI site in exon 3. The complete transgene can be excised from 
the plasmid as a XhoI/SalI double digest. 
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The DNA was precipitated before use to ensure sterility, and 
resuspended in an appropriate volume lx TE, to generate a 1mg/mi 
concentration. A confluent T-75 flask was trypsinised, and the cells added 
to 5mls of medium, and kept on ice. The cells were harvested by 
centrifugation, 220g for 5 minutes, and the pellet resuspended in 5mls lx 
HeBS buffer. The cells were pelleted and resuspended in 500jil of HeBS 
with 500p.g of Salmon sperm DNA and placed into a BIORAD 0.4cm gap 
electroporation cuvette, along with either 30ig of pSV 13—Gal or pRen2-
IRESJ3—Geo plasmid DNA. The pulse conditions advised, 300V-1180p.F, 
were not achievable with the equipment available so different conditions 
were tried, (see Table 3.3). Cells were seeded into T25 flasks after the 
electroporation and incubated with penicillin/streptomycin, (1/100 
dilution of stock solution purchased from GIBCO; code 15140-031). After 
48 hours the cells were confluent and were fixed and stained for - 
Galactosidase activity. 
Table 3.3 Comparing electroporation conditions with two plasmids and 
two Passage numbers. 
DNA used Settings used Percent and number of blue cells 
Passage 16 Passage 23 
960pFd,300V 0 0 
pSV fJGal 960j.Fd,300V 1%, 43 1-5%, 60 
pSV f3Gal 960 jtFd,250V <1%, 15 1% 20 
pRen2-IRES 
/3Geo  
960pFd,300V <0.1%, 2 0 
pRen2-IRES 
f3Geo 
960pFd,250V <0.1%, 1 0 
The results of this electroporation were disappointing. The pSVf3-
Gal plasmid indicated electroporation efficiëncies of 1-5%. Whilst the 
pRen2-IRESJ3—Geo construct had an efficiency of less than 0.1%, although 
the observation of blue cells does show that the Ren-2 promoter is active 
in these cells. The experiment shows that high Passage numbers did not 
adversely affect transfection efficiencies. 
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3.3.2 Lipofection 
The use of lipids to introduce DNA into cells is a relatively new 
technology. The DNA is incubated with the cationic lipid reagent at a 
ratio of 1:6 respectively. The lipid binds to the DNA, and this complex is 
then added to the cell culture medium. The positive charge of the lipid 
induces binding to the cells lipid membrane. The complex is internalised 
and the DNA incorporated into the cell. Initial experiments used the 
Lipofectin reagent from GIBCO, (see Chapter 2.2.2.3 for experimental 
conditions). The lipid/DNA complex was left on the cells for 6 hours and 
was then exchanged for regular culture medium. After 48 hours the cells 
were fixed and assayed for —Galactosidase activity. The results of this 
experiment can be seen in Table 3.4 and Figure 3.6. 
Table 3.4 As 4.1 transfection efficiency using the Lipofectin reagent 
Amount of 
Lipofectin 
Percentage and number of 
blue cells observed 
Percentage and number of 
blue cells observed 
pSV 13—Gal pRen-2 IRES ,(3—Geo 
P16 P23 P16 P23 
control 0 0 0 0 
2p1 <1%, 6 <1%, 16 0 <0.1%, 1 
5j.tl 5-10%, 136 5-10%, 140 <0.1%, 2 <0.1%, 5 
ioi 5%, 84 5-10%, 131 <0.1%, 1 <0.1%, 5 
15ji. 5-10%, 168 10-15%, 205 0 <0.1%, 1 
20.t <5%, 34 5%, 96 0 0 
These results show an increase in transfection efficiency compared to 
electroporation. Five to ten percent of the total cells were stained blue, 
when 5-15p.l of the Lipofectin agent was used. This was still very low, and 
so additional lipids were tried. 
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Figure3.6 Introducing pSV-Gal into the As 4.1 cells by Lipofectin. 
control plate, incubated with the lipid without any DNA and stained with X-
gal. No blue cells were observed. 
pSV-Geo plasmid introduced into the As 4.1 cells, and stained with X-gal. 
Approximately 5% of the cells were stained blue. 
Pictures were taken at xlO magnification. 
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The Perfect Lipid kit from Invitrogen, consists of a range of eight 
lipids, (see Table 3.5) to select for the perfect lipid for a given cell line. The 
transfection conditions are similar to those for Lipofectin, 2jig pSVJ3—Gal 
was mixed at a 1:6 DNA to lipid ratio and incubated with the cells at 60% 
confluency for 6 hours. The results of this experiment can be seen in 
Table 3.5, which are the mean efficiencies of duplicate samples. 
Tih1e ç Trnsfertion efficiencies with the Invitroeen Perfect Lipid KIT. 
Lipid Composition Moles of 
positive 




Pfx-1 1:1 mix of two lipids 2.20 x 10-9 5.08% 
Pfx-2 Single lipid 2.08 x 10 9 13.2% 
Pfx-3 1:1 ratio of lipid: DOPE 1.52 x 10-9 19.25% 
Pfx-4 1:1 mix of two lipids 1.73 x 1% 
Pfx-5 1:1 mix of two lipids 3.00 x 10-9 0.45% 
Pfx-6 1:1 ratio of lipid: DOPE 1.07 x 10-9 2.3% 
Pfx-7 1:1 ratio of lipid: DOPE 1.56 x 0.88% 
Pfx-8 Single lipid 3.05 x 0.64% 
These results indicate the marked differences in efficiencies between 
the lipids. Lipid Pfx-3 was chosen and further optimised for large scale 
experiments. 
Pfx-3 was used to transfect the As 4.1 cell line with the pRen-2 IRES 
/3—Geo construct. The efficiency was similar to that observed with 
Lipofectin, less than 0.1%. There appears to be a drop in efficiency as the 
size of the construct increases, pSVJ3—Gal is 7Kb whilst pRen2-IRES/3—Geo 
is 17Kb. The /3—Geo gene is a fusion of /3—Galactosidase and the neomycin 
resistance gene, therefore G418 can be used to select for positive clones. 
This antibiotic was added to the culture medium of a subsequent 
experiment 48 hours post transfection, at a concentration of lOOp.g/ml, 
however no cells survived. Given the above transfection efficiency of 
0.1% with this construct, the lack of cell growth might be due to the cell 
density being too low. 
The As 4.1 cell line originated from a kidney tumour. These cells 
express Ren1C and are assumed to have originated from JG cells. 
However Tag expression has been observed throughout the renal 
vasculature, in the adult animal (424). This indicates that the tumour 
might have originated from vascUlar smooth muscle cells, since these 
cells would have expressed renm during development. This cell line has 
lost its ability to respond to external stimuli, and so might not be useful 
for stimulatory studies. Though this cell line is still valuable and has been 
used to identify regulatory elements in the renin genes (282, 283) and 
novel mRNAs (423) expressed in these cells. The lack of stimulated 
expression indicates a requirement for an immortalised JG cell line, 
which would resemble the in vivo function of JG cells more clearly. 
3.4 The isolation of conditionally 
immortalised JG cell lines 
The expression of SV40 Tag as a means of inducing immortality has 
been successfully used for the development of numerous cell lines. 
However such cell lines have been derived from tumours which might 
have undergone multiple genetic aberrations (425, 426). Additionally 
SV40Tag has transforming activities, albeit weak (427)which could lead to 
dedifferentiation and a loss of response to external stimuli. 
Immortalisation without transformation requires the presence of 
SV40 so that cells can be grown indefinitely and the ability to switch off 
SV40 Tag expression to attain the fully differentiated phenotype. 
Temperature sensitive (ts) SV40Tag mutants contain a single amino acid 
change making it thermolabile at 39°C (428). The Tag mutation, tsA58 was 
used to generate the immorto mouse (429-431) The H2Kb promoter was 
fused to the tsA58 Tag mutant, and used to generate transgenic mice. 
Since tsTag is only active at the permissive temperature of 33°C, it should 
be inactive in animals (whose body temperature is 39°C), and should not 
induce tumours. In a number of transgenic founders high Tag expression 
corresponded with expression of Tag at the non permissive temperature 
and induced tumours in the mice. The immorto mouse was established 
from a founder animal which had no incidence of tumours, and had low 
level of Tag expression at 33°C which could be induced by y-interferon. 
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This Tag tsA58 mutant along with an additional U19 (432) mutant 
have been used to generate transgenic mice expressing tsTag in Ren-2 
expressing cells (A. Downing MPhil Thesis 1996). The same promoter 
sequences used to generate the As 4.1 cell line, were fused to the SV40 Tag 
ts mutants. Eight founder animals (TGMR2TsTagPA) were generated, 
seven of which developed subcutaneous tumours. F9080 was the only 
founder line not to develop tumours, and this line, along with F4933B 
and F9070 lines, which had shown a low incidence of tumours, were used 
in an attempt to generate conditionally immortal cell lines. 
3.4.1 Explant culture conditions 
Explant culture has been successfully used to generate a primary 
mammary cell, conditionally immortal cell line (Katrina Gordon, Roslyn 
Institute, Edinburgh). This protocol was chosen to try and isolate JG cells 
from the transgenic animals R2TsTagPA. 
Kidneys were expirated from transgenic animals, which were 
approximately two months of age, and put into dissection medium, (see 
Chapter 2.2.2.5 for experimental details). The kidneys were decapsulated 
and cut in half longitudinally, and the cortex sliced into 1 mm 3 sections. 
Approximately 30 tissue explants were positioned onto collagen coated 
T25 flasks and carefully surrounded with 1.5m1 of growth medium. The 
explants were incubated at 33°C with 5% CO 2 for two weeks, with the 
medium changed daily. Within five days cells could be seen growing out 
from the explants, and after two weeks, the explants were surrounded by a 
circle of cells (see Figure 3.7). The explants were then removed and the 
growth medium exchanged for the normal As 4.1 culture medium. After 
two months of continuous culture the cells were analysed for renin 
expression, initially by Western and Northern blots. The cells were grown 
at 33°C and 39°C, RNA and protein recovered (protein analysis was 
performed by Audrey Hobson), blotted and analysed. No renin gene 
expression was identified, indicating that either the number of renin 
expressing cells in these cultures were too low for identification by these 
techniques, or that none were present. 
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Figure 3.7 Explant cultures derived from founder F9080, positive for 
the SV40 tsTag. 
cells can be seen radiating out from the explants by day 5. 
day 7 and the cells completly surround the explant. 
At two weeks the explants are ready to be removed. 
the cells grow to confluency and are then passaged. A mixture of cell types can be 
observed. 
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102 
3.4.1.1 Analysing the explant cultures for prorenin expression 
Since the Western and Northern blots did not detect any renin or 
Tag expression within these cells, a more sensitive prorenin 
immunoàssay was used. The cells were grown at both 33°C and 39°C and 
the cell pellets and supernatants sent to Dr Peters (Heidleberg) for 
prorenin analysis. Serum free medium was used, and samples taken at 24, 
48, and 72 hours. The number of cells were counted, harvested by 
centrifugation, and resuspended in 0.1M TES and sent to Heidleberg. The 
results can be seen in Tables 3.6-3.9. 
Tih1 	Prnrenin and rnin analysis of line F4933B 263 (positive) 
Temperature Time 
points 












33°C 0 0 0.82 0 0.22 
24 0 0.91 0 0.1 
48 0 2.01 0 0.19 
72 0.3 1.72 0.03 0.15 
39°C 24 00.5 0.85 0.01 0.17 
48 1.53 1.87 0.29 0.35 
72 3.69 0 1.14 0 
Ti1dø q 7 Rpnin nnd Prnrenin analysis of line F9070 1760 (positive) 
Temperature Time 
points 











33°C 0 0.15 0.73 0.12 0.58 
24 0.07 1.9 0.01 0.27 
48 0 1.46 0 0.17 
72 0 2.16 0 0.19 
39°C 24 0 1.43 0 0.28 
48 1.17 12.36 0.29 10.59 
72 2.88 14.08 0.37 10.52 
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Table 3.8 Renin and prorenin analysis of line F9080 1782 (positive) 
Temperature Time 
points 








 ng/hIml  
Prorenin 
nglh/ml 
33°C 0 0 0.61 0 0.14 
24 0 1.86 0 0.2 
48 0 2.11 0 0.17 
72 0 2.16 0 0.16 
39°C 24 0 1.96 0 0.25 
48 0.58 3.02 0.07 10.37 
72 2.01 5.72 0.21 10.6 
Table 3.9 Renin and Prorenin analysis of line F9080 2088 (negative) 
Temperature Time 
points 








 nglh/ml  
Prorenin 
ng/h/ml 
33°C 0 0.02 0.52 0.02 0.55 
24 0 0.36 0 0.26 
48 0 0.79 0 0.19 
72 0 0.86 0 0.1 
39°C 24 0.27 0.45 0.09 0.15 
48 2.34 0 1.29 	10 
13.39 72 7.09 0 
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The results of these experiments indicate that renin expression can 
be induced and that prorenin and active renin were secreted into the 
supernatant at 39°C, indicating differentiation at 39°C into renin 
expressing cells. However the induction of renin expression in the 
negative line 2088 indicated that either the lines were incorrectly 
genotyped or that these cells did not represent conditionally immortal 
cells, but lone primary JG cells, which have been stimulated to secrete 
renin. As a consequence, these cells were regenotyped. High molecular 
weight genomic DNA was isolated from these cells (see Chapter 2.2.1.6) 
and analysed by PCR using primers designed against the SV40 tsTag 
sequence (as described in Alison Downing M.Phil thesis (433)). The PCR 
reaction mix (0.5j.il dNTP mix (10mM each nucleotide), 0.5p.l Ren-2 and 
TsA58 primers (50mM), 0.1t1 GAPDH forward and reverse primers 
(50p.M), 1.5tl MgCl2 (25mM), 2.5pl lOx Promega Taq buffer, 18.7jil dH20, 
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0.1il Promega Taq (5U/il) and 0.5p1 DNA) was subjected to the following 
amplification conditions:- 
94°C 	5minutes 	 1 cycle 
94°C 	1 minute 
64°C 1 minute 	 33 cycles 
72°C 	1.5 minutes 
72°C 	10 minutes 	 1 cycle 
All lines had been correctly genotyped, indicating that the 
immortalisation strategy used may not have been successful and that 
there might have been some primary renin expressing cells still present 
in the culture. Additional studies utilised RT-PCR to analyse for renin, 
Tag and GAPDH expression. 
3.4.1.2 RT-PCR analysis 
RNA was isolated from cells derived from the four lines grown at 
33°C and 39°C for three days. One microgram of RNA was added to each 
RT reaction and the cDNA generated used for PCR reactions. Table 3.10 
describes the primers and the products expected. 
Table 10 Primer nairs used for RT-PCR 
cDNA Primer pairs Fragment size expected 
Renin JJM-58 exon 1/I  forward primer 132 bp cDNA 
JJM-59 exon WI reverse primer (558 bp Unspliced) 
SV40 Tag JJM-71 forward primer 580 bp 
JJM-72 reverse primer (570 bp small T) 
(240 bp_largeT) 
GAPDH JJM-40 forward primer 452 bp 
___________ JJM-41 reverse primer ___ 
The following controls were incorporated to ensure correct interpretation 
of the results: As 4.1 cells ± RT, liver RNA± RNase A, and kidney RNA 
from a transgene positive founder, 6183, and a negative littermate, 163. 
The results with the As 4.1 cells, and Founder 6183 showed the correct 
sized products for spliced renin Tag and GAPDH, whilst the kidney 
sample from founder 163 had no product for Tag. The liver sample 
showed the genomic band for renin, nothing for Tag and the correct band 
for GAPDH (see Figure 3.8a). 
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Figure 3.8a RT-PCR controls using primers designed to amplify 
GAPDH, renin and Tag. 
1 14 and last lanes ? Hind ifi marker. Sample 1, As 4.1 cells; sample 2, liver RNA; 
sample 3,163 Tag -ye founder; sample 4,6183 Tag +ve founder; sample 5, As 4.1 cells 
no RT; sample 6, liver RNA + RNAseA; sample 7, d1-I0 control for RT reaction; 
sample 8, dH20 contro for PCR. 






Figure 3.8b Analysing the cell samples by RT-PCR. 
A) renin primers, B) Tag primers and C) GAPDI-I 
lanes 1 +19, 1 HindIll marker; lanes 2+3, F4933B grown at 33°C; lanes 4+5, F4933B 
grown at 39°C; lanes 6+7, F9070 grown at 33°C; lanes 8+9, F9070 grown at 39°C; 
lanes 10+11, F9080+ve grown at 33°C; lanes 12+13, F9080 +ve grown at 39°C; lane 
14, F9080 -ye grown at 33°C; lane 15, F9080 -ye grown at 39°C; lane 16, HepG2 
grown at 33°C; lane 17, HepG2 grown at 39°C and lane 18, As 4.1 cells grown at 
39°C 
C 
GAPDH 	LW 	- 	 ___ 	452bp 
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The cell samples indicated Tag expression in four of the cell samples, (see 
Figure 3.8b lanes 3, 7, 10 and 11), although none gave the expected product 
for spliced remn, just the genomic product and the correct sized product 
for GAPDH. The presence of the unspliced renin product indicates 
genomic DNA contamination in the samples, however if this was the 
case a band for Tag should have been observed in all transgene positive 
samples. Additionally the absence of the remn cDNA suggests that renin 
was not expressed in these cells, contrasting with the results obtained 
from the prorenin assay. 
Considerable work is required to further characterise these cells, 
however due to time constraints this work was terminated, and the cell 
lines frozen down until a future date. 
3.5. Conclusions 
Investigation of renin expression, stimulation and trafficking within 
the JG cells, requires a renin expressing cell line which closely resembles 
JG cells. It is known that cultured cells do not exactly mimic the in vivo 
situation, but it is necessary to use them in an attempt to identify 
elements which might be important in vivo. Apart from primary cell 
culture the As 4.1 cell line is the best model of JG cells available. 
However, it is not definite that this line originated from a JG cell tumour, 
and might have been derived from smooth muscle cells. 
The growth conditions for the As 4.1 cell line were optimised for 
prorenin secretion in response to growth in different fetal calf sera. The 
results of this analysis showed a large variation in renin expression and 
secretion. This may be due to the different growth rates observed, since 
low confluences reduce renin production (see Figure 3.2). Furthermore I 
have optimised the transfection conditions for this cell line, and can now 
reproducibly obtain transfection efficiencies of 17%, for small plasmids, 
with the Pfx-3 lipid from Invitrogen. Compared to COS-7 cells which 
have a transfection efficiency of approximately 45% with the same 
construct, (Derek Rout personal communication), it is apparent that these 
cells are indeed very difficult to transfect. In fact previous experiments 
using electroporation to introduce exogenous DNA into these cells gave 
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less than 10% efficiency. These cells have a highly glycosylated cell 
membrane (Personal communication John Mullins), which is thought to 
account for the low transfection rates. 
The loss of the stimulatoiy response to external stimuli in the As 4.1 
cell line, was believed to be a result of transformation brought about by 
the SV40Tag. An attempt to isolate conditionally immortal JG cell lines 
utilised the temperature sensitive Tag mutant previously used to 
generate the immorto mouse. SV40tsTag was fused to the Ren-2 
promoter and used to generate transgenic mice. One line, F9080, was the 
only founder line which had no incidence of tumours. This line and two 
others which displayed a low incidence of tumours, were cultured using 
the explant method. The cells were continuously grown at 33°C in an 
undifferentiated state and only grown at 39°C to induce differentiation for 
experimental analysis. The results from this analysis were encouraging, 
showing that cells cultured at 33°C can be induced to express renin at 
39°C. However the quantity of renin expressing cells within these cultures 
was very low, indicating a requirement for some type of selection in order 
to isolate cells expressing the transgene, whether by FACs sorting or 
antibiotic resistance. The introduction of a reporter gene under the 
transcriptional control of the renin promoter would resolve this problem 
and would allow the selection of JG cells. Additionally if transgene 
positive animals were crossed with the immorto mouse, conditionally 
immortalised cell lines could then be isolated. 
101-01 
Chapter 4 
Identifying and characterising 
genomic clones spanning the 
renin locus 
4.1 Introduction 
A low number of renin expressing cells was obtained from culturing 
kidney explants derived from transgenic animals harbouring the SV40 
tsTag in renin expressing cells. This result indicated that a method to 
select for transgene expressing cells in culture is required. It is possible to 
enrich for JG cells by utilising percoll gradients, and additionally by FAC 
sorting since they possess dense secretory vesicles. However these 
methods do not produce pure JG cell populations. A more elegant way in 
which to enrich for JG cells is to use selection. The introduction of an 
antibiotic resistance gene, or a gene encoding for a histochemical marker 
would create a means by which these cells could be directly selected, 
although it would be important that the introduction of this reporter 
should not interfere with endogenous renin expression. 
Numerous attempts have been made to express a reporter construct 
in the JG cells. These include transgenic studies, and gene targeting (John 
Mullins personal communication). Transgenic approaches failed possibly 
due to the transgene being subject to position effects, whilst the 
introduction of a reporter gene into ES cells resulted in no targeted clones, 
possibly because of the low level expression of the renin genes in ES cells 
(personal communication Matthew Sharp, Edinburgh University, UK). 
The method by which a reporter construct was to be introduced into renin 
expressing cells was to utilise larger transgenes. An alternative gene 
targeting approach was considered, however since even an insertional 
approach might have adverse effects on endogenous renin expression it 
was rejected. 
A number of transgenes have been used to target reporter expression 
to the JG cells. A fusion between the E. coli lacZ gene and the 4.6Kb Ren-2 
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promoter sequences (used to generate the As 4.1 cell line (228) gave no 
blue cells. The fi-Geo construct (encoding lacZ and the neomycin 
resistance gene) was fused within exon 3, incorporating the same 4.6Kb of 
promoter sequences, but immunohistochemical analysis for - 
Galactosidase activity did not show blue stained cells in the afferent 
arteriole. Isolated blue cells were identified throughout the kidney and 
adrenal gland, .but this expression is believed to be due to endogenous 3-
Galactosidase like activity in the kidney, since it was also observed in 
transgene negative animals (Dr. John Mullins personal communication). 
These results suggest that the transgenes are not expressed. Reasons for 
this might include inactivation through position effects or because of 
interference from the bacterial lacZ gene which may act as an active foci 
for gene silencing (434-437). 
Position effect is a well documented phenomenon (289), affecting 
many transgenes. Improper transgene expression is believed to be the 
result of negative effects imposed by flanking chromosomal sequences, or 
the inability of cis acting control elements within the transgene to direct 
expression irrespective of integration site (438). The inclusion of enhancer 
and promoter sequences within transgenes does show some dampening 
of position effects (331) but is still insufficient to ensure correct tissue 
specific expression. The identification of regulatory elements able to 
overcome such position effects was a breakthrough for transgenic 
research. Locus Control Regions, (LCRs), are able to direct tissue specific 
expression irrespective of integration site. They are believed to act by 
maintaining an open chromatin domain, allowing transacting factors 
access to cis elements in order to initiate transcription (290). Utilising 
larger transgenes may confer site independent and copy number 
dependent expression for a given gene. Since elements such as LCRs or 
Matrix Attachments Regions (MARs) required to maintain an "open" 
chromatin structure, are more likely to be included. 
The isolation of larger transgenes spanning the renin locus would 
not only assist in the derivation of JG cell lines, through the introduction 
of reporter genes, but would also play an important role in distinguishing 
those regulatory elements involved in site independent expression of the 
renin genes. 
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4.2 The identification of genomic clones 
Transgenic studies using a 24Kb XhoI genomic fragment spanning 
Ren-2 (Figure 4.1) showed that this transgene was able to confer tissue 
specific and cell specific expression of Ren-2 in mice and rats (12, 175). Not 
all transgene positive animals expressed Ren-2, suggesting that flanking 
chromosomal regions are effecting expression, whereas the lack of wild 
type levels of expression indicates that essential regulatory elements lie 
outwith those sequences incorporated within the transgene. LCRs can be 
located many kilobases upstream or downstream of the genes they 
regulate (310, 313). Since Ren-2 is a duplication of Ren-1, it is possible that 
elements regulating Ren-2 and Ren-1 expression might lie downstream of 
Ren-1 or further upstream of Ren-2. The two genes are located 21Kb apart 
and so it should be feasible to isolate genomic clones, from the 129.01a 
mouse strain, which span both genes including extensive flanking 
sequences. Genomic clones in excess of 60Kb were sought to try to ensure 
all elements were included. P1 clones were initially chosen since they 
have an average insert size of 100Kb. 
Figure 4.1 The 24Kb Ren-2 transgene 
5Kb 	 Ren-2 	 9Kb 
I 	 I 	liii 	liii 
XhoI 10Kb 	
XhoI 
4.2.1 Screening P1 libraries 
Dr. Linda Mullins (Centre for Genome Research, Edinburgh 
University, UK) generated a 129.01a P1 library using the pAdlOsacBII 
vector, (similar to that shown in Chapter 1, Figure 1.5). A Sau3A digestion 
of 129.01a genomic DNA was ligated into this vector, packaged and 
infected into E. coli strain NS3529. This strain constitutively expresses Cre 
recombinase which circularises the infected phage particles via the two 
loxP sites included in the vector. The inclusion of the SacB gene acts as a 
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negative selectable marker against empty clones and serves to maintain 
the insert if grown in the presence of 5% sucrose. This library had a one 
times coverage of the 129.01a genome, and was screened for renin 
containing clones by PCR using primers designed to amplify a 558bp 
product between exon 6 and 7, for either Ren-1 or Ren-2. The primary 
poois identified were subsequently analysed by colony lift and hybridised 
with the renin cDNA probe. Three clones were identified, 2 of which 
were unstable. The third clone PiRen (analysed by Dr. U Mullins), 
appeared to be a chimera, having 5' sequences similar to Ren-2 and 3' 
sequences representing Ren-1. 
As none of the clones identified contained both renin genes a 
commercial 129.01a P1 library was screened (Genome Systems Inc). Three 
renin positive clones were identified with the renin cDNA probe, two of 
which were analysed by Dr. U Mullins and Nina Kotelevtseva. P1249 had 
sequences corresponding to both Ren-1 and Ren-2 but indicated some 
internal recombination; P1250 seemed to be a chimera between Ren-1 and 
Ren-2, whilst the characterisation of the third clone P1251 will be 
described in section 4.3. 
4.2.2 The organisation of the renin locus in 129.01a 
mouse strain 
The only detailed mapping information available for the renin locus 
from a two renin gene mouse strain is derived from the DBA/2J sequence 
(129). The renin locus of strain 129.01a was compared to DBA/2J by long 
range restriction mapping to ensure that the organisation of, the renin 
locus was the same. Analysis of the renin locus was performed by 
digesting genomic DNA from both strains with a range of rare cutting 
restriction endonucleases. The genomic DNA was prepared from spleen 
cells suspended in agarose to form DNA plugs, (as described in Chapter 
2.2.1.6b). The restriction enzymes used were HpaI, NotI, Sail, SfiI and 
Smal. Following digestion the DNA plugs were loaded onto a pulse field 
gel and the DNA fragments separated by PFGE using the ChefDRII system, 
(switching times between 0.1-6 minutes, for 18 hours in 0.8% agarose gel 
in 0.5% TBE). DNA fragments were immobilised onto nylon membrane 
by the method of Southern (Chapter 2.2.1.14a) and the blot hybridised to 
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the renin cDNA probe, isolated from pBS-aT-Ren-2 (JJM-6), on a 
Hindlil/Sall fragment. The autoradiograph shows that the DNA 
fragments which hybridised to the renin probe are identical for the two 
strains for each of the enzymes used, (data not shown), indicating that the 
organisation of the renin locus in the 129.01a mouse strain is similar to 
DBA/2J. 
4.3 The Characterisation of P1251 
P1 clones are maintained at a single copy per cell (353) through the 
action of the laclq repressor, which can be inactivated by the lac inducer, 
isopropy1--D-thiogalactopyranoside (IPTG). IPTG is introduced into large 
scale bacterial cultures to activate the lytic replicon, thus increasing the 
number of copies per cell. However IPTG induction can lead to instability 
and recombination within plasmids. As we have experienced problems 
with P1 stability IPTG was omitted from our cultures. 
A single P1251 colony, derived from a frozen glycerol stock, was 
inoculated, using a sterile wire ioop, into 5m1 of L-broth containing 
25p.g/ml Kan, and incubated for 6 hours. This was then used to inoculate 
a 500ml overnight culture, incubated at 37°C in an orbital shaker. P1 DNA 
was harvested using Qiagen columns (Chapter 2.2.1.5d), incorporating the 
manufacturer's recommendations for isolating P1 DNA. Approximately 
100 jig of P1 plasmid DNA was isolated from a SOOml culture. 
4.3.1 Sizing the P1 clone 
P1 clones are on average 100 Kb in size, and so are unlikely to have 
unique endonuclease restriction sites. Sizing the P1 clone was 
accomplished by digesting the DNA with BgiII, generating a fingerprint of 
the individual clone. The B gill pattern for P1251 and PiRen can be seen in 
Figure 4.2a, lanes 6 and 7 respectively. They were sized by counting up the 
bands, however this approach was flawed since doublets may be missed, 
along with many of the smaller fragments. A more accurate approach was 
to linearise the P1 clone through the ioxP site contained within the vector 
(417). The P1 clone is incubated with the loxP oligo and Cre recombinase. 
Cre binds the two ioxP sites together and linearises the clone. 
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Figure 4.2 Sizing P1251. 
BglIl digests; lane 1, X HindlIl marker; lanes 2.6, P1251; lane 7, PiRen. 
cre loxP linearisation. Ilane 1, PFG midrange marker 1; lane 2, the upper band 
represents covalently closed circular P1251, whilst the lower band is linearised P1251 
indicating a size of 98Kb. 
1 	2 	3 	4 	5 	6 	7 




























The product was sized by separation through a pulse field gel. 
(Figure 4.2b). The BglII fingerprint indicates a size of 65Kb+ where as the 
loxP/Cre recombinase strategy shows the size to be approximately 98Kb. 
4.3.2 Analysing P1251 for renin sequences. 
The renin cDNA probe will identify any DNA fragment containing 
renin sequences. It was necessary to identify the extent of these sequences 
within the P1 clone and to' determine whether both genes were present 
intact. There are known restriction fragment length polymorphisms 
between Ren-1 and Ren-2 which can be used to distinguish between 
them. The DBAI2J restriction map, Appendix 1, was used for reference, 
with the understanding that certain polymorphisms may exist between 
the two strains. Additionally the restriction sites within the 17Kb vector 
(Chapter 1, Figure 1.5) were taken into account. 
4.3.2.1 Long range restriction mapping 
Initially P1251 DNA was digested with a range of rare and common 
cutting restriction enzymes to identify which genes were present and 
whether any rearrangments had occurred. The enzymes used were, 
BamHI EcoRI, HpaI, NotI, PvuII, Sad, Sail, SfiI, and Smal. The DNA 
fragments were separated by pulse field gel electrophoresis, using the 
ChefDRII apparatus with 0.8% agarose in 0.5xTBE. 
The conditions used were 0.1-6.0 second switches, at 6 volts per hour 
for 18 hours. The resulting DNA fragments were blotted and hybridised to 
the renin cDNA probe. Figure 4.3 shows the resulting autoradiograph, 
with the results tabulated in Table 4.1. 
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Figure 4.3 Long range mapping of P1251 by pulse filed gel electrophoresis, 
hybridised with the renin cDNA probe. 
lane 1, Baml-H; lane 2, EcoRl; lane 3, Hind!!!; lane 4, NotI; lane 5, PvuIl; lane6, Sac!; lane 7, 
Sail; lane 8, Sf1; lane 9, Smal. 
1 	2 	3 	4 
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Table 4.1 Fragment sizes observed after P1251 was digested with the 
followine restriction enzymes and probed with the renm cDNA 
Enzymes Expected size Enzymes Expected size 
DBA/2J(Kb)  DBA/2J(Kb)  
Ren-1 Ren-2 P1251  Ren-1 Ren-2 P1251 
BamHI 6.7 0.9 12 Sacl 6.7 6.8 7 
6.6 1.8 6.5 2.1 2.2 3.1 
12.2 7.4  2.8 4.0 2.1 
EcoRI 8.7 9.2 8.75 Sail 120 80 
3.8 4.3 4.2  
HpaI 80 43 SfiI 80 25 26 
NotI 28 28 27.5 Smal 26 26 26 
PvuII 6.3 0.84 11.8 
10.6 7.8 ______ _________________________________ 
The presence of only one band with NotI and Smal (lanes 4 and 9 
respectively) was expected as both Ren-1 and Ren-2 are located on similar 
sized fragments. HpaI and Sail restriction sites (lanes 3 and 7) flank the 
renin locus with fragment sizes of 80 and 120Kb respectively. The size of 
these bands in P1251, 43Kb HpaI and 80Kb Sail indicate that the whole of 
the renin locus was not present and that the vector lies in close proximity 
to the renin sequences. Sf1 should display two bands, a 26Kb Ren-1 band 
and an 80Kb Ren-2 band. The only band observed was a 26Kb band (lane 
8), indicating the presence of Ren-1 only. Additionally the bands observed 
with BamHI, EcoRI, PvuII and Sad (lanes 1,2,5 and 6) relate to Ren-1, with 
no Ren-2 specific bands identified. 
4.3.2.2 Localisation of the P1 vector 
The previous results imply that Ren-1 was present but not Ren-2. 
However it was necessary to determine the extent of 5' sequence 
upstream of Ren-1 and to see whether any 3' Ren-2 sequences were 
present. There is an EcoRI/KpnI fragment which hybridises to the 3' 
sequences of both genes. The introduction of insertion elements 
downstream of Ren-2 has introduced polymorphisms between the two 
genes. P1251 was cleaved with BamHI alone and a BamHI/NotI double 
digest. The location of the probe used can be found in Appendix 1. Table 
4.2 depicts the results from this analysis. 
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Table 4.2 Comparing the DNA fragments expected for Ren-1 and Ren-2 





Ren1d 	Ren2d  
BamHI 10Kb 	7.6Kb 11.2Kb 	16Kb 
BamHI/NotI 4.8Kb 	3.1Kb 5Kb 	2.75Kb 
The 11.2Kb and the 5Kb fragments represent the 3' of Ren-1. The 
2.75Kb fragments might represent the BamHI/NotI fragment which lies 3' 
of Ren-2, or might indicate the beginning of the vector sequences, as there 
is a NotI site within the vector. The 16Kb BamHI fragment indicates that 
the BamHI site from Ren-2 was absent and represents the P1 vector. 
4.3.2.3 Detailed mapping of P1251 
The results so far suggest that P1251 contains Ren-1 and possibly the 
3' end of Ren-2. To further analyse the renin sequences within P1251 and 
to ensure no recombination had occurred, P1251 was further digested 
with those enzymes listed in Table 4.3, 4.4 and 4.5. The DNA fragments 
were separated by horizontal electrophoresis. The first blot represents the 
enzymes listed in Table 4.3. which were hybridised with the XbaI/KpnI 
fragment specific for 5' renin sequences (see Figure 4.4). 
The second blot was probed with an oligo specific for exon I (see 
Table 4.4), whilst the third was hybridised to a fragment specific for exon 
IX. The results of this are found in Table 4.5. 
Table 4.3 Fragments observed in P1251 after digestion with the following 









Ren-1 P1251  Ren-1 P1251 
BamHI 6.8 7.3 XbaI 3.1 2.9 
EcoRI 2.8 3.15 XhoI 27 22 
HindIII ND 9.2 PstI/PvuI ND 2.65 
PstI 2.6 12.7 PvuI/XbaI ND 1.75 
PvuI 1 9.1 18.6 JXMISacl ND 6 
ND not determined 
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Figure 4.4 DNA fragments observed after P1251 was deaved with various 
restriction enzymes and hybridised with a 5' XbaI/ KpnI probe 
lanel, BamHl; lane 2, EcoRI; lane 3, Hpal; lane 4, Kpnl; lane 5, PstI; lane 6, Pvull; lane 7, 
XbaI; lane 8, Xhol; lane 9, XbaI/I'nI; lane 10, PstI/PvuII; lane 11, PvuII/XbaI; lane 12, 
XhoI/ Sad. 








Table 4.4 The size of the DNA fragments observed after P1251 was 










Ren-1 P1251 Ren-1 P1251 
BamHI 6.7 6.4 XbaI 0.8 0.65 
BglI 10.5 12 BamHI/EcoRI 2.5 2.25 
BglII 10.3 11.7 BglI/KpnI 1.6 1.8 
EcoRl 8.7 10 BglI/SacI 5.5 6.3 
HindIII 8.5 9.2 BglII/SacI 3.7 3.9 
PstI 2.5 2.12 PvuI/XbaI 0.71 0.58 
PvuI 0.7 0.55  
Table 4.5 DNA fragments observed after P1251 digestion with the 
following enzymes and probed exon IX sequences. 
Restriction 
endonuclease 
Fragment length (Kb) 
Ren-1 P1251 
BamHI 12.2 11.4 
EcoRl 3.8 4 
HindIll 8.9 8.75 
The results of these experiments confirm the presence of only a 
single renin gene, Ren-1 in P1251. This was established by the 
identification of only a single band for each restriction digest, whatever 
probe was used, which corresponds to Ren-1 with the P1 vector 
approximately 19Kb 5' of Ren-1. 
4.3.2.4 Long range PCR 
To confirm that no rearrangments had occurred within the Ren-1 
gene, long range PCR was performed. Ren-TI is approximately 10Kb in 
length, which is beyond the capabilities of Taq polymerase. Two sets of 
PCR primers were used (Figure 4.5) The first set of primers amplify a 
fragment of 4.1Kb corresponding to sequences from Exon I-ITT, and the 
second set amplifies a product of 4.8Kb spanning Exons V-TX. The 
conditions of the PCR reaction are shown in Table 4.6. The products of the 
PCR reaction were separated on 0.8% agarose gel and the sizes compared 
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to those from DBA/2J. The band sizes corresponded to those expected, 
suggesting an intact Ren-1 gene (data not shown). 
Figure 4.5 The location of the PCR primers used to amplify Ren-1 
sequences 
4.2Kb product 	 4.8Kb product 
Table 4.6 PCR program for long range PCR 




1 95°C 	1 second 95°C 	1 second 
hold 95°C 95°C 
40 
95°C 	1 minute 95°C 	1 minute 
68°C 	1 minute 66°C 	1 minute 
72°C 	6.5 minutes 72°C 	6.5 minutes 
1 72°C 	10 minutes 72°C 	10 minutes 
hold 1200C 20°C 
4.3.5 P1251 Map 
All of the preceding data indicates that the P1 clone, P1251, contains 
an intact Ren-1, with no Ren-2 sequences. The P1 vector is approximately 
19Kb upstream of Ren-1 with the Sail site positioned at the 5' end of the 
vector, and approximately 50Kb of 3' flanking sequences. Figure 4.6 shows 
the map of P1251 generated. 
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Figure 4.6 Map of P1251 
Ren-1 
I 	 I  
P1 vector 	 5000 
4.4 Generating a P1 clone spanning both 
renin genes 
The six P1 clones identified from screening two libraries did not 
identify a single clone with both renin genes intact. A strategy was 
devised to subclone a 120Kb Sail fragment which spans both genes into 
the unique Sail restriction site within the circular pAdl0sacB vector. 
4.4.1 Isolating the Sal fragment from 129.01a 
Approximately ten genomic plugs derived from 129.01a were 
incubated with the restriction endonuclease Sail, overnight at 37°C. The 
digested DNA was then separated by pulse field gel electrophoresis (20-25 
second switches with logarithmic ramping using the pulse field gel 
apparatus for 46 hours). The marker tracks were cut away from the gel 
and stained in ethidium bromide, 10pg/ml. These were then placed along 
side the rest of the gel and a gel slice was removed relating to 100-130Kb, 
two additional slices were taken one above and below to act as guides in 
subsequent steps. The gel slices were positioned in a small gel tray, 90°C to 
initial direction of migration, as shown below, (see Figure 4.7), and 
surrounded in 4% low melting point Nusieve agarose. The DNA within 
the 1.2% gel slice migrated through the slice until it reached the 4% 
agarose but was unable to move through this high percentage gel and so 
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became concentrated at the junction. The slices were subject to horizontal 
electrophoresis in 0.25x TAE at 30 volts for 24 hours. After this time 
period not all of the DNA had become concentrated in the 4% agarose, as 
observed by staining one of the additional gel slices in ethidium bromide, 
therefore it was left for another 24 hours, (30V, 4°C). The second extra 
slice was removed and stained in ethidium bromide, and showed that all 
the DNA had been concentrated into the Nusieve agarose. This slice was 
then aligned with the 120Kb slice and a plug of 4% Nusieve 
corresponding to the concentrated DNA was removed. The subsequent 
agarase treatment and subcloning was performed by Nina Kotalevtseva. 
Thousands of clones were generated, and analysed by a colony lift using 
the renin cDNA probe. Several renin positive clones were identified but 
upon further analysis they were found to have small inserts, 
approximately 60Kb, indicating recombination had occurred between the 
renin sequences. 
Figure 4.7 lsolatmg the ILUIS.D ball rragment 
129.01a DNA 
plugs digested 	 4% JJ.4J) 
with Sal I 	 agarose 
+ve 




Pulse field gel, 0.8% agarose 
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The high incidence of recombination observed with P1 clones 
spanning the renin locus was believed to be a problem associated with 
instability of the P1 vector, as other cases of recombination had been 
highlighted (Linda Mullins personal communication). The development 
of bacterial artificial chromosomes, and the access to commercial libraries, 
gave another opportunity to identify renin clones. 
4.5 Screening BAC libraries 
Bacterial artificial chromosomes have an average insert size of 150Kb 
and represent another option for isolating large genomic clones. A 
commercial BAC 129.01a genomic library (Research Genetics) was 
screened. Dr. Linda Mullins used the same PCR based strategy as 
previously mentioned. Initially 48 superpools were analysed by the exon 
6/exon 7 PCR screen. Each pool represented 96 secondary pools, which 
again were screened by PCR. The results of this screen indicate which 
primary filter the clones were located on. Four filters were hybridised 
with the renin cDNA probe and three clones were identified, Nb, E23 
and B17. 
N10 and E23 contained both genes with extensive flanking 
sequences, (see Figure 4.8). N10 which is 150Kb, had both renin genes 
placed centrally within the clone, whilst E23 only had 15Kb 5 of Ren-2 
sequence. B17 was not fully characterised since it only contained Ren-1 
sequences. 
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Figure 4.8 A comparison of the BAC clones. 
Miul 
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(170086 bp) 	 1 6000bp 
4.6 Conclusions 
In our attempt to isolate P1 clones spanning the renin locus we have 
observed that P1 clones can be unstable. Five out of the six renin positive 
clones identified showed some rearrangement. However once established 
P1 clones appeared to be resistant to recombination, since P1251 had been 
grown for over 100 generations continuously with no rearrangements 
identified. Characterisation of P1251 has identified that only Ren-1 is 
present, which may account for the stability of this clone, with the P1 
vector located 19Kb upstream. On the other hand two of the three BAC 
clones identified contained both renin genes with varying amounts of 
flanking sequences without any observed rearrangements, indicating that 
BAC clones were more stable. 
The BAC clone N10 may posses all the cis acting regulatory elements 
necessary to confer tissue specific and site independent expression over 
both renin genes. P1251 may include the elements necessary for Ren1d 
expression, although it is possible that some important elements lie 
upstream of Ren-2. Dr. Linda Mullins has generated transgenic mice 
using linearised N10 DNA, and is currently analysing the expression 
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profile of the two renin genes on a Ren1c  background. P1251 and N10, are 
ideal clones with which to drive reporter gene expression in renin 
expressing cells. The P1 clone has 19Kb of 5' and approximately 50Kb of 3' 
flanking sequences, whereas N10 has both genes centrally located with 
45Kb of flanking sequences either side. To take full advantage of the these 
clones to potentially direct site independent expression of a reporter gene, 
it was necessary to introduce modifications into the clone without 
removing any regulatory elements. Initial experiments were performed 
with P1251, since it only contains one renin gene to make analysing the 
subsequent clones easier. Despite the identification of Nb, P1251 is still 
an important clone which will allow characterisation of the regulatory 




Linear in vivo recombination 
5.1. Introduction 
Ren-2 is a duplication of Ren-1. Transgenic studies, using the 24Kb 
XhoI fragment, have intimated that regulatory. elements required for 
quantitative expression are located out with those sequences, and in fact a 
hypersensitive site has been located more than 5Kb upstream of Ren-1' 
(Dr Ken Gross, Roswell Park, Buffalo, NY, USA). Since the BAC clone has 
45Kb of flanking sequences both 5' and 3' it was possible that this clone 
might confer site independent and copy number dependent expression 
over both renin genes. P1251 would be predicted to confer tissue specific 
expression, as observed with the Ren-2 transgene, since only 5Kb of 5' 
flanking sequences represent ancestral Ren1C  sequences. To ensure 
accurate expression of a reporter gene introduced into the renin genes it 
was important not to disrupt any regulatory elements, and so it was 
proposed that the reporter cassette should be introduced in between exons 
3 and 4. 
Traditional molecular cloning techniques become increasingly 
inefficient as DNA fragments exceed 15Kb (personal experience). 
Furthermore, the presence of the two highly homologous genes in the 
BAC complicates matters making it very difficult to target a specific gene. 
Therefore an alternative strategy was required. In vivo homologous 
recombination was chosen since it has been successfully utilised to 
introduce modifications into Yeast artificial chromosomes, the E. coli 
chromosome (369, 372, 439), as well as gene targeting in ES cells (240). 
The recombination system in F. coli has been mutated to produce 
strains which are proficient at intermolecular recombination (440). 
Mutations in genes recBCD and sbcABC result in E. coil utilising 
additional recombination pathways which have various roles in 
homologous recombination (Chapter 1.8). Different strains have been 
utilised to promote slightly different types of recombination, JC8679 
(recBC,sbcA) for inter and intra molecular recombination with plasmids 
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(373, 376); JC7623 (recBC,scbBC) for intermolecular recombination between 
linear DNA fragments and the E. coil genome (372) The use of 
intermolecular recombination to introduce exogenous sequences into P1 
or BAC clones appears to be a potentially useful option. Initial - 
experiments utilised the in vivo cloning (IVC) technique (described by 
(379, 380) to demonstrate that the methodology was reproducible with 
small plasmids. 
5.2 The In vivo cloning technique 
The IVC technique was designed to aid the cloning of PCR products. 
Basically it utilises E. coli to recombine two exogenous, linear DNA 
fragments (379, 380). Bubeck and colleagues introduced sequences 
homologous to a plasmid vector onto the ends of a PCR product, 33bp one 
side and 42bp on the other, and transformed this into DH5a cells, together 
with pBluescript linearised at the EcoRI/XhoI sites located within the 
homologous sequence (379). Transformants were selected by Ampicillin 
resistance, and were found to have correctly recombined the two 
fragments, without any duplication of the homologous sequences. They 
obtained maximum yields when equimolar concentrations of plasmid 
and insert were used. 
The in vivo cloning technique described by (380) used the strain 
JC8679, known to participate in double stranded gap repair (376). Similar 
to the previous technique, a plasmid vector was linearised within the 
homologous sequence and electroporated into strain JC8679 along with 
the PCR product. By utilising this technique this group have cloned 
products ranging from 608bp to 2132bp. However they did notice a drop in 
efficiency as the size of the insert increased, for a given length of 
homologous flanking sequence. However if they increased the length of 
homology the efficiency also increased. To show that this technique was 
reproducible initial experiments utilised JC8679 to introduce the zeocin 
resistance cassette into the plasmid vector pSP72.polyl. The DH5a strain 
was not used since both Bubeck et ai and Oliner et ai observed a 25 fold 
reduction in efficiency with this strain compared to JC8679, which was 
only seen when chemical transformation was used. No recombinant 
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plasmids were recovered with strain DH5a when the two fragments were 
introduced by electroporation (379, 380). 
5.3 In vivo cloning with small plasmids. 
Initial studies were designed to introduce the zeocin resistance 
cassette (Invitrogen) into the plasmid vector pSP72.polyl (Chapter 2, 
Figure 2.1) so that recombinants could be selected for. The experimental 
strategy utilised cloned fragments rather than PCR products since these 
would be used to introduce reporters into the renin genes. The homology 
arms were generated by subcloning the 1.275Kb BamHI/BglII fragment 
from pZeoSV (Chapter 2, Figure 2.5) into the unique BamHI site in 
pSP72.polyl, to generate pSPZeo (Figure 5.1). Zeocin is under the 
transcriptional control of a modified T7 promoter, EM7, which is active in 
all bacterial cells, and the cytomegalo virus (CMV) promoter for 
transcription in mammalian cells. The linear recombination fragment 
was isolated on a HpaI/SspI fragment from pSPZeo to give 478bp of 
homologous sequences 5t,  and llObp 3' to pSP72.polyl (Figure 5.2). 
In order to isolate the 1.8Kb linear DNA fragment from pSPZeo an 
additional enzyme, PvuI, was added to cut the vector backbone in half. 
The plasmid fragments were loaded onto a 0.8% agarose gel and separated 
by horizontal gel electrophoresis. The 1.8Kb fragment was isolated from 
the gel using the Qiaex Kit (Qiagen) and dialysed against 1xTE. Ten 
micrograms of the vector pSP72.polyl was linearised with 
BamHI/HindIII, with 5ig treated with shrimp alkaline phosphatase. Both 
vector preparations were separated from any uncut vector by horizontal 
gel electrophoresis and were isolated from the gel slices using the Qiaex 
Kit and dialysed against 1xTE. 
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Figure 5.1 Subcloning CMV EM7 zeocin into pSP72.polyl 
pSPZeo was generated by subclonrng the CMV EM7 zeocin fragment 
(cleaved from pZeoSV (Invitrogen) on a BglllI BamHI fragment) into the 


























Figure 5.2 Introducing the zeocin resistance gene into pSP72.polyl by IVC. 
The CMV EM7 zeocin fragment was cleaved from pSPZeo on a SspI/HpaI fragment. 
pSP72.polyl was linearised at the Hindllh/ BamHL sites. Both fragments were 




















CMV EM7 zeocin I I ' paI  
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Ten nanograms of the linear plasmid, either phosphorylated or 
dephosphorylated, along with an equimolar quantity (13.4ng) of the linear 
insert were electroporated into 40il of electrocompetent JC8679 cells. The 
vector pSP72.polyl is ampicilin resistant, and the insert confers Zeocin 
resistance, so recombinants will be both Amp and Zeo resistant. The 
electroporation mix was plated onto L-agar plates containing Amp ± 
Zeocin. One hundred microliters of a 1:10,000 dilution was plated onto 
Amp plates, whilst lOOjil from the electroporation was plated onto 
Amp/Zeo plates. Control experiments included linear vector alone and 
insert alone, (see Table 5.1. for the results). 
The colonies observed with linear vector alone and insert alone 
indicate that either the linear vector preparation included uncut 
molecules, or that linear fragments had recircularised by intramolecular 
recombination, known to occur with high incidence in this strain (373, 
376). However the numbers observed with insert and vector were 4 fold 
greater than any carry through from the insert preparation. Furthermore 
approximately 50% of the Amp resistance colonies were also Zeo 
resistant, indicating the presence of recombinants. 
Table 5.1 The results of the in vivo cloning experiment in E. coli strain 
JC8679 
DNA added Ampicillin plates Ampicillin/Zeocin 
pSP72.polyl B/H 











Insert alone 18 14 
dH2O 0 0 
To analyse these clones a Sail digest was performed, since an 
additional Sail site introduced into the recombinant clone produces a 
novel 152bp fragment. DNA from representative clones from each 
electroporation were prepared and analysed by Sail digestion (Figure 5.3) 
and sequencing. 
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Figure 5.3 Analysing the colonies recovered from the in vivo cloning 
experiment for the unique 152bp Sal! fragment. 
pSP72.polyl digested with BarnHJ/HindIH,introduced without insert; 
pSP72.polyl digested with Ba,nHl/ Hindul and treated with calf intestinal 
phosphotase, introduced without insert; 
C)pSP72 poiyl, digested with Sail; 
pSP72.polyl digested with Barnl-H/ Hind ifi introduced with an equimolar quantity of 
insert; 
pSP72.polyl digested with BwnHJ/ HindIl,I treated with calf intestinal phosphotase 
and introduced with an equimolar quantity of insert; 
pSPZeo digested with Sat!. The middle band in sections D-F are believed to be RNA. 
A 	 B 	 C 
D 	 E 	 F 
152bp 	- 
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Primers were designed outside the arms of homology and ten clones 
were sequenced using the ABI automated sequencer. The Sail digest 
showed the presence of the unique Sail fragment in the expected clones, 
whilst the sequencing data indicated that there had been a complete 
transfer of the insert sequence into the vector without any duplication. 
These results indicate that the IVC protocol may have worked, however 
since the resulting plasmid is exactly the same as the initial plasmid from 
which the fragment originated it is impossible to say. The introduction of 
a single base mutation or deletion could have been used to differentiate 
between uncut plasmid contamination and a genuine recombination 
event. Although it was believed to have worked and thought to be worth 
proceeding with the introduction of reporter constructs into larger 
genomic clones. 
5.4 IVC with large genomic clones 
5.4.1 Generating the reporter construct 
The reporter gene chosen to be introduced into Ren-1 was the gene 
f3—Geo (441), which is a fusion between the E. coli lacZ gene and the 
neomycin resistance gene. 3—Galactosidase activity can be used to stain for 
renin expressing cells in both transgenics and cultured cells, whilst the 
neomycin resistance gene can be used to isolate JG cells in culture, 
utilising G418 resistance. Since J3-Geo was to be introduced between exons 
3 and 4, an internal ribosomal entry site (IRES; (230) was included to allow 
independent translation of the fusion gene in culture and in vivo. 
Additionally, the zeocin resistance gene was included with its bacterial 
and mammalian promoters, so that recombinants could be selected both 
in bacteria and in cell culture. It was necessary to test whether zeocin 
could confer Zeocin resistance when maintained at a single copy per cell, 
so the BglII/BamHI fragment from pZeoSV was ligated into the unique 
BamHI site in the P1 vector pAdlOsacBII. Successfully cloned plasmids 
were selected on L-agar plates containing Kan and Zeo. Several Zeocin 
resistant clones were observed and analysed, all giving the correct 
restriction patterns, suggesting that zeocin was able to confer Zeocin 
resistance when maintained at a single copy. The recombination fragment 
was constructed as in Figure 5.4. 
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Figure 5.4 Generating the reporter construct 
The IRES/3-Geo cassette was cleaved from pIRESI3-Geo on a NotI/partial KpnI 























Initially the IRES /3—Ceo construct was to be placed upstream of zeocin / in 
the opposite orientation, so that the expression of zeocin didn't affect the 
expression of f3—Geo. However this construct proved unclonable, despite 
numerous attempts. 
An alternative strategy utilised the unique NotI/KpnI sites in 
pSPZeo. However since there are numerous KpnI sites in pIRES/3—Geo a 
partial digestion was necessary. The NotI digestion was performed first 
and the DNA precipitated with 1/10th vol 6M ammonium acetate and 2 
vols isopropanol. A time course of the KpnI digest was performed to 
determine the time at which the greatest quantity of the correctly sized 
product could be isolated. Forty micrograms of NotI digested pIRESJ3—Ceo 
was resuspended in lOOjil TE, and incubated with 40units of KpnI at 37°C. 
Twenty microlitres were taken out of this reaction after 2, 4, 6, 8, 10 20, 40 
and 60 minutes (Figure 5.5), and the reaction stopped by adding 5.6jil of 
0.4M EDTA. The samples were loaded into a 0.8% agarose gel and the 
fragments separated by electrophoresis. Only the samples corresponding 
to 2, 4, 6, 8 and 10 minutes had the 5Kb fragment. The DNA was eluted 
from the agarose slice by electroelution, (Chapter 2.2.1.10). The NotI/KpnI 
fragment was subsequently ligated into the pSPZeo plasmid, (to give 
pSPzeocin-IRESI3-Geo pSPZIG) and analysed by the following restriction 
enzymes: HindIII, KpnI, NotI, Sail, XbaI and XhoI. (Figure 5.6), all of 
which showed the expected restriction pattern. 
5.4.2 The homology arms 
The efficiency of IVC increases with the length of homologous 
sequence flanking the insert (380), but there is a decrease in efficiency as 
the size of the insert increases for a given length of flanking sequence 
homology. Since the zeocin-IRESJ3-Geo construct was 6.3Kb, it was 
decided that a large amount of flanking DNA should be used. The 
construct designed to knock out Ren-1 in ES cells, pR1KO (Chapter 2 
Figure 2.7), contains 7Kb of Ren-1 sequence with unique NotI/SalI sites 
located in the centre of the construct in between exons III and IV. The 
Recombination construct was generated as seen in Figure 5.7. 
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Figure 5.5 Time course of the KpnI partial digest of pIRES/3-Geo 
The 5Kb fragment is the second band which can be observed in all tracks upto 
lOminutes 
Minutes 
2 	4 	6 	8 	10 	20 	40 	60 
5Kb 
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Figure 5.6 Restriction digests of pPSZIG to confirm identity 






Table 5.2 Fragment sizes expected for pSPZIG 
HIndIII KpnI NotI Sail XbaI XhoI 
Fragment 4.5 4.69 8.8 7.68 4.8 7.521 
sizes (Kb) 3.96 4.19 1.1 2.4 1.36 
0.347 0.045 1.6 
0.048 
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Figure 5.7 Diagramatic representation of the generation of the 
recombination plasmid. 
The recombmation cassette is cleaved from pSP-ZIG on a NotI/ partial XhoI 
fragment and introduced into the NotI/SaiI sites of the plasmid pRi-KO. 
Noti 
pR1KO 
' digested with 
No ti/Sail 
+ 	pSPZIG digested with 
Noti 	 NotI/partial 
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The zeocin-IRESJ3-Geo fragment was introduced into the plasmid 
pR1KO at the unique NotI/SalI sites. pSPZIG has a unique NotI site 5' of 
the IRES but contains multiple Sail sites, so the isochizimer XhoI was 
used. Forty micrograms of pSPZIG were digested to completion with NotI, 
and precipitated as before. The DNA pellet was resuspended in lOOp.l TE 
and incubated with 40units of XhoI at 37°C. Twenty microlitres were 
taken from the sample after 4, 8, 10, 20 minutes, and 1 hour. The reactions 
were stopped by the addition of 5.6p.1 0.4M EDTA. All samples, including 
pR1KO digested to completion with NotI/SalI were loaded into a 0.8% 
agarose gel then separated by electrophoresis. All pSPZIG samples 
contained the 6.3Kb fragment which was isolated by electroelution along 
with pR1KO. These two fragments were ligated together, and resultant 
clones analysed by various digests including: AscI, BamHI, HpaI, KpnI 
and XhoI (Figure 5.8), which indicated that the correct plasmid had been 
cloned. 
5.4.3 Isolating the recombination fragment. 
The recombination fragment was isolated on an AscI/XhoI partial 
digest. Forty micrograms of DNA were cut to completion with AscI and 
then precipitated as before. The DNA pellet was resuspended in 10Op1 TE 
and incubated with 40units of XhoI at 37°C. Twenty microlitre aliquots 
were taken after 2, 5, 10, 20 minutes and 1 hour, then separated by gel 
electrophoresis. The 15.3Kb fragment was seen in all tracks, and was 
electroeluted from the gel, and stored at -20°C until required. This 
procedure was found to be highly inefficient (see Figure 5.9), so to aid the 
isolation of the recombination fragment a PacI linker was introduced into 
the XhoI site located between /3—Geo and the EM7 promoter. The Pad 
linker was designed to have compatible ends with XhoI so that it could be 
ligated into this site, but instead of reconstituting the XhoI site a PacI site 
is generated. A partial XhoI digest of pR1ZIG, was performed and the Pad 
linker ligated to it. A colony lift, using the PacI linker as a probe, 
identified numerous clones containing the linker. However since either 
site could have been disrupted, it was necessary to analyse several clones 
to ensure that the correct site had been disrupted. pR1ZIG.1 was 
subsequently used to isolate the recombination fragment. 
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Figure 5.8 Confirmation of restriction sites located in pRi-ZIG 
lane 1, AscI; lane 2, BanzHI; lane 3, HpaI; lane 4, KpnI; lane 5, XhoI 
I 	 I 
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Table 5.3 Fragment sizes expected upon digestion of pRi-ZIG with 
the following restriction enzymes. 
Fragment AscI Bam,HJ 
size (Kb)  
HpaI KpnI XhoI 
pRi-ZIG 16.310 6.86 7.08 10.263 8.86 
3.92 5.302 4.69 7.450 




Figure 5.9 Partial XhoI digestion of pR1ZIG for the isolation of the 
recombmation fragment. 
The recombination fragment is located directly underneath the NotI linear product, 




15 .3 Kb 
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5.5 E. coli strains 
The IVC technique used strain JC8679 which is a recBC, sbcA strain. 
Mutations in recBC disable exonuclease V. which degrades double 
stranded linear DNA, but also makes the strain recombination deficient. 
The addtional sbcA mutation is included to reinstate RecBC' 
recombination. Additionally these mutations induce the RecET pathway 
which can promote recombination without participation of RecA (391). 
The P1 clone was electroporated into strain JC8679 at an efficiency of 5x10 3 
per jig of DNA. P1 DNA from 5 colonies was isolated and analysed bu 
BglII digestion, but only 2 out of five clones gave the correct BgiII pattern, 
indicating instability. This suggests that a different F. coil strain would be 
required for P1 or BAC recombination. 
Previously published intermolecular recombination experiments 
have used one of two strains, JC8679 which induces the RecE pathway, 
and JC7623, which utilises the RecF pathway. Both sbcA and B mutants 
suppress recBC mutations, and therefore initiate recombination without 
exoV activity. However recD mutations inactivate exoV activity leaving 
recBC intact, and thus removing the need for sbc mutations to make the 
strains recombination proficient. Additionally RecF is not required for 
intermolecular recombination with recD strains (395, 396). P1 and BAC 
clones are routinely maintained in strain DH10B (see Chapter 2.13for 
genotype). However this strain does not possess any of the previously 
mentioned mutations, having an active recBCD and being recA. Two 
potentially useful derivatives of DH10B were available; DH10B recA 
(Prof Bloom, cold spring harbour labs), and DH10B recA recD (Dr 
Sternberg). These two strains were obtained and characterised to check 
their designated phenotype by appropriate phage tests (the phage were 
obtained from Dr Leach University of Edinburgh). 
The recBCD complex works by degrading double stranded linear 
DNA until it encounters a X  (chi) site. The RecD protein then dissociates 
from the complex, protecting the DNA strand from further degradation 
and initiating recombination. If the E. coli strain is recBC or recD then 
there is no exonuclease activity. The two phage used to check for these 
mutations are both red ,gam and so are dependent upon the E. coil recA, 
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recBCD recombination system to replicate and infect bacteria. 
Additionally these phage can only infect recA host strains. The E. coli 
strains initiate rolling circle replication of the phage by recombining the 
two cos sites, followed by subsequent packaging and infection. Phage 104 
possesses x  sites and phage 105 does not. If recD is active the phage 
without X sites will not be protected against exonuclease, and will not be 
packaged efficiently, producing pin point plaques. If the strain is recD 
then the phage will be recombined, replicated and packaged producing 
very large plaques. 
Serial dilutions of the two phage were spotted onto a bacterial lawn 
of the three E. coli strains, DH10B, DH10BrecA and DH10BrecArecD 
and incubated overnight. The results of this test (Figure 5.10) showed no 
plaques on DH1OB, which is recA- and large plaques with the other two 
strains, indicating that both these strains are in fact recA and recD. 
The three strains were tested for their ability to achieve IVC by 
utilising the same strategy as for JC8679, (section 5.3). The results can be 
seen in Table 5.4. 
Table 5.4 The results of the IVC experiments using DH10B and its 
derivatives. 
DH10B DH10BrecA DH1OBrecA+ 
recD 
DNA added Amp Amp! Amp Amp! Amp Amp! 
Zeo Zeo Zeo 
pSP72.polyl B/H 62 0 135 0 138 0 
- Insert  
pSP72.polyl B/H 192 44 383 115 536 92 
+ Insert 
pSP72.polyl B!H!Phos 9 0 47 0 51 0 
- Insert ________ ________ ________ _______ I pSP72.polyl B!H!Phos 129 36 273 90 203 72 
+ Insert  
Insert alone 11 13 20 18 22 15 




Figure 5.10 Phenotypic test for recD mutations 
Two phage 104 and 105 ± x sequences are spotted onto bacterial lawns. If 
the bacteria are deficient in exoV activity the x minus strain will be able to 
produce large plaques, if the bacterium have exoV activity pin point 
plaques will be observed. Phage can only infect recA+ strains. 
DH1OBrecA- no plaques observed, 
DH1OBrecA+ large plaques indicating recA+ and exoV deficient, 
DH1OBrecA+,recD- large plaques therefore recA+ and exoV deficient. 
A 
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The results suggest that all these strains were capable of IVC with 
small piasmids and that DH1OBrecA+ was more efficient. The 
DH1OBrecA+recD- strain gave very sticky colonies, indicating some 
mutation within the membrane proteins. Therefore DH1OBrecA+ was 
used in all further experiments. 
5.6 Introducing J3-Geo into Ren-1 
Initial experiments targeted Ren-1'1 from P1251 so that there could be 
no confusion through recombination with Ren-2. Primarily lOng of 
circular P1251 and an equimolar quantity of the linear recombination 
fragment, 1.8ng were mixed together and electroporated into 
electrocompetent DH1OBrecA+. Recombinants were selected for by 
growth on L-agar plates containing 5% sucrose, 25mg/mi Kan and 
25mg/mi Zeo and grown at 37°C overnight. The controls for this 
experiment were P1251 alone and the linear fragment alone, (Table 5.5). 
Table 5.5 Results from the initial large scale NC experiment 
DNA added Kan/Suc Kan/Suc/ 
plates Zeo plates 
lOng P1251 alone 347 colonies none 
1.8ng linear fragment none none 
alone 
lOngPl25l and 1.8ng 189 41 
linear fragment 
The majority of the clones were observed within 24 hours and were 
analysed by colony lift and hybridised with an IRES probe (JJM-149). 
Sixteen positive colonies were identified. Additionally four colonies grew 
on a separate plate after 48 hours. These colonies also hybridised with the 
IRES probe. Small scale preparations (Chapter 2.2.1.5b) were made of these 
twenty colonies for Southern analysis. Recombinant clones are identified 
by two enzymatic digestions (Table 5.6). The recombination fragment 
introduces an additional EcoRI site 5' of the reporter construct whilst a 
PvuII restriction site is introduced into the 3' arm (Figure 5.11). 
146 
Figure 5.11 The screening strategy for isolating a Ren-TI targeted event in 
P1251. 
The 5' exon I probe is highlighted red, whilst the 3' exon IX probe is in green. 
The expected sizes are given. 
P1251 	
MMM 77 E 	Ren-ld;,, 	P 
8.75Kb 10.6Kb 
Recombination 	00000 
fragment 	 L 
E IRESf3-Geo 
Recombined 
7m P1251 SEEM 
E 	E 	 P 	 P 
5.75Kb 	 8.6Kb 
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Therefore to identify a double crossover event the P1 clones isolated 
were digested with EcoRJ and PvuII. The digests were loaded onto a 0.8% 
agarose gel and separated by horizontal gel electrophoresis. The gel was 
observed under UV light and in addition to faint P1 bands very strongly 
staining plasmid bands, of unknown origin, were identified in the sixteen 
clones which grew up after 24 hours, but not in the four which appeared 
after 48 hours growth. The linear fragment is unable to replicate as it does 
not have an origin of replication. However if some linearised plasmid 
had been carried over with the linear fragment it is possible that this 
fragment had undergone intramolecular recombination to give the 
plasmid observed. The DNA fragments were blotted onto nylon 
membrane and the EcoRI blot was hybridised with the 5' probe whilst the 
PvuII blot was hybridised with the 3' probe (see Figure 5.11 for the 
location of the probes). The results can be seen in Figures 5.12. 
Table 5.6 Fragment sizes exvected with a Ren-1 recombination event 
Restriction digest Ren-1 
endogenous  
Ren-1 targeted 
EcoRl 8.75 5.75 
PvuII 10.6 8.6 
The EcoRI digest showed that all twenty clones were identical to the 
P1 clone, whilst the PvuII digest indicated a targeted event in all twenty 
clones. These conflicting results could have meant that a single crossover 
event had occurred leaving the 5' end intact. The IVC experiment was 
repeated as before but only 4 Zeocin resistant clones were identified. 
These clones were analysed by the 5' and 3' screens but all showed bands 
the same size as the P1 clone, although all were Zeocin resistant, 
indicating that the insert might have integrated into the E. coli genome. 
5.6.1 Characterising the recombinant clones 
In order to identify whether a single crossover event had occurred, 
the four with no plasmid contamination were screened alongside one of 
the zeocin resistant clones from the second round of IVC. The 
recombination fragment would have introduced many new rare 
restriction sites into Ren-1, such as NotI, Sail, SfiI, Smal and XhoI. 
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Figure 5.12 Screening twenty Zeocin resistance clones obtained from in vivo 
recombination with P1251 
5' EcoRl screen showing no recombination events, andthe contaminating plasmid band 
3' PvuH screen, indicating that all twenty clones had a targeted 3' end. 
lane 1, P1 251; lanes 2-17, plasmids derived from colonies which grew after 24 hours; 
lanes 18-21, plasmids isolated from colonies which grew after 48 hours 
A) EcoRI 
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These digests and a KpnI digest were performed on the five clones 
and wild type P1251. The DNA fragments were separated by switch back 
gel electrophoresis. The switch times used were 0.6-6 second pulses at 150 
volts for 22 hours. The gel was blotted and hybridised with the 5' probe 
and the 3' probe separately, (Table 5.7, Figure 5.13 and 5.14). Initial analysis 
indicated that the fifth clone has the same banding pattern as the P1 clone 
throughout and was omitted from any further analysis. Additional 
results with the 5' probe indicated no change with KpnI (not included in 
the picture) and Sf11 enzymes, a slight increase in size with NotI and 
maybe a slight decrease in the Smal bands, but a definite decrease in size 
with Sail and XhoI. The 3' probe indicated no change with KpnI, NotI and 
SfiI, but noticeable changes in Sail, SmaI and XhoI bands. All these 
changes were only noticeable in the four clones from the original IVC 
experiment. 
Table 5.7 Long range screening of five recombinant clones. 
Restriction 
endonucleases 
Band sizes identified 
with the 5' probe (Kb) 
Band sizes identified 
with the 3' probe (Kb) 
P1251 4 Recombinant 
clones 
P1251 4 Recombinant 
clones 
KpnI 1.4 1.4 22 15 
NotI 25 30 25 27 
SaIl 80 35 80 38 
SfiI 1 	28 28 28 28 
SmaI 1 	26 24 26 12 
XhoI 1 	26 20 26 14 
To summarise these results, only some of the expected restriction 
sites had been introduced into Ren-1, indicating that possibly an 
illegitimate insertion event had occurred. To clarify these contradictory 
results pulse field analysis using additional restriction enzymes was 
undertaken. The enzymes used were HpaI, NotI, PvuII, Sac!, Sail, SfiI, 
SmaI and XhoI. The results (Table 5.8 and Figure 5.15) from HpaI, Not! 
and SfiI indicate that an insertion of approximately 6Kb has been 
introduced into Ren-1, whilst all the other enyzmes show two bands 
indicating the introduction of those sites in the insertion. 
These results indicate either that the insertion was not the 
recombination fragment, or that it had been rearranged. 
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Figure 5.13 Restriction digests of a selection of recombinant clones 
compared to P1251, separated by Switch back gel electrophoresis and 
hybridised to the 5' probe. 
samples 1-4, represent the four plasmids which grew after 48 hours; sample 5, a Zeocm 
resistant clone without a targeted event; sample 6, P1251, KpnI and Sf1 only 3 
recombinant samples show. 
The expected fragment size for KpnI is 1.4Kb and so not shown on this autoradiograph, 
however all the observed bands were the same size. 
KpnI 	 NotI 	 Sail 
SfiI 	 SmaI 
	
XhoI 
I 	I 	 I 	I 
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Figure 5.14 Restriction digests of a selection of recombinant clones 
compared to P1251, separated by Switch back gel electrophoresis and 
hybridised to the 3' probe. 
samples 1-4, represent the four plasmids which grew after 48 hours; sample 5, a Zeocin 






Figure 5.15 Pulse field gel analysis of a single Zeocin resistant clone 
which grew after 48 hours compared to P1251 and hybridised with the 
renin cDNA. 
The first track for each digest represents P1251, whilst the second represents one of the 
targeted plasnuds 
153 
Table 5.8 Band sizes identified from the PFG probed with the renin cDNA 
Clone HpaI NotI PvuII SacI SalT SfiI SrnaI XhoI 
P1251 40 27 9.25 6.7 80 28 26 26 








5.6.2 Identifying the insertion 
The enzymes used previously were mostly rare cutting restriction 
enzymes: HpaI, NotI, Sail, SfiI, SrnaI and XhoI, located around genes in 
CpG islands, rather than within the coding sequence. A range of more 
regularly cutting enzymes were used in an attempt to identify the origin 
of the insertion. The enzymes used were BarnHI, EcoRI, KpnI, PvuII, Sad, 
SstI and XbaI. These DNA fragments were separated by horizontal gel 
electrophoresis and probed with an exon II probe. 
This probe was chosen as exon II should be present in the 
recombination fragment and might be useful in indicating whether the 
insertion originates from this fragment. The results (Figure 5.16) show 
only one band for each digest indicating no duplication of exonTl, and that 
only Barn HI and PvuII show any change in band size. Since the EcoRI 
band was the same size as wild type P1251, and the BarnHI fragment was 
larger the location of the insert was within intron E 3 of the EcoRI site 
and 5 of the BarnHI site. Further PvuII and BarnHI digests were set up 
and the blots hybridised with oligos to exons I, II, VI and IX. The results 
indicate that the latter part of the renin gene 3' of exon VI was P1251 like 
as there was no change in BarnHI fragments with the exon VI and IX 
probes. Therefore a 6Kb insertion has been introduced within intron E 
which contains BarnHI, PvuIT, Sail, Smal and XhoI sites. 
Since the location of the insertion had been narrowed down to 
within 600bp it was decided to sequence the insert using the ABI 
automated sequencer. Direct sequencing from P1 clones involves using 
primers in excess of 30nt, so it was decided that it would be easier to 
amplify through the insert by PCR, using two primers located outside the 
known site of the insertion. 
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Figure 5.16 Comparing the restriction patterns of two Zeocin resistant 
plasmids with P1251 after digestion with a range of regular cutting 
restriction enzymes and hybridised to the exon II probe. 
The first two tracks represent the two Zeocin resistant clones, whilst the third is P1251 
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Table 5.7 The fragment sizes observed after digesting P1251 and two 
Zeocin resistant plasmids and hybridising with the exon H probe 
BarnHI EcoRI KpnI PvuII Sacl SstI XbaI 
P1251 	6.8Kb 8.5Kb 4Kb 10.6Kb 6.6Kb 6.6Kb 5.5Kb 
Zeocinr 	13Kb 8.5Kb 
plasmid  
4Kb 9.1Kb 6.6Kb 6,6Kb 5.5Kb 
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The product was 7Kb, indicating a 6Kb insertion, and was digested 
with BamHI, EcoRI, PvuII, Sail and XhoI, to identify the location of these 
sites within the fragment. BamHI did not cut the insert whereas EcoRI, 
PvuII and Sail cut once and XhoI twice. The sequencing primers together 
with the PCR primers used, can be seen in Figure 5.17. 
Figure 5.17 Diagramatic representation of the position of the primers 
used to sequence the insert. 
El and Fl are the PCR primers used to amplify the product from the P1 clone; E3, E4, 
E51, and E61 were used as sequencing primers. 
Insert 
EcoRI \ 	/ BamHI 
Exon V 	 . . Exon VI 
E3 E61 	E4 E51 
El 	 Fl 
The sequence primers chosen are located throughout the 600bp 
region. Two recombinant clones were sequenced and compared with 
P1251. The sequences were aligned using the DNA Star Multiple sequence 
alignment package. The sequence obtained from primers E2 E3 and E61 
aligned with the Ren-1 sequence as did those from the Fl primer. 
However the sequence obtained from E51 and E4 did not align and read 
straight into unique sequence. This sequence was copied into the BLAST 
search program from the National Centre for Biotechnology Information 
to identify the origin of the insert. This package compares unidentified 
sequence to those kept within their databases. The sequence from the 
insert showed 100% homology to a transposon Tn1000. The restriction 
map of which matched the one preliminary identified, so no further 
sequencing was necessary (see Figure 5.18). 
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Figure 5.18 A restriction map of Tn1000 
showing the restriction enzymes identified by Southern hybridisation 
Pv u II 
XhoI 	 XhoI 
I EcoRI 	S 
I 
a EcoRI 	 il 	PvulI / BarnHI 
.r \ 	I, 1  
Tn 1000 
(5970 bp) 
Apparently the transposon had become integrated when the P1 had 
been transferred into the DH10B bacterial strain from the original NS3529 
E. coli strain by conjugal transfer. This transposon had never been 
identified before and may have moved during the recombination steps. 
The PvuII fragment identified with the 3' screen was thought to be 8.6Kb, 
however from the orientation of Tn1000 the exact size is 8.3Kb. 
Subsequently all P1 stocks were re-established from the original host 
strain and introduced into DH10B by electroporation. 
5.7 Additional strategies. 
The identification of Tn1000 indicated that no recombination had 
occurred between the linear fragment and the P1 clone. Zeocin resistant 
bacteria were either derived from fragment integration into the bacterial 
chromosome or from the plasmid identified in some of the clones (Figure 
5.12). Subsequent experiments were performed in an attempt to identify 
recombinant clones 
5.7.1 Chemical transformation 
Oliner et al (1993) published that DH5a only produced recombinant 
clones by intermolecular recombination when the fragments were 
introduced via heat shock. Since DH10B is a derivative of DH5a it was 
thought that the method of transformation might be a problem. As 
previously mentioned, P1 clones can not be efficiently introduced into E. 
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coil by transformation. Therefore chemically competent cells were 
generated from bacteria already containing the P1 clone, introduced by 
electroporation. The linear fragment could then be introduced either by 
heat shock or electroporation. One hundred and eighty zeocm resistant 
clones grew from the electroporation experiment and 98 from the 
chemically transformed cells. These clones were pooled into groups of ten 
for analysis. The same restriction digests were used as before, but all of the 
clones showed wild type P1251 pattern. 
5.7.2 BAC clones 
The inherent instability of P1 clones might prevent recombinants 
from being identified, and so IVC was performed using the BAC clone 
Nb. Electrocompetent, and chemically competent, BAC containing cells 
were generated, and the linear fragment introduced via electroporation 
and heat shock. Screening BAC clones for a targeted event is slightly 
harder due to the presence of Ren-2 (see Figure 5.19 for screening strategy 
and Table 5.9 for the expected sizes for a Ren-Ti targeted event). One 
hundred and twenty five zeocin resistant colonies were observed from 
the electroporation experiment and only 76 from the heat shock 
experiment. Again these colonies were pooled into groups of ten and 
analysed as previously mentioned. All bands resembled the wild type N10 
(Figure 5.20), suggesting that IVC had not been successful. 
Table 5.10 Expected band sizes for endogenous and targeted Ren-1 or 
Ren-2  
5'EcoRI Endogenous bands (Kb) Targeted bands (Kb) 
Ren-1 8.75 5.75 
Ren-2 9.25 6.25 
3'PvuII  
Ren-1 10.6 8.6 
Ren-2 7.9 5.5 
5.7.3 Mismatches in the homology arms 
Eleven mismatches have been identified in the 3' homology arm of 
the incoming linear fragment (Allan Clark PhD Thesis(442)). It was 
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Figure 5.19 The screening strategy for in vivo recombination with BAG N10. 
The reporter gene will recombine with Ren-1. 
A correctly targeted BAC. 
The 5' probe is highlighted in red, whilst the 3' probe is green. 
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Figure 5.20 Results of in vivo recombination with the BAC plasmid N10 
The 5' EcoRl digest hybridised to the exon I probe, 
The 3' PvulI digest hybndised with exon 9 sequences. lane 1, N10; lanes 2-18 seventeen Zeocin resistant colonies obtained 
All resemble wild type N10 
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The recombination machinery would traverse the homologous sequence 
until mismatches were encountered causing instability within the 
Holliday junction. As some of these mismatches are quite close together it 
might cause sufficient instability to cause the recombination machinery to 
fall apart (personal communication Dr Leach). The enzyme which 
recognises these mismatches is coded for by mutS. Dr David Leach 
(University of Edinburgh) kindly donated two E. coli strains, one which 
was mutS and the other mutS+.  The mutS- strain was tolerant to 
mismatches with a similar strain used to allow recombination between E. 
coli and Salmonella typhimurium (397, 443). The P1 plasmid was 
introduced into both strains, but without success. The lack of transformed 
cells was thought to be due to the lack of the deoR mutation which is 
believed to be important for bacteria to maintain large DNA molecules. 
5.8 Conclusions 
The IVC technique was chosen as a method to introduce site specific 
modifications into large genomic clones. Initially IVC was used to 
introduce the zeocin resistance gene into the plasmid vector pSP72.polyl. 
Even though not proven this method indicated that intermolecular 
recombination was a suitable method by which to introduce a reporter 
gene into Ren-1'. Initial experiments utilised the P1 plasmid, P1251, since 
it only contains Ren1d. 
The reporter construct to be introduced was j3-Geo, the 
lacZ/neomycin fusion. Additionally the IRES isolated from the 
encephalomyocarditis virus was incorporated to allow independent 
translation of 3-Geo in Ren-1' expressing cells. The zeocin resistance gene 
was included so that recombinants could be selected for in bacteria and 
mammalian cells. This reporter cassette was flanked by 3.5Kb of Ren-1" 
sequence both 5' and 3'. Oliner et al (380), had previously shown that the 
efficiency of IVC decreases with increasing insert size, for a given length 
of homology. However they also stated that as the length of homology 
increases so does the efficiency. Therefore it was reasoned that the 
inclusion of extensive flanking sequences should improve the chances of 
obtaining recombinant P1 plasmids. 
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The E. coli strain used had to be changed, since JC8679 did not 
efficiently maintain P1251, with 60% of the clones isolated displaying 
extensive recombination. Derivatives of DH1OB, the strain in which P1 
and BACs are maintained, were obtained. DH10BrecA+ and 
DH1OBrecA+,recD- were phenotyped by phage infection. Not only did this 
test show that these strains were recA+, but also that DH1OBrecA+ strain 
was recD-. Both strains were able to participate in IVC with small 
plasmids. However the DH1OBrecA+,recD- strain produced sticky colonies 
indicating some mutation within the membrane proteins, and so the 
DH1OBrecA+ strain was used in all subsequent experiments. 
Numerous attempts were made to generate a recombinant P1 clone. 
Initially equimolar quantities of P1251 and linear fragment were 
electroporated into the bacterial strain, but none of the colonies which 
grew had incorporated the linear fragment into Ren-1'. Subsequently 
competent cells were prepared which contained the P1 and various 
concentrations of the linear fragment were introduced, but to no avail. 
The only change to P1251 observed was due to the insertion of the 
transposon Tn1000, introduced into the P1 clone during conjugal transfer 
from strain NS3529 to DH1OB. The size of this fragment is 8.3Kb which 
had been mistaken for a 3' recombination event which gives a 8.6Kb 
PvuII fragment. Since the transposon had not been previously observed it 
was assumed that it had moved during the recombination experiment. 
Additional attempts included introduction of the fragment by 
chemical transformation. Neither the P1 nor the BAC clone incorporated 
the linear fragment. It was known that the 3' homology arm includes 
eleven mismatches and it was suggested that these mismatches might be 
causing the recombination machinery to fall apart. E. coli strains were 
obtained which had mutations in mutS, but the P1 clone was not 
successfully introduced into these strains and so this hypothesis could not 
be verified. 
The isolation of Zeocin resistant clones without any observed 
recombination is believed to be due to either plasmid contamination in 
the linear fragment or through recombination between the host 
chromosome and the linear fragment. However chromosomal DNA 
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isolated from these Zeocin resistant clones did not hybridise with zeocin 
sequences. 
Intermolecular recombination with very large clones is a rare and 
very inefficient event, and requires the screening of a large number of 
clones in order to identify a recombination event. Rather than continue 
screening by Southern blot and colony hybridisations it was decided that 
an alternative strategy should be used which incorporated negative 
selection, for example a suicide vector to prevent plasmid replication. 
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Chapter 6 
Introducing P-Geo into Ren-1 
6.1 Introduction 
The results of the last chapter indicated that a change in strategy was 
required. The high incidence of false positive clones suggested a need for 
a counterselectable marker, which would force the recombination event 
to occur, and prevent replication of the plasmid. Additionally the 
efficiency of transformation with a linear fragment is 102103  less efficient 
than covalently closed circular (ccc) plasmids (373). Since the size of the 
recombination fragment was 15.3Kb, it was conceivable that the linear 
fragment was not being efficiently introduced. Hence using a circular 
plasmid might ensure efficient delivery. Several alternative strategies 
were considered. 
6.1.1. Prophage introduction 
Phage X has two life cycles, the lysogenic and the lytic cycle (444). 
Lysogeny occurs when the phage integrates into the bacterial 
chromosome through the phage chromosomal attachment (att) sites. The 
action of the ci repressor acts to prevent independent replication of the 
phage and so it is replicated along with the rest of the bacterial 
chromosome. The lytic cycle occurs when the phage circularises via two 
cohesive (cos) sites, and is maintained as a circular prophage. The ci 
repressor is inactivated and rolling circle replication can occur. 
Concatenated phage particles are then cleaved at the cos sites and 
packaged into phage heads, ready for infection. There are many ?. cloning 
vectors available which are not able to undergo lysogeny, as they have 
deletions in the ci repressor, integrase and the att sites (445). Such phage 
vectors could be used to introduce the recombination fragment into the 
bacterial cell. The addition of the ci repressor would prevent phage 
replication, with recombination induced between the prophage and the 
Pi/BAC by selecting for the recombination event. As the prophage cannot 
replicate, all resistant clones should possess a recombined P1/BAC. This 
strategy had merits and in principle would be effective (Noreen Murray 
164 
ICMB University of Edinburgh, Chris Boyd Western General Hospital, 
Edinburgh) but would require a high titres, a plasmid containing the ci 
repressor, and a method by which to remove phage sequences. 
6.1.2. TnlO retrofitting 
Transposons can be used to introduce DNA into any site, although 
not entirely randomly (446). Tn 10 has been used to introduce up to 10Kb 
of DNA sequence into the Pi/BAC plasmids (447, 448). Incorporation of 
an additional loxP site into the inserted DNA sequence, meant deletions 
and inversions were possible through the action of cre on the two loxP 
sites. This technique, although not site specific, would introduce the 
insert DNA at multiple sites, resulting in the generation of a nested 
deletion series, the interruption of functional elements and the insertion 
of a reporter gene. However it would be necessary to analyse many clones 
before the required insertion event was isolated. 
6.1.3. RecA assisted restriction endonuclease (RARE) 
cleavage 
The RecA protein catalyses homologous pairing and strand exchange 
between DNA molecules sharing regions of homology (see (449) for a 
review). RecA can also be used to protect restriction sites from 
methylation, by utilising an oligo which is homologous to the restriction 
site to be protected (450). Once the triplex has been formed, unprotected 
sites are methylated by the corresponding methylase. Subsequently the 
RecA triplex dissociates and the protected site can be cleaved. Specific 
mutations may then be introduced by ligation. If more than one site is 
protected one can delete, or replace wild type sequence with point 
mutations or reporter constructs (451) The technique is limited since only 
methylase sensitive enzymes can be used. The site of insertion is 
restricted to the enzyme sites available and there is a limited number of 
specific methylases commercially available. 
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6.1.4. Suicide vectors 
There are many allelic exchange procedures reported for E. coli. 
Many of these employ either a counter selectable marker or a host strain 
or vector which is conditional for replication (452). 
The counter selectable marker, sacB from Bacillus subtilis, encodes 
the secreted enzyme levansucrase, which confers sucrose sensitivity to E. 
coli. It has been incorporated in allelic exchange vectors in E. co/i (452), 
and Mycobacterium smegmatis (453), as well as in P1 cloning vectors 
(353). The latter makes this strategy unusable since recombination could 
occur between the two sacB genes. 
An alternative strategy is to utilise vectors which are dependent on 
host proteins. Co1E1 vectors are dependent on the bacterial polA gene 
product for replication (454), and there is a Ts polA strain which can be 
used to select against maintenance of Co1E1 vectors (455). Another 
strategy utilises a plasmid vector which requires a trans supply of the pir 
encoded it protein from plasmid R6K for replication. Efficient plasmid 
suicide results following introduction of the plasmid into a host which 
does not harbour pir (456). Under appropriate selection conditions both 
strategies would force recombination to occur for the continued presence 
of vector sequences. 
Other suicide vectors employ temperature sensitive origins of 
replication. Such vectors have been used to introduce modifications into 
the E. co/i chromosome (400). This group used the Ts mutant plasmid 
isolated from the Tet resistant R plasmid pSC101 (457). The origin of 
replication is active at the permissive temperature of 30°C, but inactivated 
at 42°C. Hamilton et al utilised this ts pSC101 replicon, to induce 
recombination between sequences within the Ts plasmid and 
homologous sequences in the E. coli chromosome, at the non-permissive 
temperature of 42°C. This caused a single crossover event, generating co-
integrants with the plasmid vector integrated within the E. co/i 
chromosome. The co-integrants were resolved by subsequent growth at 
30°C which caused a second recombination event to occur, which either 
left the E. co/i chromosome intact, or introduced the desired mutations. 
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The problem associated with this protocol was that the site of the second 
recombination event was not specific, and so it would be necessary to 
screen many isolates to find the deletion/insertion desired. 
6.2. The BAC targeting strategy 
The isolation of false positive clones in IVC strategies suggest that a 
negative selectable marker or a suicide vector, is a prerequisite for 
selection against the retention of unrecombined transformed plasmids. 
All of the above strategies had merits and after much consideration the 
use of a temperature sensitive suicide vector was chosen. A temperature 
sensitive plasmid was kindly provided by Phillipe Gabon (Belgium). 
Initial experiments were carried out to check the sensitivity of the 
plasmid to growth at 43°C; isolated colonies were observed indicating 
leaky expression. However at this time a protocol for site specific targeting 
in BACs was published (458). This technique is a modification of the ts 
pSC101 technique described above (see Figure 6.1). 
Briefly the recombination fragment is ligated into the suicide vector, 
which contains the pSC101 ts replicon, a Tet resistant gene and a 
functional copy of the E. coli recA gene. The suicide vector is then 
electroporated into the P1 /BAC host strain, DH10B, and allowed to co-
exist with the Pi/BAC when maintained at 30°C. When the bacteria are 
grown at 42°C the vector cannot replicate and is forced to recombine with 
Pi/BAC sequences to survive. This single cross over event generates co-
integrants using either the 5' or 3' homology arms. These are then 
screened using probes located outside the regions of homology. Co-
integrants are then grown on Cm plates at 37°C to generate single 
colonies. Subsequently these single colonies are streaked onto fusaric acid 
plates which induced the second recombination event in order to lose the 
vector sequences. Fusaric acid is lethal to Tet resistant bacteria (459), since 
the product of the Tet resistance gene alters the bacterial cell membrane 
allowing fusaric acid to enter into the cell. Resolved clones will either 
have an intact BAC or inserted the desired mutations. The Heintz group 
used this technology to introduce the IRES lacZ construct into a BAC 
containing the RL149 gene, using just 500bp of homology. 
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Figure 6.1 Diagramatic representation of the BAC Targeting Strategy 
The targeting construct contains the desired modification flanked by sequences 
homologous to the site of integration. It is introduced into the suicide vector and 
then electroporated into DH10B cells containing the BAC 
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The BAC targeting strategy introduces mutations in a site dependent 
manner, and should be equally applicable to P1 plasmids. The suicide 
vector and protocol was therefore requested so that we could introduce 
the f3—Geo reporter construct into Ren-1 as planned. 
6.3 Introducing the recombination fragment 
into pSV1.RecA 
Several modifications had to be made to the recombination 
fragment in order to accommodate the change in protocol. Firstly the 
zeocin resistance gene was omitted from the construct, as it was not 
required. Secondly a new splice acceptor IRES 13—Geo construct was kindly 
donated by Ken Lee (PhD student CGR). This incorporated an optimised 
IRES, which placed the J3—Geo ATG 12bp 5' of its original location. This 
introduced three additional stop codons 5' of the IRES to ensure that 
translation of —Geo would initiate from the IRES. Furthermore, a 
nuclear localisation signal was introduced into 13—Geo, to direct 
expression to the nucleus. Additionally the engrailed splice acceptor was 
introduced into the construct, 5' of the IRES, as RNAse protection 
analysis of the Ren-1 knockout animals (460) identified a smaller, 
inactive, Ren-1 product. This indicated that there had been splicing 
around the insert. The same homology arms were used as previously 
described. Hamilton et al observed that efficiency of allelic exchange 
increased when homology arms were similar in length to that of the 
insert. The generation of the recombination fragment is shown in Figure 
6.2. Briefly pKL53 and pR1KO were digested with Sail and the fragments 
separated by electrophoresis. The 7Kb Sail fragment from pKL53 was 
ligated into the Sail site in pR1KO to generate pR1SAIRES/3—Geo. 
pSV1.RecA only has unique Hindlil and Sail sites which can be used 
for subcloning. To introduce the recombination fragment into 
pSV1.RecA, additional sites were added. The multiple cloning site from 
pSP72.poly2 includes many rare restriction enzymes. An XhoI/SalI 
fragment excises these sites and was introduced into the unique Sail site 
in pSV1.RecA (see Figure 6.3). The XhoI/SalI 60mer was isolated on a 2% 
Nusieve agarose gel and the DNA fragment electroeluted from the gel 
slice. 
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Figure 6.2 Subcloning strategy used for generating pR1SAIRESJ3-Geo. 
The recombination cassette was cleaved from pKL53 on a Sail fragment and ligated 
into the unique Sail site in pR1KO, to generate pR1SAIRES/3-Geo. 
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Figure 6.3 Introducing additional restriction sites into the suicide 
vector pSV1.RecA. 
The multiple cloning site from pSP72.poly2 was cleaved on a XhoI/SaiI 
fragment and introduced into the unique Sail site in pSV1.RecA. 
NotI 	MunI 	KasI 	Asci 	BclI EcoRI BamHI 
TCGAGCGGCCGCAATT GAAGGCGCCAAGGCGCGCCAATGATCAGAATT CCGGATCCAAG 
CGCCGGCGTTAACTTCCGCGGTTCCGCGCGGTT ACTAGTCTTAAGGCCTAGGTTCAGCT 
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The vector was digested with Sail the ends dephoshorylated, followed by 
phenol/ chloroform/ isopropyl alcohol extraction and precipitation. The 
60mer and the pSV1.RecA fragment were ligated together, with positive 
clones identified by oligo hybridisation with the 60mer. Since pSVl.RecA 
is maintained at approximately 5 copies per cell a midi plasmid 
preparation of one of the positive clones was performed using a modified 
Qiagen protocol (Chapter 2.2.1.4d). Subsequent restriction analysis of the 
DNA showed a laddering effect. When Triton lysis was used (Chapter 
2.2.1.40 as the method of isolation the laddering effect was prevented. 
The recombination fragment was introduced into the suicide vector 
on an AscI! XhoI fragment and introduced into the AscIi Sail sites in the 
vector. Positive clones were identified using the IRES reverse primer 
oligo probe, pSV1.13—Geo was isolated using Triton lysis and its restriction 
pattern confirmed by enzymatic digestion. 
6.4. Targeting Ren-1 in P1251 
pSV1./3—Geo was introduced into electrocompetent DH10B cells 
containing the P1 plasmid. Transformed cells were selected on L-agar 
plates containing 25ig!ml Kan and 10pg!ml Tet grown at 30°C overnight. 
A 1:1000 dilution produced 43 clones. Six of these were inoculated into 
100jil L-broth and plated on fresh plates (25jig!ml Kan and 10ig!m1 Tet), 
and grown at 42°C overnight. The plates were sealed with parafilm and 
covered to protect the plates from drying out. Two hundred colonies 
grew, forty of which were cultured in lOmi L- broth (Kan/Tet) and grown 
at 42°C. Ten microlitres of the isolated DNA was used for EcoRI and PvuII 
digests, to identify co-integration of the suicide vector, as specified in 
Table 5.6. The first recombination event can occur at either the 5' or the 3' 
arm of homology, and Figure 6.4. shows the two possible outcomes. Each 
co-integrant will have one targeted and one wild type band (Figure 6.5). 
The 5' EcoRI screen identified eight 5' co-integrants, whereas the 3' 
PvuII analysis showed 6. These 14 co-integrants were streaked onto a fresh 
L-agar plate (Kan) and incubated at 42°C. This growth step produced a 
fraction of resolved P1 clones. 
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Figure 6.4 Diagramatic representation of the first single crossover event 
to produce co-integrants. 
The suicide vector integrates with the P1 plasmid when the bacteria are grown at 42°C 
This recombination event can occur by either the 5' or the 3' homology arm, which will 
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Figure 6.5 Screening for 5' and 3' co-integrations into P1251. 
Plasmid DNA from forty Cm/Tet resistant colonies were analysed by an EcoRI and 
aPvuII digest and hybndised with the exon I or exon IX probes. 
A) EcoRI digest; lanes 21 and 42 represent P1251 , B) PvuIl digest; lanes 20 and 40 
represent P1251. 
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Single colonies were then streaked on TB plates with fusaric acid and 
Kan, and incubated at 37°C for 48 hours until large colonies were 
observed. Twenty-five fusaric acid resistant colonies from each of the 
twelve co-integrants, were streaked onto fresh Kan plates, for analysis by 
colony lift. The IRES reverse primer oligo was used as a probe. Only a 
fraction of the P1 colonies grew, (Figure 6.6a), however after hybridisation 
with the IRES probe most of these colonies were positive (Figure 6.6b). 
Twenty four positive clones, 12 from original 5' events and 12 from 3' 
events, were used to inoculate lOmis L-broth and DNA was analysed for 
targeted events (Figures 6.7). 
The 5' EcoRl screen, indicated that fifteen out of the 24 clones had a 
targeted 5' end. However some of the original 5' targeting events had lost 
the targeted bands, and resolved back to wild type (lanes 5, 6, 7, 8, 11 and 
12 Figure 6.7a). It was observed that some clones had both wild type and 
targeted bands indicating mixed clones, (lanes 1, 2, 3, 4, 9, 10, 16, 18, 21, 22 
and 23). 
The 3' PvuII screen showed similar results as above, with four 
original 3' events reverting back to wild type (lanes 19, 20, 22 and 23 
Figure 6.7b). The same mixed clones were observed, apart from clone 21, 
which had lost the wild type band. There were 4 clones which had 
targeted bands, both 5' and 3', with no wild type P1 bands, numbers 13, 15, 
17 and 24 (summarised in Table 6.1). DNA from one P1251J3—Geo clone 
was prepared and compared with P1251 to ensure that no additional 
recombination had occurred (Figure 6.8). The insertion of /3-Geo into Ren-
id introduces NotI and Sail restriction sites. Ren-1" is flanked by 
recognition sites for NotI, Sail andSfil and these were used to show that 
only the Ren1d  specific bands had been altered within the P1 clone. The 
Ren-1' specific 28Kb NotI fragment was altered to 16 and 19Kb fragments, 
the 80Kb Sail fragment was cleaved to 48 and 39Kb fragments, whilst the 
25Kb SfiI fragment was increased to 32Kb. All other restriction fragments 
remained unchanged. 
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Figure 6.6 Resolved bacterial colonies, hybridised with an IRES oligo 
probe. 
Indicates that a large proportion of the bacterial colonies did not grow. 






Figure 6.7 Southern blots of 24 resolved P1 plasmids, two from each 
of the initial co-integrants. 
EcoRI screen hybridised with the exon I probe, there are many mixed clones 
however lanes 13, 15, 17 and 24 show unique targeted bands. 
Pvull screen hybridised with the exon IX probe, similar mixed clones with lanes 
13, 15, 17 and 24 showing a unique targeted band. 
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Figure 6.8 A comparison of P1251-Geo with P1251 to ensure that 
no additional rearrangements had occurred. 
For all digests lane 1, P1251; lane 2, P1251-Geo, The DNA markers are Midrange 
markers I and II. 
Not! 	Sail 	Sf1 
I 	I II 
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Table 6.1 A summary of the P1 targeting experiment 
Number of clones 
analysed 
Number of co- 
integrants 
Number of resolved 
clones from initial 
5' 3 , 5' events 3 events 
40 8/40 6/40 6/12 9/12 
all mixed 5 mixed 
clones 
These results suggest that this protocol was reproducible and 
applicable for targeting Ren-1 in the P1 clone. As the two genes in the 
BAC clone are 97% homologous at the nucleotide level it was interesting 
to see whether this technique would be specific enough to target Ren-1" 
and not Ren-2. 
6.5. Ren-1 specific targeting in BAC N10 
The same recombination plasmid pSV1.13—Geo was introduced into 
electrocompetent, DH10B cells containing BAC N10. Transformed cells 
were selected on Cm and Tet plates. Forty three large clones were seen on 
a hazy background. Six were carefully picked and inoculated into lOOj.tl of 
L- broth and spread onto a fresh L-agar plates (Cm! Tet), sealed and 
incubated at 42°C overnight. Several hundred clones grew and forty were 
analysed as before. Since N10 has both renin genes, two bands were 
observed in each track. (See Table 5.9 for the expected band sizes for a 
targeted event in either Ren-1 or Ren-2). 
The 5' EcoRl digest, was difficult to distinguish as the Ren-1/Ren-2 
bands were very close together (Figure 6.9). However since the targeted 
band was 3Kb smaller these were easily identified. Only the bottom Ren-1 
band was replaced with a targeted band, with all Ren-2 bands remaining 
intact. The 3' PvuII digest (Figure 6.10) however, did not reveal any 
targeted bands. 
Since no 3 co-integrants were observed another thirty, Tet/Cm 
colonies grown at 42°C, were analysed for a 3' event, but again none were 
observed. 
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Figure 6.9 Screening 36 BAC clones for a 5' co-integration event. 
There are 5 targeted clones analysed lanes 14,16, 20, 21 and 30. 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
5.75Kb - 
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9 25Kb
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5.75Kb - 
Figure 6.10 Screening 36 BAC clones for 3' co-integration event. 
All tracks give wild type pattern indicating no 3' recombination events. 
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The five positive clones were grown on a fresh L-agar plate (Cm) and 
incubated at 42°C overnight. Several colonies had grown up and several 
of these were streaked onto fusaric acid plates containing Cm, and grown 
at 37°C for 48 hours. Twenty-five colonies from each individual co-
integrant were streaked onto a fresh Cm plate for a colony lift, which was 
hybridised with the IRES probe. All the colonies grew but very few were 
identified as positive (Figure 6.11). Twenty possible clones were picked 
and analysed for 5' and 3' events (Figure 6.12). Four clones, which were 
all derived from a single co-integrant, had lost the Ren-1 specific band 
completely (lanes 14, 15, 16 and 17). One clone showed both a 5' and 3' 
event in addition to wild type bands indicating a mixed clone, (lane 2) 
Table 6.2 summarises the results of this experiment. This clone was 
streaked out onto a fresh L-agar plate (Cm) single colonies were screened 
and three correctly targeted BACs were identified, and checked to ensure 
that no additional recombination had occurred. 
Th1 12 A summary of the BAC N10 tareetina experiment. 
Number of clones Number of co- - Number of resolved 
analysed integrants clones from initial 
5' 5' events 3' events 
70 5/70 0/70 1/20 
mixed 
n/a 
Four restriction enzymes were chosen, NotI, Sail, Sf11 and SmaI to 
show whether any internal recombination had occurred during the 
recombination event. The recognition sequence for all these enzymes, 
except SfiI, are located within J3-Geo cassette therefore the Ren-1 specific 
bands should be altered leaving the Ren-2 bands intact (see Figure 6.13). 
The DNA fragments were separated by PFGE and stained with ethidium 
bromide. The 28Kb Not! band was cleaved to 19 and 16Kb fragments, the 
100Kb Sail fragment was altered to 47 and 53Kb bands, the 25KbSfiI 
fragment was increased to 33Kb whilst the 25Kb Smal specific band was 
altered to 20 and 9.8Kb bands. All other bands including the Ren-2 bands 
were unaltered. These results show that only the desired modifications 
had been introduced. 
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Figure 6.11 Resolved BAC plasmids grown on Cm plates. 
all the BAC colonies have grown, 
all appear to hybridise with the IRES oligo. suggesting background, as 





Figure 6.12 Screening BAC colonies for a correctly targeted plasmid. 
A) EcoRl digest hybridised to the exon I probe. Only one clone, lane 2, shows a 5' 
targeted band. 
B)PuuII screen hybridised with the exon IX probe. lane 2 is the only plasmid which shows 
a targeted band. 
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Figure 6.13 Comparing the organisation of N1ORn1-Geo with N10 to 
ensure no additional rearrangements had occurred within the renin locus. 
For each enzyme used lane 1, N10; lane 2, N1ORn1-Geo. The markers are midrange 
markers I and II. 
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The modification of N10 by the BAC targeting strategy indicate the 
specificity of the RecA mediated recombination event, since only Ren-1 
was targeted. No 3' co-integrants were observed after the first round of 
recombination and only 1 successful BAC recombination event was 
- produced. The P1 clone however showed both 5' and 3' co-integrants but 
it appeared that 5' co-integrants were more likely to resolve back to wild 
type than an initial 3' event. This suggests that the 3' event was less 
efficient perhaps due to the mismatches known to be located in this arm. 
Despite this, J3—Geo had been successfully introduced into Ren-1" located 
within the BAC Nb. 
6.6 Conclusions 
The decision to use a suicide vector to select against plasmid 
replication was validated with the publication of the BAC targeting 
strategy (458). This method was similar to that published by Hamilton et 
al(400), utilising the ts pSC101 origin of replication. Recombination was 
promoted between the Pi/BAC and homologous sequences located in the 
suicide vector by growing bacteria at 42°C. The incorporation of the E. coli 
recA gene in the suicide vector, removed the need to use recA+ strains, 
reducing the chance of internal recombination within the Pi/BAC. 
The recombination fragment introduced into the suicide vector was 
altered to incorporate an optimised IRES. Additionally a nuclear 
localisation signal and the engrailed splice acceptor was also included, 
whilst the zeocin resistance gene was removed, since there is no need to 
select for recombinants. The same homology arms were used and the 
recombination fragment introduced into the modified suicide vector. 
Both P1 and BAC plasmids were successfully targeted using this strategy. 
The results also intimated that the 5' arm was utilised for recombination 
more efficiently than the 3' arm. A vast proportion of initial 5' co-
integrants reverted back to wild type, whilst initial 3' events were more 
likely to produce a recombined plasmid. The efficiency was also seen to 
drop when using BAC clones, which might be due to the presence of Ren-
2. Importantly none of the BAC plasmids showed any change to the Ren-
2 sequence indicating the specificity of this technique. The BAC clone 
PISISI 
N1ORn1J3-Geo was subsequently used to generate transgenic mice in an 
attempt to express f3-Geo in the JG cells. 
The aim of this project was to introduce a histochemical marker into 
the coding region of Ren1d, within a large genomic clone inorder to 
overcome position effects which have hindered previous transgenic 
approaches. The successful introduction of J3-Geo into N10 permits this 
hypothesis to be tested. 
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Chapter 7 
Generating transgenic mice with 
N1O.Rn1J3-Geo 
7.1 Introduction 
Expression of a histochemical marker in the juxtaglomerular cells of 
the kidney has proved unsuccessful to date believed to be caused by 
position effects and the bacterial origin of f3-Geo. The introduction of J3-
Geo into the Ren-1 sequence within BAC N10 should, theoretically 
counteract these position effects and damped any effects caused by f3-Geo. 
Wild type N10 has been linearised and used to generate transgenic mice 
on the Ren1cbackground. The transgenic animals produced are currently 
under analysis for site independent and copy number dependent 
expression. Initial studies reveal that all three renin genes are expressed 
in the kidney of transgene positive animals, however due to the strict 
regulatory mechanisms governing renin expression in this tissue copy 
number dependent expression cannot be demonstrated. Expression in the 
submaxillary gland has been shown to be correctly regulated by androgen 
and has the highest level of expression ever observed with any other 
renin transgenes. The fact that all three renin genes were expressed in the 
kidney suggestes that /3-Geo should also be expressed. 
N10.Rn1/3—Geo was linearised (Chapter 2.2.1.17) at the unique loxP 
site located within the BAC vector and was microinjected into the male 
pronuclei isolated from superovulated fertilised Fl (CBA/C57BL/6) 
females (Gillian Brooker and Morag Meikie). Vector sequences were not 
removed and did not appear to have any effect on the generation of 
transgenics. 
7.2 Transgene expression 
Renin expression in the adult mouse kidney is restricted to the 
juxtaglomerular cells, in normotensive animals. However expression of 
renin in the embryo follows the development of the renal vasculature 
It.L.J 
(167, 461). Renin can be detected in the adrenal gland and the interlobar 
artery from day 14.5p.c. and subsequently observed to branch into the 
arcuate and the interlobular arteries. Renin expressing cells migrate 
through the developing arteries and by E18.5 expression begins to be 
restricted to the more distal arteries. At birth renin staining can be seen in 
the interlobular and afferent arterioles, which subsequently becomes 
restricted to the classical juxtaglomerular position (within the first three 
weeks of life, Figure 7.1). 
In the literature there are several examples where the expression of 
bacterial reporters have been shut down in adult transgenic animals 
despite being transcribed from strong eukaryotic promoters (434, 437, 462). 
In an attempt to visualise $-Geo expression embryos were taken at day 
16.5p.c. since there should be strong expression in the arteries at this time 
point. All pups were collected and the kidneys and adrenal glands taken 
from each embryo. Additionally tail and liver tissue was taken for 
genotyping. One kidney was placed in O.C.T. freezing fluid for the 
preparation of frozen sections, whilst the other kidney was fixed in 
formaldehyde and stained with X-gal for 48 hours at pH8.5 at room 
temperature. Fifty one pups were analysed for the presence of the 
transgene by a PvuII digest. Since the transgene, with an intact Ren-2 and 
a targeted Ren-1' was introduced into a Ren 1C background, transgenic 
founders will have three renin specific bands (Table 7.1) around 8Kb, and 
an additional transgene derived band at approximately 6Kb. From the 51 
pups analysed, 4 were transgene positive (see Figure 7.2 for an example of 
the bands observed). 
Table 7.1 Size of the expected bands for transgenic positives. 
PvuII band (Kb) 
Ren 1C 7.5 
Ren-1" (targeted) 8.6 
Ren-2 7.9 
IM 
Figure 7.1 Identifying transgene positive animals by PvuII digest of genomic 
DNA hybridised with the renin cDNA. 
genomic DNA from the recipient mother (Fl; CBA/C57BL/6 Ren 1); 
genomic DNA from an NlO transgenic founder (Ren1c;Ren1d  and Ren-2); 
genomic DNA from a N1ORn1-Geo positive animal ((Ren-lc, a targted Ren-1' andwild 
type Ren-2). 
—10.6Kb Ren-l" 




Figure 7.2 Whole moimt X-gal stain of a 16.5p.c. kidney and adrenal gland 
from a transgene negative littermate. 




A) 	 B) 
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Kidneys from the four transgene positive animals, stained for 3-
Galactosidase activity, were cut in half longitudinally and observed by 
light microscopy. All transgene positive animals had lacZ staining in the 
renal vasculature and adrenal gland, similar to that observed by 
immunohistochemistry with the renin cDNA (170); (Figures 7.3, 7.4 and 
7.5). 
Frozen kidneys were sectioned into 30 micron sections and stained 
for lacZ expression. Blue staining was observed, however due to the 
thickness of the sections the individual cells could not be distinguished. 
To date there has been no reporter gene successfully introduced into 
the renin genes which emulates renin expression. The developmental 
expression of renin was characterised using immunohistochemistry with 
renin specific antibodies. The N10.Rn1J3—Geo transgenic mice, represent 
the first animals to successfully express a reporter gene in renin 
expressing cells. Further studies were preformed to ensure that /3-Geo was 
expressed throughout development and in the adult. Additional 
microinjections were set-up to obtain founder lines. 
7.3 Developmental expression profile 
A further thirty pups were analysed for the presence of the N10Rn-
1/3—Geo transgene. Five transgene positive animals were identified F9583, 
F9675, F9677, F9678, F9687, which had integrated between 1-2 copies. All 
potential founder animals were backcrossed onto the CBA background 
and all but F9687 produced litters. Line F9677 was found to have two 
insertion sites which segregated into F9677A a low copy (<1 copy) and 
F9677B a high copy line (2 copies). Timed matings were set up for each 
line to establish the developmental profile of ,6-Geo and to examine the 
reproducibility of expression between founder lines. Embryos were 
harvested from day E13.5-E18.5 whilst newborns, iweek and 2 week old 
pups were culled appropriately. Thirteen and fourteen and a half day 
embryos were placed in OCT fluid directly, since the kidney is very 
delicate at this stage. 
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Figure 7.3 Whole mount X-gal staining of a 16.5p.c. Kidney and adrenal, 
excised from Founder No.11. 
The kidney and adrenal gland were stained in X-gal (pH 8.5), for 48 hours at room 
temperature. 
Kidney cut in half longitudinally, showing the arcuate artery staining blue. 






Figure 7.4 %Vhole mount X-gal staining of a 16.5p.c. kidney and adrenai 
excised from Founder No. 51. 
The kidney and adrenal gland were stained in X-gal (pH 8.5), for 48 hours at room 
temperature. 
half a kidney showing 7 points of blue staining, representing branches of the arcuate 
and interlobular arteries, 
Closer view of the arcuate artery branching into the interlobular artery, 
Bule staining in the adrenal gland. 
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Figure 7.5 The expected -Ga1Iactosidase expression profile in the 
developing kidney, extrapolated from the known developmental 
profile for renin. 
E14.5 and E15.5 Blue staining is first 
observed in the interlobar artery. E16.5 As the arcuate artery is formed blue staining should 
be visualised in this vessel. 
I 
E17.5 Blue staining 
observed in th interlobar 
and throughout the 
arcuate artery. 
E18.5 and newborns 
Blue staining becomes restncted to the distal arteries 
with expression located in the interlobular artery. 
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For all other time points kidneys and adrenals were dissected from 
the embryos and stained for -ga1actosidase activity in X-Gal reagent for 
48Hrs at room temperature at pH8.5. At E15.5 blue staining was detected 
in the interlobar artery and was seen to follow the developing renal 
vasculature throughout development. At E18.5 staining had begun to be 
restricted to the more distal arteries with staining observed in the arcuate 
and interlobular arteries. , At birth only the interlobular aretery and the 
afferent arterioles showed 3-galactosidase activity (See Figures 7.6, 7.7 and 
7.8). The 3-galactosidase activity was observed to co-localised with 
developed glomeruli where the cortex-medullary boundary would be 
located (Stewart Fleming, Renal Pathologist in the Midlothians). After 
two weeks of age the blue staining was located throughout the cortex 
suggesting that the kidney is fully developed. This expression profile was 
observed for lines F9675, F9677B and F9678 however no expression was 
determines in lines F9583 and F9677A. DNA from each founder line was 
digested by a range of rare cutting restriction endonucleases and the 
fragments separated by PFGE. F9583 and F9677A showed some internal 
rearrangment within the transgene which could account for the lack of 
expression. 
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Figure 7.6 -Ga1actosidase activity in the developing kidneys of 
line F9678. 
A) E15.5 kidney and adrenal, B) E16.5 kidney. 
Transgene positive and a negative littermate. 
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Figure 7.7 t-Galactosidase activity in the developing kidney of line F9678. 
A) E17.5 kidney, 1ongitudina1 and traverse sections. B) E18.5 kidney. 
Transgene positive and a negative littermate. 





Figure 7.8 3-Ga11actosidase activity in the postnatal kidney of line F9678. 
A) newborn kidney, B) 1 week old kidney, C) 2 week old kidney. 
Transgene positive and a negative littermate. 
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7.4 Conclusions 
N1ORn1/3—Geo was linearised and used to generate transgenic mice. 
Initially embryos were harvested at day E16.5 since lacZ expression might 
be shut down in adults. Four of the 51 embryos recovered had 
incorporated the transgene, all of which showed blue staining in the 
developing interlobar and arcuate arteries (see Figures 7.3, 7.4 and 7.5). To 
identify whether 13-Geo is expressed throughout development and in the 
adult mouse founder lines were generated through further 
microinjection. Five animals were identified which had integrated the 
transgene F9583, F9675, F9677, F9678 and F9687. One line, F9785, has not 
produce any litters to date, whilst F9677 had two integration sites which 
were segregated into a low, F9677A, and high copy line, F9677B. F9677A 
and F9583 were found not to express the transgene, however this was 
thought to be due to rearrangements identified within the transgene. The 
other three lines expressed the transgene throughout development and 
had the correct temporal expression profile (Figures 7.6, 7.7 and 7.8). 
N1ORn1J3-Geo was also transfected into the As 4.1 cells using the Pfx-
3 lipofectin reagent to identify whether this construct could confer G418 
resistance. However no blue cells were observed nor were any G418 
resistant cells isolated. Since the transfection efficiency with a 17Kb. 
plasmid was less than 0.1% this result was not unexpected. Recent 
developments using inactive adenovirus as a carrier (463, 464) might 
prove to be the most efficient method by which to introduce BACs into 
the As 4.1 cells or indeed any JG cell line. 
The expression of lacZ in all transgene positive animals indicated 
that the BAC might not be subject to position effects, although more 
animals will have to be analysed before it can be determined whether the 
BAC confers site independent expression. Furthermore this result 
validates the use of large genomic clones to direct wild type expression 
over a given transgene. The successful introduction and expression of 0-
Geo in transgenic animals opens the door to numerous experiments 
including deletion studies, insertions and the introduction of point 
mutations into a given gene. 
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Chapter 8 
Mutating the glycosylation sites in 
Ren-1 
8.1 Introduction 
The single renin gene of humans, rats and some inbred mice strains, 
expresses a protein in the kidney which can be directed to either a 
regulatory or secretory pathway. The two pathways for prorenin 
processing are that prorenin is either constitutively secreted from 
eñdoplasmic reticulum derived transport vesicles, or passed through the 
golgi apparatus and stored in protogranules which pinch off from the 
golgi cisternae (465, 466). The signal directing prorenin to either of these 
pathways is unknown. 
The situation in two renin gene mouse strains is slightly more 
complicated, with renm-1 thought to be stored in the granules and renm-
2 constitutively secreted into the circulation. This hypothesis was 
confirmed by gene targeting. Ren-1'1 null animals (460), which express 
Ren-2 only, did not possess renin storage granules in their renin JG cells 
(Figure 8.1), whereas the Ren-2 null mice express Ren-1 and had 
granulated JG cells (244). The major difference between renin-1 and renin-
2 is the lack of three potential N-linked glycosylation sites in renin-2. This 
lack of glycosylation has been attributed to the difference in 
thermostability between the two proteins (119), and has also been 
hypothesised to be important in directing renin-1 to the granules. 
Generally the signal which targets proteins to either the constitutive 
pathway or the regulatory pathway, has been located in either the 
propeptide (467, 468), or within the mature protein (469-471). 
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Figure 8.1 A comparison of the aJtered morphology of the macula 
densa cells (B), the diffuse renin staining (D), and the degranulation of 
the jaxtaglomerular cells (F) of the Ren-1 KO animals with wild type 
129.01a mouse strain (A,C,E) 
C, glomerulus; A, arteriloe; E, endothelial cell; SM, smooth muscle cell. A and B the 
arrow point to the macula densa cells, C and D, to the renin immunostaming, E, to 
the granules in wild type juxtaglomerular cells. 
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Mutant renin proteins, lacking the propeptide sequence, were found 
to be processed correctly in mouse pituitary cells, AtT20 (270, 472-475), and 
in the rat pheochromocytoma, PC 12, cell line (472). This indicated that 
some moiety within the mature protein might be involved in directing 
prorenm to the regulatory pathway. Additionally, when a mutated Ren-2, 
which introduced the first two glycosylation sites of renin-1 into renin-2, 
was transfected into AtT20 cells, no difference was observed in the 
regulated secretion of renin-2. The reduced secretion of active glycosylated 
renin-2 in AtT20 cells, was restored when glycosylation was prevented by 
tunicamycin treatment (266). These two results would suggest that 
neither the prosegment, nor glycosylation, had an effect on the sorting of 
prorenin to the granules in AtT20 cells. However, AtT20 cells are not 
renin expressing cells, and importantly renin-2 is known to be sorted to 
granules in the SMG but not in the kidney. 
The major difference between renin-i and renin-2 is the lack of three 
potential asparagine linked glycosylation sites in renin-2, so it was decided 
that the glycosylation sites of Ren1d  would be mutated to those sequences 
of Ren-2. N-linked glycosylation occurs only if the asparagine is part of an 
Asn-X-Ser(Thr) sequence (where X=any amino acid, Ser=Serine and 
Thr=Threonine), therefore even though Ren-2 sequence does code for an 
asparagine there is no serine or threonine amino acid located 
appropriately. Cell culture studies to identify the effects of removing the 
first two glycosylation sites of renin-1 were not practical in the cell lines 
currently available, and so a transgenic approach was devised. Since 
sequences within Ren-1 are thought to be necessary for granulation, the 
BAC clone N10 should be able to restore granulation in the Ren-1 null 
animals, this study is currently under investigation by cross breeding N10 
transgenics with the Ren-1 KO animals. By mutating the amino acids 
(a.a.) around the first two glycosylation sites, and introducing this 
mutated BAC into the Ren-1 knockout animals, the contribution of these 
sites can be determined. If granulation is restored, then obviously these 
glycosylation sites are not important. However, if granulation is not 
restored, then it indicates that the glycosylation of renin-1 is involved in 
targeting the protein to the granules. 
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8.2 Site directed mutagenesis by PCR 
It was proposed to mutate the first two glycOsylation sites by PCR and 
to introduce these mutations into Ren-1" within N10 using the BAC 
targeting strategy. The two glycosylation sites are separated by 1.2Kb, the 
first site being located in exon II, and the second in exon [V. A three step 
PCR strategy was devised, involving PCR primers which span the 
glycosylation sites (Figure 8.2). The initial step involved generating three 
PCR products which overlap the glycosylation sites by 21 or 18bp. The first 
PCR product, (primers JJM-280-281)  is 634bp which consists of intron A 
sequences and the glycosylation site in exon II. The second PCR product 
(primers JJM-286-287) is 1,200bp, which contains both sites, and the 
intervening sequences, whilst the third product (JJM-288-289), is 350bp 
and contains the second site and intron D sequences. The second round of 
PCR involved using the first and second PCR products as templates, and 
the two outermost primers (JIM 280-287). The two primers will bind to 
their respective templates and generate single strands. As the PCR 
reaction cycles the two products will anneal at the overlapping sequences 
and the PCR primer will be able to generate a single PCR product from the 
two templates. The third step involves using the third PCR product 
generated from the first round with that generated in the second, using 
the outer two primers (JJM-280-289). This PCR reaction generates the 
whole product since the PCR templates can anneal at the overlapping 
sequences. This 2.2Kb PCR fragment will then be ligated into the suicide 
vector and used to target the BAC clone by intermolecular recombination. 
8.2.1 Generating the recombination fragment 
Three pairs of PCR primers were designed from the Ren-1' genomic, 
and the Ren-2 cDNA sequences, (see Table 8.1 and Figure 8.3), to make the 
a.a. around the glycosylation site of Ren-1", like those in Ren-2. The 
primers were also designed to introduce a novel restriction enzyme site 
into the exons, to allow identification of the mutations. 
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Figure 8.2 The three step PCR strategy to mutate the first two glycosylation 
sites of Ren-1 
Shows the organisation of Ren-1 and the location of the N-linked glycosylation sites. In 
addition the PCR primers (bold), the overlap (shown in red), the base changes (in blue), the 
restriction sites introduced (in green), and the size of the PCR products are also shown. 
The first two PCR products are joined by using the two fragments as templates for the 
second round of PCR with primers JJm-280 and JJm-287. 
The third fragment is joined in the same way, using the outermost primers JJM-280 and 
JJM-289. 
The final product displaying the mutated sites in exons II and IV. 
A 	BC 	D E 	FGH 
A 	1 	 I 	I 	I I 	I II 	• 
I llfflN V VIVIIVI1X 
BglII 	 KpnI 
I 	 U Muni 
ATC AAT CTT ACC AAC CCC TCC 
I 	N 	L 




BamHI 	 634bp 
350bp... 	 M289 
1 
CGCAAGGAACTATCTAGAATAGA AATGGAGACGACTTCACCATC 
1,200bp JJM288 JJM-281 	2 
CTTCTrGATAIGATCFTATCTCC ATGTACcTCrFAICCTCTGCTcA 















BamHI 	B 111 	K nI 	BsmBI 
D 	 BgJII 	Hi9dIII MynI 
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Figure 8.3 The mutations introduced into Ren1d. 







Tie Asn Leu - Thr Ser 
ACT-GAT-CTT-ATC-TCC 
Thr Asp Leu Tie Ser 
ATA-GAT-CTT-ATC-TCC 
The adenme and cytosine were changed to guanine and thymine respectively, to 
make the a.a. Ren-2 like, whilst the cytosine was changed to adenine introducing a 
silent mutation, and generating a BglII site 
Site mutations introduced into exon IV 
Ren-1 d  sequence 	GAG-AAc-GG-IcC-GAC 
(a.a. 138-142) 	 Glu Asn Gly Ser Asp 
Ren-2 sequence GAG-AAT-GGA-GAC-GAC 
(a.a. 138-142) 	 Glu Asn Gly Asp Asp 
Mutated sequence 	GAG-AAT-GGA-GAC-GAC 
The thymine and cytosine were changed to guanine and adenine to make the a.a. 
Ren-2 like, and the cytosine and guanine to thymine and adenine as silent mutations, 
to introduce a BsmBI site 
Table 8.1 The PCR primer pairs with the specific product expected. 
Primer pair - 	 - 	 Sequence PCR 
product 
intron A-exon II Forward primer Fl (JJM-280) 
TAGGATCCTFGGGCACATATCA (Tm 58.4 °C) 634bp 
Reverse primer Ri (JJM-281) 
AGATAAGATCTATCAAGGAAGGC (Tm 57.1°C)  
exon Il-exon IV Forward primer F2 (JJM-286) 
CTFCC1TGATAGATCTFATCTCC (Tm 57.1°C) 1,200bp 
Reverse primer R2 (JJM-287) 
AGTCGTCTCCATFCTCCATGTA (Tm 58.4°C)  
exon IV-intron Forward primer F3 (JJM-288) 
D GGAGAATGGAGACGACITCAC (Tm 59.8°C) 365bp 
Reverse primer R4 (JJM-289) 
CTCCAAACCTGGTCTCAATFAG (Tm 58.4°C)  
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PCR conditions 
Each PCR primer pair was tested to identify the optimal temperature 
for the generation of a single specific product. These experiments used 
Taq polymerase (Promega), with the reaction mix as described in Table 7.2. 
The annealing temperatures used ranged from 4°C below the 
manufacturers calculated Tm, increasing by 1°C until 2°C above the stated 
Tm. 
Table 8.2 PCR reaction mix used for optimising reaction conditions 




Primer # 1 (30j.tM) 0.25 
Primer # 2 (30M) 0.25 
dNTP's (lOnM) 0.5 
lOx buffer (-MgC12) 2.5 
M902 (25mM) 1.75 
Taq (5UIitl) 0.16 
dH2O 19.09 
The PCR reagents were split into two master mixes. The first 
contained the primers, M902  and dNTPs, whilst mix 2 contained the 
enzyme buffer and enzyme, (the water was split between the two). The 
25p1 reactions were prepared on ice, covered with 30pi of mineral oil, and 
placed in the Hybaid Omnigene Thermal Cycler, using the following 
program:- 
94°C 2 minutes 1 cycle 
94°C 10 seconds 
54-59°C 30 seconds 30 cycles 
68°C 2 minutes 
68°C 10 minutes 1 cycle 
Each sample was analysed by gel electrophoresis (see Figure 8.4). The first 
product, PCR# 1 was generated at all temperatures and was specific. PCR# 
2 was only amplified at 54°C and only slightly at 55°C, whilst product 3 
was not amplified at any temperature, including 52°C. 
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Figure 8.4 Optimising the temperature for PCR products 1,2 and 3. 
lane 1, pR2IRES/3-Geo digested with BamHI; lanes 2-8, PCR1; lanes 9-15, PCR2; and lanes 
16-22, PCR3. 
The first track represents the water control; the second - seventh increased annealing 
temperatures from 54°C-59°C. 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 2122 
1.2Kb 
634bp. 
PCR# 3 was further optimised by varying the MgC1 2 concentration from 
1mM to 3mM, since Taq polymerase is inactive in the absence of adequate 
free Magnesium. Eight reactions were set up, increasing the magnesium 
concentration by 0.3mM, with an annealing temperature of 54°C. 
However still no product was observed. 
Qiagen have a 'Q reagent, which they supply with their polymerase 
enzyme. The Q reagent is supposed to help amplify difficult products. 
Five microliters of the Q reagent was added to a 25jil reaction, using an 
annealing temperature of 54°C, but still no product was observed. The 
two primers were scrutinised for secondary structure. 
The exon IV forward primer, JJM-288, was found to have a hairpin 
structure involving the 3' end, and so an additional primer was 
purchased, (see Figure 8.5). However, since this exon IV primer includes 
the mismatches, it can only be changed by a couple of base pairs. 
Figure 8.5 The secondary structure of JJM-288 
/ A-G-G-T-A-A-G-A-G-G 5 
C 	 I I I 	I 
A-C-G-A-C-T- T-C-A-C 3 
JJM-298- AATGGAGACGACTTCACCATC (Tm 57.9°C) 
There is still secondary structure, but the 3' end is not free 
JJM-298 has a 13 base overlap with the exon IV reverse primer, 
which is adequate to generate the contig. JJM-289 and JJM-298 were used 
to determine the optimum annealing temperature, ranging from 54°C to 
59°C, with the same reaction conditions as before. Five microliters of the 
PCR products were analysed on an agarose gel, all of which showed a 
specific product of 350bp (see Figure 8.6.) for all temperatures. 
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Figure 8.6 Successful amplification of PCR3 at all temperatures. 
lanes 1,3,5 and 7 represent the water control for each reaction; lane2, 54°C; lane 4, 56°C; 
lane 6, 58CC; lane 8, 59°C. 
1 	23 	4 	5 	6 	78 
350hp 
nucleotid€ 
Figure 8.7 The generation of PCR4 and its characterisation. 
Sml of each PCR reaction: lane 1 and 2, PCR4; lane 3, P1251 all showing a 1.9Kb band, as 
well as a smaller none specific band. 
B gill digest of the three PCR products. lane 1 and 2, PCR4; lane 3, P1251 all displaying 
the same bands, indicating that the PCR product is derived from P1251. 
1 	2 	3 
	1.9 	1 	2 	3 
LI 1.5 
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Generating the contig 
The 4th product was to be generated by using PCR products 1 and 2 
with primers .JJM-280 and JJM-287. PCR produts 1 and 2 were purified 
before use, using the PCR clean up kit from Boehringer Mannhein (see 
section 2.2.1.9), and diltued 1:10 with TE. One microlitre of each template 
was added to each PCR reaction, with the following annealing 
temperatures 55°C, 57°C and 59°C, using the same reagent mix as before, 
and P1251 as a positive control. The products were analysed by gel 
electrophoresis and indicated a band of the correct size, 1.9Kb. These PCR 
products were then purified with the PCR clean-up kit and digested with 
BglII, since the mutations in exon II introduced BglII site. PCR #4 would 
have a doublet of 300bp and another band of 1.3Kb, whilst P1251 has a 
single 300bp and a 1.6Kb product. All lanes had a 1.6Kb product indicating 
that the mutations had not been introduced, and that the amplified 
product had arisen from P1251 and not from PCR# 1 or 2 (see Figure 8.7a 
for the PCR product and 8.7b for the BglII digest). 
These results indicated that the P1 template was not removed by the 
PCR clean-up kit. Subsequently PCR fragments were purified by gel 
elution, using Gene Clean (section 2.2.1.8). The eluted products were 
resuspended in SOjfl with, 0.5j.il, lj.tl, 2i1 and 4il used per PCR reaction. 
Annealing temperatures of 55°C, 56°C and 57°C were used, and the 
products analysed on an agarose gel, but still no product was observed. It 
was believed that the two PCR products were not annealing and so it was 
decided that the PCR products should be cloned, and ligated together to 
create the recombination fragment. 
8.2.2 Cloning the PCR products 
PCR products 1, 2 and 3 were subcloned into the pCR2.1 cloning 
vector (Invitrogen, see section 2.2.1.9). The PCR products were generated 
using Expand1M Long template PCR (see table 7.3), which contains a proof 
reading enzyme, and were directly ligated to the vector. 
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Table 8.3 The reaction conditions for ExpandlM  Long template PCR 
Master Mix 1 Master Mix 2 
Components Quantity (pi) Components Quantity (p.1) 
dNTP's (10mM) 1.75 lOx buffer 1 5 
Primer # 1 0.5 
(30p.M)  
enzyme 0.75 




ExpandTM polymerase adds deoxyadenosine residues onto the ends of 
the PCR products. pCR2.1 vector is obtained linearised, with compatible 
deoxythymidine residues on the ends, so that the PCR product is easily 
ligated with the vector directly from the PCR reaction (Chapter 2 Figure 
2.6). The ligations were set up as described in Table 8.4, to give a 1:1 and a 
1:3 ratio of vector to PCR product. The ligation mix was transformed into 
TOP10F' competent cells, and then plated onto fresh L-agar plates 
containing IPTG and X-gal, and incubated overnight at 37°C. White 
colonies indicated the presence of an insert. 
Table 8.4 The ligation reactions for the three PCR products into the 
nCR2I vector 
Components PCR #1 (634bp) PCR #2 (1.2Kb) PCR #3 (350bp) 
1:1 ratio 1:3 ratio 1:1 ratio 1:3 ratio 1:1 ratio 1:3 ratio 
PCR product ijil 3 p1 1.5 p1 3 p1 1 p.1 3 p.1 
lOx ligation 1 p.1 1 p.1 
buffer  
1 p.1 1 p.! 1 p.1 1 p.1 
vector 2 p.1 2 p.1 2 p.1 2 p.1 2 p.1 2 p.1 
dH20 5 p.1 3 p.1 4.5 p.1 3 p.1 5 p.1 3 p.1 
ligase 1 p.1 1 p.1 191  191 191  191  
Ten white colonies from each ligation were prepared using the 
PlasmidPURE mini prep kit (Sigma; see section 2.2.1.5), and analysed by 
restriction digestion, to orientate the insert within the vector. pCR1 and 2 
were digested with BglII, pCR2 and 3 with BsmBI, and pCR3 with ApaI, 
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(see Figure 8.8). The digests indicated that the mutations had been 
introduced as designed. 
Direct subcloning and religation of these plasmids inserts failed to 
produce the required recombination fragment. Therefore the plasmids 
were used as PCR templates, since their presence would not adversely 
affect subsequent reactions. Three sets of PCR reactions were set up, using 
pCR1, 2 and 3 as the template, ExpandTM polymerase for fidelity of 
sequence and the annealing temperatures stated in Table 7.6. 
Table 8.6 The primers used to generate the PCR products and the 
annealing temperatures. 
Reaction Primers PCR product annealing temp 
PCR # 1 JJM-280/JJM-281 634 bp 56°C 
PCR #2 JJM-286/JJM-287 1,200 bp 54°C 
PCR #3 JJM-298/JJM-289 365 bp 56°C 
PCR #4 JJM-286/flM-289 1,500 bp 54°C 
PCR #5 JJM-280/JJM-289 1 	2,134 bp 56°C 
PCR # 1,2 and 3 were successfully generated. PCR # 4 was generated 
by mixing PCR# 2 and 3 (purified away from the primers by utilising the 
PCR clean-up kit), with primers JJM-286 and JJM-289 using an annealing 
temperature of 54°C. The quantity of template added to the reactions was 
ljtl of a 1:10 dilution, lp.l, 2j.tl or 4p.l of the purified product. Five 
microlitres of the PCR product was analysed on an agarose gel and the rest 
purified and digested with BsmBI, Hindlil and KpnI, to determine 
whether the correct product had been amplified (see Figure 8.9). The 
results show that a specific product of 1.5Kb, which contained the expected 
restriction enyzme sites, had been amplified. BsmBI did not cut the PCR 
product, probably due to high salt inhibiting the reaction. 
PCR 5 was generated from PCR products 1 and 4 using primers JJM-
280 and JJM-289, and an annealing temperature of 56°C. The PCR products 
were analysed on an agarose gel, cleaned-up and digested with, BsmBI, 
B gill and Hindlil, to ensure the correct product had been amplified 
(Figure 8.10). 
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Figure 8.8 Analysing the colonies obtained from ligating the three PCR 
products into the pCR2.1 vector 
BsrnBI digest: lanes 2-11, ten colonies from pCR 2; lanes 12-21, ten colonies from 
pCR3, lanes 6,7,and 11, have incorporated the primer JJM-281. 
BglII digest: lanes 2-11, ten colonies from pCR1; lanes 12-21, ten colonies from pCR2 
BglII/MunI digest of pCR3 to orientate the insert 
Marker track is pRen2IRES/3-Geo digested with BamHI. 
I 	2 	3 	4 	5 	6 	7 	8 	9 	10 	11 
C 3138bp O69bp 
lS2bp 
093bp 
Table 8.5 The fragment sizes expected from the three pCR clones 
BsinBI BglII BglII/MunI 
pCR1 305bp 	305bp 
1277bp 	959bp 
2592bp2910bp  
pCR2 5204bp 2271bp 	957bp 
2933bp 	4247bp  
pCR3 4251bp 1093bp 	1182bp 
3158bp 	3069bp 
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Figure 8.9 Characterising the PCR 4 product 
shows the correct sized band 1,550bp lanes 1-5, annealing temperature of 54°C; lanes 6-
10, annealing temperature of 56°C. 
First track liii  of a 1:10 dilution of each template; second, 1tl of each (undiluted); third, 2tl 
of each; forth 'ipi of each; fifth water control 
Analytical digests of the products from lanes 1 and 6 (from A), lanes 1 and 4, BsrnBI; 
lanes 2 and 5, HindIll; lanes 3 and 6, KpnI. All which indicate the correct product. 
1 2 3 4 5 6 7 8 9 10 
A 
1 ,550bp 
B 	12 	4 	6 
Figure 8.10 Characterising the PCR 5 product 
The 2.,184bp product lanes 1-5, annealing temperature 54°C; lanes 6-10, annealing 
temperatu,re 56°C 
First track water control; second, ipi 1;10 dilution of each PCR product; third lj.il of the 
undiluted PCR product; forth, 2pi ; fith, 4j.tl. 
analytical digests. lane 1 and 4, BsrnBI; lanes 2 and 5, BglII, lanes 3 and 6, HindIll. 
1 2 3 4 5 6 7 8 9 10 
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The results indicated that the strategy to introduce the mutations by 
PCR, was successful and PCR 5 was subcloned into the pCR2.1 vector. The 
ligation conditions can be seen in Table 8.8. 
Table 8.7 Ligation conditions for introducing PCR#5 into the pCR2.1 
vector. 
Components 1:1 ratio 1:3 ratio 
vector 2tl 2 .tl 
PCR product 1 p1 3 p1 
lOx ligase buffer 1 p1 1 p1 
ligase 1 p1 141 
dH20 5p1 3i1 
Ten white colonies from the ligations were prepared and the 
plasmids isolated with the PlasmidPURE mini-prep kit. The plasmids 
were analysed by BsmBI and BglII digestion (see Figure 8.11). PCR# 5 was 
successfully cloned into the pCR2.1 vector (some of the plasmids obtained 
had inserted PCR # 4 as determined by the single BglII restriction site; 
lanes 8, 10 and 11). pCR5 was cleaved by BsmBI suggesting that previous 
undigestion was due to salt sensitivity. The exons of the PCR product 
were sequenced before the recombination fragment was ligated into the 
suicide vector, to ensure that no other mutations had been introduced. 
Six sequencing primers were used, designed using the published Ren-1' 
sequence (129). The ABI 377 Automatic sequencer was utilised, and the 
reactions set up with 400ng of plasmid DNA, 3.2pmoles of each primer, 
an annealing temperature of 50°C and an elongation temperature of 60°C, 
as advised by Davy Fettes (Edinburgh University). The primers used and 
their location can be seen in Table 8.8, and Figure 8.12. 
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Figure 8.11 Identification of pCR5 by restriction analysis. 
BglIl digest, pCR5 has three sites, fragment sizes depend upon the orientation within the 
vector. 
BsmBI digest, a single BsniBI site is present in pCR5 and will generate a 6.3Kb fragment. 
The plasmids in lanes 7,8 and 10, probably represents PCR4 template DNA. 
Marker track is pRen2IRES/3—Geo, digested with BamHI. 
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Table 8.8 The sequencing primers used to ensure only the desired 
mutations had been introduced into exons II and IV 
Primer Sequence 
Exon 11(F) GGCAACATCTGGGCTCTGTC 
Exon II (R) GTGCTCTTTGGCTCTCAGTC 
Exon Ill (F) AGAGCCGAGAAGGGGTCCAG 
Exon III (R) TGAGGAGAAGCAGGTCATAG 
Exon IV (F) CTTCTATGTAAATCAATCTC 
Exon IV (R) I GGCTGGAGTATACCTGTCTG 
Figure 8.12 The positioning of the sequencing primers 
Fil 	Fill 	F1V 
EEl10  
R11 	RiiI 	R1V 
Sequence data from three pCR5 plasmids using the six primers 
indicated that only those modifications introduced via the PCR primers 
were present in the recombination fragment (see Figure 8.13). 
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Figure 8.13 Sequence data obtained from three pCR5 plasmids 
First line, Ren-id genomic sequence; second to forth, sequence obtained from three clones 
















































8.2.3 Introducing the recombination fragment into pSV1.rec6O 
The recombination fragment could not be directly ligated into the 
suicide vector since it lacked the appropriate restriction sites. Instead 
PCR# 5 was cleaved from the vector, utilising the EcoRI sites which flank 
the PCR product, and ligated into the unique EcoRE site in pSP72.poly2. 
The vector was dephosphorylated, before ligation to prevent vector re-
ligation, and electroporated into the E. coli strain DH5a (see section 
2.2.1.9). Ten colonies were grown up and the plasmids isolated using the 
PlasmidPURE kit, and analysed with Hindill, since there is a single 
recognition site located within the insert. 
pSP-PCR5 was subsequently cleaved with Sail and AscI to cut either 
side of the insert, and PvuI to cut the vector sequences in half. This 
fragment was separated on an agarose gel and eluted using Gene clean 
(section 2.2.1.8). The fragment was ligated to the suicide vector, also 
cleaved with AscI/SaiI, electroporated into DH10B cells, and incubated at 
30°C overnight. The resulting colonies were analysed for the insert by 
colony lift, using the exon II oligo JJM-216, as a probe. Several colonies 
were identified, and one of these was prepared using triton lysis 
purification (section 2.2.1.5). The plasmid pSVgly was analysed with 
various restriction enzymes which confirmed the presence of the insert. 
8.3 Introducing the mutations into N10 
Ten nanograms of the suicide vector were electroporated into 
DH10B electrocompetent cells carrying BAC N10 and lOOjil (diluted 
1:1000) was plated onto agar plates containing Cm and Tet (see section 
2.2.1.1), incubated at 30°C overnight, Of the several hundred colonies 
which grew, 6 were picked into imi L-broth, and 100il spread onto two 
fresh Cm, Tet plates- one incubated at 30°C the other at 43°C overnight. 
The plate grown at 30°C was covered in bacterial colonies, whilst 
only 57 colonies grew at 43°C. Fifty clones cultured in 10mls of fresh L-
broth, containing Cm and Tet, and grown at 43°C overnight. The BAC 
plasmids were isolated from the bacteria by modified alkaline lysis, (see 
section 2.2.1.5) and analysed for the insertion of the suicide vector. Co- 
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integrants were analysed by EcoRI digest, using the exon I probe. The 
expected fragment sizes are displayed in Table 8.9 and the screening 
strategy is depicted in Figures 8.14 and 8.15. 





5' targeted Ren-1" 6.7 
3' targeted Ren-1". 7 
The results indicated that 34 out of the 50 colonies screened had 
correctly integrated the fragment into Ren1d,(whether these were 5' or 3' 
events was not distinguished). Approximately 14 of these were mixed 
clones, i.e. had both a wild type and a targeted clone, (see Figure 8.16). 
Eight of the co-integrants were streaked onto fusaric acid plates containing 
Cm, and were grown at 37°C for two days. Southern blotting was used to 
identify the introduction of the seven mismatches which was expected to 
be a rare event. Fifty colonies were picked from the fusaric acid plate and 
each grown in lml L-broth at 37°C overnight. Ten cultures were then 
pooled and the DNA isolated by the modified alkaline lysis protocol. The 
DNA pellets were resuspended in 20p1, for BglIIIBsmBI digestion, and the 
fragments were separated by gel electrophoresis. The gel was blotted onto 
nylon membrane and probed with the exon II oligo probe (JJM-216), 
which is located 3' to the introduced BglII site (see Figure 8.14). The 
fragment sizes expected were 3Kb, which represented a BglII fragment 
from wild type Ren1d  sequences, a 1.5Kb fragment representing a targeted 
RenTId fragment from the introduced BglII and BsmBI sites, and a Ren-2 
BglII/BsmBI fragment of 1.8Kb. 
222 
Figure 8.14 Diagramatic representation of the co-integration screening 
strategy. 
An EcoRI digest of N10/pSVgly co-integrants is hybridised with the exoni probe (in red), to 
give a Ren-2 band (9.3Kb) and either a wild type Ren-1 band (8.8Kb), or a targeted band 
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Figure 8.15 Analysis of the resolved glycosylation mutants. 
The mutated BAC will have extra Barn HI, Bgl H and BsrnBI sites which can be 
identified by comparing the fragment sizes identified from either an intron C (red) or 
an exon II probe (green).A, wild type Nb. B, NiOglyl. 
The fragment sizes are displayed:B- Barn HI; Bg - Bgl II; Bs - BsrnBI. 
A 	B;lIIt BsmBI 
BamHI I / Bgl 
1.8KbBg/Bs - 
3.OKbBg/Bg - 















0.97Kb BIBs - 
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Figure 8.16 EcoRI screen of 50 N10/pSVgly co-iritegrants hybridised with 
the exon I probe. 
Wild type N10 would generate a doublet of 9.3 and 8.8Kb, whilst a targeted band would 
be observed at around 7Kb. 
34 out of 50 plasmids analysed possessed the targeted bands, however most of these also 
have the wild type bands as well indicating a mixed clone. A 5' or a 3' targeting event 
cannot be resolved on this gel. 
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Figure 8.17 BglII/BsmBI analysis of three hundred and forty 
resolved BAC plasmids for a mutated Ren-1, hybridised to an exonil 
oligo probe. 
Each track represents ten individual colonies. The bands expected are a 3Kb B gill 
fragment representing wild type Ren-1, a 1.5Kb wild typeBgill/BsrnBI fragment 
specific for Ren-2. and a 1.2Kb band representing a BglII/BsrnBI fragment 
representing a targeted Ren- 1. 
No targeted bands are observed. 
1 	2 	3 	4 	5 6 	7 8 	9 10 11 12 13 14 15 16 17 
3.OKI' — 	 -* 0 
1.5M. 
18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 
3.OKI. —f& MV W #a& 	- 	 '- 
1.5Kb - - --- 	 - - 
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Figure 8.18 The analysis of twenty potential N10 mutants, from pools 22 and 
24, hybridised with an intron C probe. 
BglII digest. lanes 1-10, pooi 22; lanes 11-20, pooi 24; lane 21, Nb. Targeted clones will 
have a 3Kb wild type band and a 2.7Kb targeted band. 
BsrnBI/BarnHl digest. lanes 1-10, pooi 22; lanes 11-20, pooi 24; lane 21, N10.wild type 
clones will have a 6.6Kb Ren-1 band and a 0.97Kb Ren-2 band, whilst a targeted Ren-1 will 
have a 1.8kb band. 
The extra band located around 6-7Kb is belived to be the Ren-2 BamHI fragment thought to 
be a result of incomplete digestion by BsmBL The origin of the 4.2Kb band is not known but is 
also present in the N10 track. 
1 	2 3 4 	5 	( 7 	8 	0 10 11 12 11 14 15 16 17 18 10 2P 
3Ki 	 w 
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The Southern blot (Figure 8.16) indicated that BsmBI had not 
efficiently cleaved the BAC mini prep DNA, and that none of the samples 
contained the targeted event. Two samples had a less intense upper band 
compared to the bottom band, which might represent loss of the wild type 
Ren1d band. 
The twenty cultures, corresponding to these two samples were 
individually prepared and cleaved with BglII alone or a BamHI/BsmBI 
double digest. The BglII pattern, obtained with an intron C probe, would 
give a 3Kb wild type Ren-1 or Ren-2 band, and a 2.7Kb targeted Ren-1 
band, whereas the introduced BsmBI and the BamHI site (introduced into 
intron A), would give a 1.8Kb fragment for a targeted Ren-1 compared to a 
6.6Kb wild type BamHI fragment for Ren-1 and a 0.9Kb Ren-2 band (see 
Figure 8.14). This analysis should indicate whether a targeted event is 
present within these twenty clones. The bands identified on the 
autoradiograph indicated that a correctly targeted clone was not present 
(Figures 8.17). The presence of the band around 6Kb was possibly the Ren-
2 BamHI fragment, which had not been cleaved with BsmBI. 
8.4 Conclusions 
It is believed that renin-2 cannot be stored in renin granules since 
the JG cells in the Ren-1 KU animals were devoid of granules. Since the 
lack of potential N-linked glycosylation is the major difference between 
renin-1 and renin-2 it was decided to mutate the glycosylation sites of 
renin-1 to be renin-2 like. Introduction of the mutated renin gene into 
Ren-1 null animals would reveal whether these sites were indeed 
important. 
The glycosylation sites were successfully mutated by a three step PCR 
strategy, which utilises 10-20 nt overlaps to generate a single PCR product 
from two smaller templates. Seven mismatches were introduced, which 
not only made the Ren-1 sequences Ren-2 like but also introduced 
additional restriction sites for subsequent analysis. 
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The recombination fragment was introduced into the suicide vector 
in the unique AscI/SalI sites and electroporated into DH1OB competent 
cells containing BAC N10. Sixty eight percent of the analysed clones had 
integrated the suicide vector into Ren-1, and a small selection of these 
were resolved on fusaric acid. Three hundred and forty clones were 
pooled into groups of ten and analysed for the two additional restriction 
sites. However initial analysis revealed no targeted clones, but did show 
two poois with less intense Ren-1 bands, which might have indicated a 
targeted event. The screening strategy was subtly changed however none 
of these twenty clones showed the expected banding pattern. 
It was anticipated that the required homologous recombination 
event in N10 would be rare. Since the desired plasmid was not identified 
a different screening strategy was devised. The oligos used to generate the 
PCR products could be used as probes, since there are three mis-matches 
in exon II and four in exon IV to detect the resolved clones after colony 
hybridisation. On determination of the wash stringency and temperature 
it would be possible to selectively hybridise the oligo with a targeted 
clone. An alternative strategy is to utilise PCR, to screen multiple bacterial 
colonies for the exon II mutation, with the exon IV mutation identified 
through Southern blotting. However due to time constraints these 
screening strategies have yet to be applied, but they would be expected to 
identify a recombined clone. 
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Chapter 9 -- 
Discussion 
9.1 Introduction 
The aim of this thesis was to tag Ren-1" expressing juxtaglomerular 
cells with a gene encoding for a histochemical marker, since no previous 
attempts had been successful. This was achieved using a transgenic 
approach, utilising large genomic clones, spanning the murine renln 
locus. The /3-Geo reporter gene was inserted into the coding region of 
Ren-1'1  by intermolecular recombination, a technique which allows site 
specific modifications to be introduced within a given gene. The resulting 
BAC clone, N10 Rnl-/3-Geo, was used to generate transgenic mice which 
express J3-Geo in the kidney mimicking the known developmental profile 
of renin. This is the first successful expression of a histochemical marker 
in mouse juxtaglomerular cells. 
9.2 Characterising renin expressing cell lines 
Cell lines are a valuable resource for identifying elements necessary 
for gene expression and trafficking within cells. There are few kidney 
derived renin expressing cell lines available; primary JG cells which are 
the best in vitro model of JG cells are only 80-90% pure, and lose renin 
activity within three weeks of culture; the As 4.1 cell line was derived 
from a kidney tumour, which developed in transgenic animals 
harbouring the SV40 Tag under the transcriptional control of the Ren-2 
promoter, and expresses its endogenous Ren1C  gene. Whether this 
kidney tumour originated from a JG cell is unknown since Tag expression 
has been observed throughout the renal vasculature in the adult mouse 
(424); additionally there is a human embryonic kidney cell line HEK 293, 
which expresses the human renin gene. 
The As 4.1 cell line proved to be difficult to transfect. Previously the 
highest transfection efficiency obtained was < 10%. In this thesis I have 
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described the use of lipid reagents to increase transfection efficiencies to 
17% with small plasmids using the lipid Pfx-3, supplied by Invitrogen, 
though when a plasmid of 17Kb (pRen2IRES/3-Geo) was used transfection 
efficiencies dropped to less than 0.1%. Furthermore no blue cells were 
observed when the BAC clone N10 Rn-l-/3-Geo was transfected, whether 
linear or circular. - 
Since the As 4.1 cell line has lost the ability to respond to external 
stimuli it does not represent an archetypal JG cell. In order to isolate 
conditionally immortal cell lines an explant culture technique was used 
(Katrma Gordon, Roslin Institute, UK). Kidneys from transgenic animals 
expressing the SV40 tsTag in Ren-2 expressing cells were cultured at 33°C 
for Tag expression. After 3 months of continuous culture the cells were 
analysed for renin and Tag expression by growing the cells at 39°C, which 
should shut down lag and stimulate renin expression. Northern and 
Western analyses were unable to detect any renin expression, but RT-PCR 
analysis did indicate Tag expression, whilst a prorenin 
radioimmunoassay (Dr Jorg Peters, Heidleberg) did show that renin was 
stimulated, to various degrees in the different lines. However, a Tag 
negative line was also observed to stimulate renin expression when 
cultured at 39°C which might indicate that primary JG cells were present. 
The number of renin expressing cells in these cultures was very low, 
compared to the positive control As 4.1 (Dr Jorg Peters, Heidleberg; 
personal communication), indicating a need to select for renin expressing 
cells. This was to be achieved by introducing a reporter construct into a 
large genomic clone spanning the renin locus, followed by the generation 
of transgenics. 
9.3 Introducing f3-Geo into Ren-f 
The introduction of a reporter gene mimicking Ren-1'1 expression 
was to be accomplished without affecting the expression of the 
endogenous gene. A gene targeting approach was considered, but even 
using an insertion approach, there was no guarantee that endogenous 
expression would not be affected. A prerequisite for the transgenic 
approach was to utilise genomic clones which might overcome the 
position effects, previously observed with renin transgenes (175, 227, 397). 
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Since Ren-2 is a duplication of Ren-1 it is feasible to assume that elements 
essential for Ren-1 expression might reside 5' of Ren-2. Furthermore 
insulator elements have been located up to 50Kb from the gene they 
regulate (310, 313). Genomic clones with inserts of 100Kb were sought 
which should accommodate both renin genes and extensive flanking 
sequences. 
P1 libraries were screened, but the clones identified were found to be 
either chimeric, having the 5' end of Ren-2 and the 3' end of Ren1d, or 
contained a single renin gene. P1251 was characterised to contain the 
entire Ren-1' gene with 19Kb of 5', and approximately 50Kb of 3' 
sequences. BAC clones were found to be more stable with two clones 
identified to contain both renin genes without rearrangements. One 
clone, Nb, was characterised (by Linda Mulims and Nina Kotelevtseva) 
to have the two genes placed centrally within the 140Kb insert. N10 has 
been used to generate transgenic mice and all transgene positive animals 
expressed the two genes. Expression levels in the SMG were higher than 
observed with any previous transgene construct, though copy number 
dependent expression was not demonstrable in the kidney indicative of 
negative feedback control (Linda Mullins personal communication). 
Molecular cloning is highly inefficient with clones of this size and 
since the renin genes are 97% homologous it would be difficult to 
specifically mutate a single gene. An intermolecular recombination 
approach was designed to introduce modifications into Ren-1' located in 
both P1251 and BAC Nb. 
9.3.1 The linear approach 
The use of intermolecular recombination between a linear fragment 
and the E. coli chromosome has been published by many groups (368-372), 
and was also used to recombine two linear fragments together (379, 380). 
These techniques use a one step, double cross-over recombination event 
between homologous sequences, replacing the genomic copy with the 
mutated one, or used to subclone two fragments together. The feasibility 
of an in vivo recombination approach was assessed by utilising the in 
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vivo cloning technique (380)to introduce the zeocin resistance gene into a 
multicopy plasmid. 
The E. coli strain JC8679 was utilised, with the linear plasmid vector 
and an equimolar quantity of the linear fragment introduced by 
electroporation. Recombinants were selected for by Zeocin' and screened 
for the addition of a unique 152bp Sail fragment. Analysis of the plasmids 
obtained indicated that this technique was reproducible and that a similar 
technique could be attempted to recombine a linear fragment and a 
circular P1 /BAC clone. 
Before the linear approach could be utilised, several changes had to 
be made. A different E. coli strain was required, since P1 clones were 
neither efficiently maintained, nor stable in JC8679. Two strains 
designated, DH1OBrecA+, (Professor Bloom, Cold Spring Harbour, USA) 
and DH1OBrecA+,recD- (Dr Sternberg), which are derivatives of DH10B 
were obtained. The recD mutation gives the same phenotype as the recBC, 
sbc mutations, inactivating exoV and being hyper-recombinogenic. The 
two strains were phenotyped for the presence of the .recD mutation by the 
appropriate phage test and were both shown to be able to participate in 
intermolecular recombination with small plasmids. The DH1 OBrecA + 
strain was used for subsequent experiments, since the DH1OBrecA+,recD-
strain gave very sticky colonies suggesting a mutation within a 
membrane protein. 
The reporter to be introduced into Ren-1 was f3-Geo since it would 
give blue stained JG cells. The IRES element, isolated from the 
encephalomyocarditis virus, was incorporated to allow independent 
translation of the fusion protein, whilst the zeocin resistance gene 
(confirmed to confer Zeocin resistance when maintained at a single copy) 
was included for selection of recombinants in bacteria. The reporter 
cassette was flanked both 5' and 3' with 4.5 Kb of Ren-id sequence, in 
order to increase the efficiency of the recombination reaction. 
The linear recombination fragment was isolated from the plasmid 
pR1ZIG and co-electroporated with the P1 clone into the E. coli strain 
DH1OBrecA+. Recombinants were selected for by Zeocin resistance. Initial 
experiments generated few Zeocin resistant clones, none of which had 
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generated a recombined P1 plasmid. The linearised fragment was 
subsequently electroporated into cells which already contained P1251. 
However no targeted P1 clones were obtained due to the increased 
presence of clones which had integrated the fragment into the E. coli 
genome, or contained the recombination plasmid. The only observed 
change to the Renid restriction pattern, was due to the transposon, 
Tn1000, which was believed to have been introduced into the P1 clone 
during conjugal transfer from the E. coli strain NS3529, into DH1OB. Since 
the presence of this transposon had not previously been observed it had 
probably moved during the recombination event. 
Subsequent experiments utilised chemical transformation, since 
Bubeck et a! (379) and Oliner et a! (380) only observed recombination, in 
the DH5a E. coli strain when the DNA was introduced by heat shock. 
However neither the P1 nor the BAC showed any recombination. 
Additionally, due to the large number of false positive clones, the method 
by which the recombination fragment was isolated was altered. A Pad 
linker was introduced into the internal XhoI site making it easier to 
isolate the fragment, but to no avail, a decrease in the number of Zeocin 
resistance colonies was observed, but there was still a very high incidence 
of false positive clones to be screened by Southern blotting. The major 
problem associated with this technique was the difficulty in screening 
thousands of colonies for a recombination event. Since any probes used 
would hybridise to false positive clones as well as recombinant clones. 
The inclusion of a negative marker to select against unrecombined 
plasmid sequences was required. 
Numerous approaches were considered including: using X vectors 
defective in lysogeny to introduce the recombination fragment and 
infecting them into bacteria containing the P1 /BAC and the ci repressor. 
Due to mutations carried by the phage recombination would be necessary 
for its maintenance. However a method to remove phage sequences 
would be required; RecA assisted restriction endonuclease (RARE) 
cleavage was another option, although due to the high homology 
between the two genes, the oligos required to protect the restriction 
enzyme sites in Ren1d would most probably have protected Ren-2 as 
well; or utilising suicide vectors, with origins of replication which were 
either temperature sensitive or dependent upon an external factor not 
233 
produced by the bacterium. A temperature sensitive suicide vector 
approach was chosen and a plasmid with a temperature sensitive ori was 
obtained from Dr Phillipe Gabant (Belgium), and was characterised for 
temperature sensitive expression. However at this time the vectors for 
the BAC targeting strategy became available. This strategy involves two 
recombination steps which is not as elegant as the single linear 
recombination method, but productive. 
9.3.2 The BAC targeting strategy 
The BAC targeting strategy utilises a suicide vector with a 
temperature sensitive origin of replication, a tetracycline resistance gene, 
and the E. coil recA gene. The recombination fragment used was altered, 
removing the zeocin resistance cassette and including an optimised IRES 
13-Geo construct with a nuclear localisation signal, and the engraiied splice 
acceptor (to prevent splicing around exons 3 and 4, which had been 
observed in the R1KO animals). The modified recombination fragment 
was introduced into the suicide vector and electroporated into DH10B 
cells containing the Pi/BAC. The cells were then grown at 42°C to 
promote recombination between the suicide vector and the Pi/BAC, 
utilising one of the homology arms, thus generating co-integrants. 
Subsequent growth on fusaric acid induces the loss of suicide vector 
sequences, since fusaric acid is lethal to Tetr bacteria. This second event 
can again occur using either homology arm, to generate either a wild type 
Pi/BAC, or to introduce the desired mutations. Although this technique 
involves two recombination steps, recombinant clones can be identified 
within 2 weeks. 
This technique was successfully used to introduce f3-Geo into the 
coding region of Ren-1' in the P1 clone, P1251, and BAC N10, which 
-• contains both Ren-TI and Ren-2.. Additionally no change in Ren-2 was 
observed, indicating the stability of BAC clones. The BAC, N10Rn-1/3-Geo 
was subsequently linearised, utilising the unique ioxP site located in the 
vector, and used to generate transgenic mice. Initially embryos were 
harvested at day E16.5 and 3-Ga1actosidase activity was found to mimic 
Ren1d expression at this stage. Additional microinjections were 
performed and 5 founder lines were identified. One line, F9687 has had 
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no litters survive, another, F9677, had two integration sites which 
segregated into a low, F9677A, and a high, F9677B, copy line. There was no 
detectable -Galactosidase expression in lines F9583 and F9677A, however 
initial analysis has indicated that the transgene is either incomplete or 
has been rearranged in these two lines. All the other transgene positive 
lines, F9675, F9677B and F9678, showed the correct developmental profile 
and was expressed in the afferent arteriole after 3 weeks of age. 
9.4 Introducing Reñ-2 sequences into Ren-1' 
The successful introduction of a reporter construct into Ren-1'1 , led to 
the application of the BAC targeting strategy to introduce site specific 
mutations into Ren-1', to study the processing of renin-1 to the granules. 
The generation of Ren-1' and Ren-2 null animals allows the relative 
contributions of the individual genes to be assessed. The main difference 
between the two is the lack of renin storage granules in the Ren1d 
knockout animals. This lack of granulation could either be due to renin-2 
being constitutively secreted into the circulation to maintain blood 
- pressure, or because renin-2 cannot participate in renin granule 
formation. Since the major difference between these two proteins is the 
lack of glycosylation in renin-2, it was hypothesised that glycosylation 
plays a role in directing renin-1 to the golgi and hence the granules, 
leaving renin-2 to be constitutively secreted via endoplasmic reticulum 
derived transport vesicles. By utilising the R1KO animals, and 
intermolecular recombination with the BAC clone, we can ask direct 
questions as to the importance of glycosylation in granule formation or 
the contribution of the other amino acid changes identified between the 
two genes. 
One TGMN10 line (3766A) has been crossed with the R1KO animals, 
the progeny of which are expected to have restored granulation in the JG 
cells. The cleanest means by which to detect the precise structures 
involved in targeting renin-1 to the granules, is to introduce defined base 
changes into the BAC. The initial experiment was to identify whether the 
first two glycosylation sites in renin-1 are important for granule 
formation. The modified BAC would then be introduced into the R1K0 
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line, and the JG cells analysed for granulation. If granulation was restored, 
then the glycosylation sites are not important, however if granulation 
was not restored, then the implication is that glycosylation is the sorting 
signal, sending renin-1 to the granules. Additional experiments would 
then include, introducing the glycosylation sites into renin-2, within the 
same BAC to ensure that granulation was restored. 
9.4.1 Site directed mutagenesis by PCR 
The generation of the recombination fragment by PCR, in 
conjunction with the PCR cloning kit, 'was highly successful. The three 
step PCR strategy can be used to introduce several mutations 
simultaneously, although the length of the final product is limited to the 
fidelity of the PCR polymerase used, since sections of the final product 
will have been through 90 PCR cycles. ExpandTM long template polymerase 
includes proof-reading enzymes, and generates high fidelity PCR 
products. However it was necessary to sequence the final product, to 
ensure no other mutations had been introduced. The initial co-
integration event was very efficient, with 34 out of 50 clones containing 
the suicide vector. The identification of a resolved BAC, which had 
incorporated the base changes, was expected to be a rare event. Three 
hundred and forty clones derived from seven independent co-integrants 
were analysed for the presence of the mutations, however none 
contained the desired base changes. 
Due to time constraints the other co-integrants have yet to be 
analysed. However due to the rarity of this event a modified screening 
strategy has been devised for subsequent screenings. Two methods have 
been proposed; colony lifts, using the exon II PCR primer (which contains 
three mutations) as an oligo probe. On determining the wash conditions 
it should be possible to identify mutated BACs; alternatively a PCR 
strategy could be used, utilising exon II sequencing primers and a BglII 
digestion to identify the site introduced into exon II. The exon IV 
mutations and the introduced BsmBI site would have to be screened by 
Southern blotting since BsmBI does not cleave PCR products. Despite the 
fact that a mutated clone has not been identified to date, the BAC 
targeting strategy should be applicable for introducing base changes. 
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9.5 Alternative recombination techniques 
Since the publication of the BAC targeting strategy, another BAC 
modification protocol has been published. Jessen et a! (476) have utilised 
linear recombination using. x  (chi) sequences, to promote recombmation 
using the wild type E. coli recBCD pathway. This technique involves 
electroporation of the BAC clone into a wild type E. coil strain MC1061, 
which is then used to generate chemical competent cells. The 
recombination fragment, includmg a kanamycin resistance gene, to select 
for recombinant clones, is introduced into the vector pRM4-N, in 
between three pairs of correctly oriented X sequences. The linear fragment 
is then cleaved from the ori of replication by NotI digestion, leaving the 
ampicillin resistance gene intact. This fragment is chemically transformed 
into the bacteria containing the BAC plasmid. After an hours incubation 
at 37°C, the cells are harvested and resuspended in lOOixl L-broth and 
plated on to L-agar plates containing Cm and Kan. Colonies are then 
selected by Cm and Kan resistance and screened for the loss of ampicillin 
resistance. This technique was used to introduce green fluorescent protein 
into the Zebrafish GATA-2 gene. Jessen et al calculated that 2.8 gene 
replacements were obtained per transformation. The mutated BAC was 
then used to generate transgenic Zebrafish embryos which expressed GFP, 
in the correct spectrum of tissues. 
This protocol is similar to the linear strategy described in this thesis. 
The recombinants are selected for by Kan resistance and a double 
crossover event by the loss of Amp resistance. However by utilising 
sites mutations in recD, to prevent exoV degradation are not required. 
There are problems associated with this technique since introducing large 
genomic clones into a wild type E. coli strain may induce recombination. 
Additionally by using NotI sequences to remove the ori these sites cannot 
be incorporated into the recombination fragment. 
Another linear approach has been developed by Dr Francis Stuart 
(EMBL labs Heidleberg). This strategy utilises the RecA independent 
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RecET recombination pathway. The recombination fragment is generated 
by PCR and is introduced into a recA- E. coli strain which contains the 
Pi/BAC in addition to an episome which overexpresses recET. This 
technique has been used to mutate P1 plasmids, multicopy plasmids and 
the E. coli chromosome by utilising 50bp of homologous sequence. 
However to date this technique has not been published. Both of these 
strategies are variations of the BAC targeting strategy and can be used to 
introduce deletions or insertions into a given gene, however since these 
strategies select for recombinants they are not suitable for introducing 
point mutations. 
9.6 Future studies 
The TGM N1ORn-1f3-Geo line expresses f3-Geo in the embryo 
throughout development, and in new born pups upto three weeks of age. 
Visualising adult expression is hindered by endogenous —galactosidase 
like activity which sends the whole kidney blue, which is seen despite 
using a higher pH and lower incubation temperature. The use of a 
monoclonal antibody for LacZ would provide the opportunity to observe 
the expression pattern of /3-Geo in the adult. In addition it would be 
necessary to show that the blue staining observed co-localises with renin 
expression. Serial sections taken from frozen kidneys should permit this 
analysis to be performed. Furthermore an enymatic assay for - 
Galactosidase would enable us to see whether -Galactosidase activity 
increases with increasing transgene copy number, and by inducing certain 
phsyiological conditions in the adult it would be possible to show that the 
transgene has all the necessary regulatory elements. 
These animals could be a valuable tool for the isolation of pure 
primary JG cells, and facilitate the visualisation of Ren-1' expressing cells 
in kidney slices, or in vivo for perfusion or electrochemical analysis by 
utilising vital dyes for f3—Galactosidase. Additionally by cross breeding 
these animals with the immorto mouse, there is an opportunity for 
isolating conditionally immortalised Ren-1'1 expressing cell lines. 
Furthermore the BAC, N10 Rn-1J3-Geo, can be used to identify sequences 
involved in site independent expression of the renin locus, by deletion 
analysis and subsequent introduction into appropriate cell lines. 
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The high expression of J3-Geo in the developing kidney intimates 
that the N10Rn1/3-Geo transgenic line could be used to study the role of 
the renin angiotensin system on the developing vasculature during 
kidney development. It could also be used as a tool to study how 
physiological changes within the developing kidney might effect the 
appropriate spatial and temporal expression of renin. 
P1 and BAC clones have been successfully introduced into cell lines, 
via liposomal transfection. However this was not accomplished in the As 
4.1 cell line, where the largest plasmid introduced was 17Kb. There was a 
significant drop in efficiency, from 17% with a 7Kb plasmid, to less than 
0.1% with the 17Kb plasmid. Recent publications have introduced the 
concept of adenovirus mediated transfection. YACs and BACs have been 
introduced into mammalian cells by a psoralen-inactivated adenovirus 
carrier (463, 464). The protocol involves linking the DNA to the carrier 
virus via a condensing polycation, polyethylenimine (PEI), and gives 
transfection efficiencies 2-3 log levels higher than cationic lipid systems. 
The BACs introduced by this method, are intact and show stable 
expression (464). 
The ability to introduce specific modifications into BAC or P1 clones 
spanning the renin locus, presents the opportunity to identify those 
sequences within the renin locus which are important for tissue specific 
expression. Additionally it could be used to confirm the importance of 
elements identified in culture to regulated renin expression, such as the 
cyclic-AMP responsive element and its interactions with the negative 
regulatory element (278, 280, 281), as well as the enhancer element located 
2.6Kb 5' of the Ren-1' promoter (282). 
9.7 Concluding remarks 
The aim of this thesis was to introduce mutations into the renin 
locus by intermolecular recombination. The initial technique to introduce 
the f3-Geo reporter gene into Ren-1'1 , utilised a single linear 
recombination event. However, experimental results indicated a need for 
negative selection which was corroborated with the publication of the 
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BAC targeting strategy, and the linear strategy using X sequences. The 
BAC targeting strategy was successfully used to introduce /3-Geo into Ren-
1d located in the P1 clone P1251 and additionally to specifically target Ren-
1d in the BAC clone N10 which contained both Ren-1' and Ren-2. 
Although yet to be confirmed, the BAC targeting strategy might also be 
utilised to introduce base changes, and deletions into a given clone. 
The TGM Rn-i f3-Geo lines generated, should not only facilitate the 
isolation of renin expressing cells, but may also be utilised to identify the 
insulator elements involved in site independent expression of the renin 
genes. The high expression in the kidney during development indicates 
that these animals could be used to study the effects of the renin 
angiotensin system on vascular development. The results of this thesis 
have justified the use of large genomic clones as a means to direct 
reporter gene expression to a given cell type, and has generated a valuable 
tool for isolating pure JG cell populations. 
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